<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61171</article-id><article-id pub-id-type="doi">10.7554/eLife.61171</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-199551"><name><surname>Atkins</surname><given-names>Alisa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-199552"><name><surname>Xu</surname><given-names>Michelle J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199553"><name><surname>Li</surname><given-names>Maggie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1047-1554</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199554"><name><surname>Rogers</surname><given-names>Nathaniel P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0411-5249</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-199555"><name><surname>Pryzhkova</surname><given-names>Marina V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3462-5768</contrib-id><email>mpryzhk1@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-186092"><name><surname>Jordan</surname><given-names>Philip W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4890-2647</contrib-id><email>pjordan8@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Biochemistry and Molecular Biology Department, Johns Hopkins University Bloomberg School of Public Health</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e61171</elocation-id><history><date date-type="received" iso-8601-date="2020-07-16"><day>16</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-11-16"><day>16</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Atkins et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Atkins et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61171-v2.pdf"/><abstract><p>Mutations of SMC5/6 components cause developmental defects, including primary microcephaly. To model neurodevelopmental defects, we engineered a mouse wherein <italic>Smc5</italic> is conditionally knocked out (cKO) in the developing neocortex. <italic>Smc5</italic> cKO mice exhibited neurodevelopmental defects due to neural progenitor cell (NPC) apoptosis, which led to reduction in cortical layer neurons. <italic>Smc5</italic> cKO NPCs formed DNA bridges during mitosis and underwent chromosome missegregation. SMC5/6 depletion triggers a CHEK2-p53 DNA damage response, as concomitant deletion of the <italic>Trp53</italic> tumor suppressor or <italic>Chek2</italic> DNA damage checkpoint kinase rescued <italic>Smc5</italic> cKO neurodevelopmental defects. Further assessment using <italic>Smc5</italic> cKO and auxin-inducible degron systems demonstrated that absence of SMC5/6 leads to DNA replication stress at late-replicating regions such as pericentromeric heterochromatin. In summary, SMC5/6 is important for completion of DNA replication prior to entering mitosis, which ensures accurate chromosome segregation. Thus, SMC5/6 functions are critical in highly proliferative stem cells during organism development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>structural maintenance of chromosomes</kwd><kwd>SMC5/6</kwd><kwd>neurogenesis</kwd><kwd>DNA replication</kwd><kwd>DNA damage</kwd><kwd>microcephaly</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM11755</award-id><principal-award-recipient><name><surname>Jordan</surname><given-names>Philip W</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21OD023720</award-id><principal-award-recipient><name><surname>Jordan</surname><given-names>Philip W</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R03NS106486</award-id><principal-award-recipient><name><surname>Jordan</surname><given-names>Philip W</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007880</institution-id><institution>Johns Hopkins University</institution></institution-wrap></funding-source><award-id>Catalyst Award</award-id><principal-award-recipient><name><surname>Jordan</surname><given-names>Philip W</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>T32CA009110</award-id><principal-award-recipient><name><surname>Xu</surname><given-names>Michelle J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The structural maintenance of chromosomes complex, SMC5/6, is crucial for brain development and function as it ensures proficient DNA replication in neural progenitor cells prior to chromosome segregation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Preservation of genomic integrity is crucial for normal organism development and homeostasis. Structural maintenance of chromosomes (SMC) complexes (cohesin, condensin, and SMC5/6) function as guardians of chromosome architecture and genomic stability (<xref ref-type="bibr" rid="bib39">Hagstrom and Meyer, 2003</xref>; <xref ref-type="bibr" rid="bib58">Kschonsak and Haering, 2015</xref>; <xref ref-type="bibr" rid="bib65">Lehmann, 2005</xref>; <xref ref-type="bibr" rid="bib108">Remeseiro and Losada, 2013</xref>; <xref ref-type="bibr" rid="bib131">Uhlmann, 2016</xref>). During DNA replication, newly synthesized sister chromatid DNA is held together by cohesin (<xref ref-type="bibr" rid="bib85">Morales and Losada, 2018</xref>). Removal of cohesin is essential for mediating chromosome segregation (<xref ref-type="bibr" rid="bib10">Batty and Gerlich, 2019</xref>). Condensin complexes are required for ordered compaction of chromatin to facilitate the formation of condensed chromosomes prior to chromosome segregation (<xref ref-type="bibr" rid="bib42">Hirano, 2016</xref>; <xref ref-type="bibr" rid="bib54">Kagami and Yoshida, 2016</xref>). SMC5/6 is the least characterized of the three SMC classes, but studies in yeast and mammalian cell lines have demonstrated that the complex is important for response to DNA replication stall/block, mediating DNA repair, and ensuring accurate chromosome segregation (<xref ref-type="bibr" rid="bib5">Aragón, 2018</xref>; <xref ref-type="bibr" rid="bib135">Verver et al., 2016</xref>).</p><p>The SMC5/6 complex is composed of a heterodimer of SMC5 and SMC6, which interact at their central hinge domains. SMC5 and SMC6 harbor long coiled coil domains emanating from both sides of the hinge domain that fold back on each other to form an ATPase at the juxtaposed C and N termini (<xref ref-type="bibr" rid="bib41">Hassler et al., 2018</xref>). The ATPase head/tail domains of SMC5 and SMC6 are bridged by NSMCE4A (non-SMC element 4A), a kleisin protein. NSMCE4A interacts with NSMCE1, an E3 ubiquitin ligase, and NSMCE3, a MAGE (melanoma-associated antigen gene) domain-containing protein (<xref ref-type="bibr" rid="bib94">Palecek et al., 2006</xref>; <xref ref-type="bibr" rid="bib97">Pebernard et al., 2008a</xref>). Additionally, the SMC5/6 complex comprises an E3 SUMO ligase, NSMCE2, which interacts with a region of the coiled coil domain of SMC5 (<xref ref-type="bibr" rid="bib4">Andrews et al., 2005</xref>; <xref ref-type="bibr" rid="bib143">Zhao and Blobel, 2005</xref>). Two additional proteins, SLF1 and SLF2 (SMC5/6 localization factors), form a dimer that primarily interacts with the SMC5/6 complex during DNA repair in response to DNA lesions that block DNA replication (<xref ref-type="bibr" rid="bib107">Räschle et al., 2015</xref>). SLF2 binds to the arms of SMC5 and SMC6 and may lock the arms together to immobilize SMC5/6 at sites of DNA damage (<xref ref-type="bibr" rid="bib1">Adamus et al., 2020</xref>; <xref ref-type="bibr" rid="bib107">Räschle et al., 2015</xref>).</p><p>Mutations within genes encoding SMC complex components are associated with human developmental defects. Collectively known as cohesinopathies, mutations in cohesin components lead to an array of abnormalities, including growth retardation and cognitive impairment (<xref ref-type="bibr" rid="bib17">Boyle et al., 2015</xref>; <xref ref-type="bibr" rid="bib101">Piché et al., 2019</xref>). Mutations in condensin components lead to primary microcephaly due to chromosome decatenation failure during mitosis (<xref ref-type="bibr" rid="bib74">Martin et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Nishide and Hirano, 2014</xref>). In regard to SMC5/6, mutations in <italic>NSMCE3</italic> result in immunodeficiency and lung disease, where patient-derived cells exhibit hallmarks of chromosome instability and replication stress (<xref ref-type="bibr" rid="bib132">van der Crabben et al., 2016</xref>). Moreover, mutation of <italic>NSMCE2</italic> causes primordial dwarfism and primary congenital microcephaly (<xref ref-type="bibr" rid="bib96">Payne et al., 2014</xref>). Assessment of patient cells harboring the <italic>NSMCE2</italic> mutation revealed chromosome instability and increased sensitivity to DNA replication stress (<xref ref-type="bibr" rid="bib96">Payne et al., 2014</xref>). Thus, the microcephaly is likely the consequence of neural progenitor cell (NPC) depletion due to compromised genomic integrity. Furthermore, genetic variations in other components of the SMC5/6 complex, including <italic>SMC5</italic>, are potentially associated with congenital defects including heart and neurodevelopmental anomalies (<xref ref-type="bibr" rid="bib43">Homsy et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Jin et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Landrum et al., 2018</xref>).</p><p>Despite the relevance of SMC5/6 mutations to human health, in vivo studies in mammalian models remain limited. One study found that conditional knockout (cKO) of <italic>Nsmce2</italic> in mice during adulthood causes premature aging and susceptibility to cancer (<xref ref-type="bibr" rid="bib48">Jacome et al., 2015</xref>). Analysis of cell cultures from mice with <italic>Nsmce2</italic> mutation revealed increased formation of micronuclei and sister chromatid exchange events (<xref ref-type="bibr" rid="bib48">Jacome et al., 2015</xref>). Two other studies have focused on using <italic>Smc5</italic> cKO to address the sexually dimorphic roles of SMC5/6 during gametogenesis, wherein SMC5/6 is largely dispensable for spermatogenesis but is essential for mediating chromosome segregation during oogenesis (<xref ref-type="bibr" rid="bib46">Hwang et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>). Null mutations of SMC5/6 components in mice result in a failure to reach blastocyst stage (<xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Jacome et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Ju et al., 2013</xref>). Thus, the roles of SMC5/6 during later stages of embryonic development have not been assessed. Because of the link between SMC5/6 perturbation and neurodevelopmental disorders in humans (<xref ref-type="bibr" rid="bib43">Homsy et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Jin et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Landrum et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Payne et al., 2014</xref>), we modeled the consequences of SMC5/6 depletion by conditionally mutating <italic>Smc5</italic> in the developing neocortex of mice.</p><p>Development of the cerebral cortex is a remarkably complex process that relies on the capacity of NPCs to undergo a series of coordinated cell division, migration, and differentiation steps. NPCs reside in the ventricular zone (VZ) of the cerebral cortex and undergo symmetric and asymmetric divisions to self-renew and produce intermediate progenitors (IPs) or neurons. IPs are mainly located in the subventricular zone (SVZ) (<xref ref-type="bibr" rid="bib57">Kowalczyk et al., 2009</xref>; <xref ref-type="bibr" rid="bib95">Paridaen and Huttner, 2014</xref>). During embryonic development, apical NPCs and IPs divide to produce neurons, which then migrate in the process of cortical lamination. This migration occurs in an inside-out manner, in which early-born neurons give rise to deep cortical layers (V and VI) and late-born neurons form superficial layers (II–IV) (<xref ref-type="bibr" rid="bib83">Molyneaux et al., 2007</xref>; <xref ref-type="bibr" rid="bib95">Paridaen and Huttner, 2014</xref>; <xref ref-type="bibr" rid="bib122">Shibata et al., 2015</xref>). Disruption of NPC genomic integrity during embryonic development causes increased NPC apoptosis, reduced neuron production, and neuron mislocalization, ultimately resulting in decreased cortex size or microcephaly (<xref ref-type="bibr" rid="bib75">McKinnon, 2013</xref>). The rapid proliferative activity of NPCs imparts a high degree of endogenous replication stress and DNA damage, which can lead to the formation of excess single-stranded DNA (ssDNA) and double-strand breaks (DSBs) (<xref ref-type="bibr" rid="bib40">Harley et al., 2016</xref>; <xref ref-type="bibr" rid="bib63">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">McKinnon, 2017</xref>; <xref ref-type="bibr" rid="bib91">O'Driscoll, 2017</xref>; <xref ref-type="bibr" rid="bib109">Reynolds et al., 2017</xref>). The failure to complete DNA repair and resolve replication intermediates may contribute to chromosome segregation errors and p53-mediated apoptosis (<xref ref-type="bibr" rid="bib71">Mankouri et al., 2013</xref>; <xref ref-type="bibr" rid="bib110">Rodrigue et al., 2013</xref>).</p><p>The DNA damage response (DDR) is a first line of defense against insults to genome integrity in the nervous system. ATM and ATR kinases play independent and essential roles in DDR, and their loss can lead to neurodevelopmental disorders and neurodegeneration (<xref ref-type="bibr" rid="bib25">Enriquez-Rios et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Madabhushi et al., 2014</xref>). ATM can be activated by DSBs in both NPCs and immature neurons, while ATR is responsible for G2/M checkpoint induced by RPA-bound ssDNA during replication stress in proliferating NPCs (<xref ref-type="bibr" rid="bib25">Enriquez-Rios et al., 2017</xref>). Both kinases can initiate either DNA repair or cell apoptosis. DNA DSB repair by homology-directed repair (HDR) is prevalent in mitotically active NPCs, and non-homologous end joining becomes the pathway for DNA repair in postmitotic neurons (<xref ref-type="bibr" rid="bib25">Enriquez-Rios et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Madabhushi et al., 2014</xref>). ATR and ATM act through their respective downstream targets CHEK1 and CHEK2 to activate p53-mediated cell cycle arrest or apoptosis if DNA damage remains unrepaired (<xref ref-type="bibr" rid="bib120">Sengupta and Harris, 2005</xref>; <xref ref-type="bibr" rid="bib121">Shaltiel et al., 2015</xref>).</p><p>In this study, we show that depletion of SMC5 at early stages of mouse brain development resulted in reduced cerebral cortex size due to mitotic abnormalities in NPCs, perturbed differentiation, and increased apoptosis, which collectively affected cortical layer formation. We observed that SMC5 depletion leads to genome instability and DDR activation. We found that the cortex size of <italic>Smc5</italic> cKO mice was restored upon knockout of <italic>Trp53</italic> or <italic>Chek2</italic> genes. Subsequently, using an auxin-inducible degron (AID) system to deplete SMC5 in mouse embryonic stem cells (mESCs) we mimicked cell proliferation and cell death phenotypes observed in vivo, which were also rescued by inhibition of p53 or CHEK2. Using the AID system, we determined that SMC5/6 is important for DNA replication fork stability and propose a role for SMC5/6 in the processing of under-replicated DNA intermediates to ensure accurate chromosome segregation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Smc5</italic> cKO causes neurodevelopmental and sensorimotor defects due to aberrant chromosome segregation and apoptosis of NPCs</title><p>To model the consequences of SMC5/6 depletion during neurodevelopment, we used mice harboring a <italic>Smc5</italic> cKO allele (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Exon 4 of the <italic>Smc5</italic> cKO allele was flanked by <italic>loxP</italic> Cre recombinase target sequences. Depletion of SMC5 via <italic>Smc5</italic> cKO has been shown to destabilize the entire SMC5/6 complex (<xref ref-type="bibr" rid="bib29">Gaddipati et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Hwang et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). We employed two different Cre recombinase transgenes driven by tissue-specific promoters <italic>Nestin-Cre</italic> and <italic>Emx1-Cre. Nestin-Cre</italic> is expressed throughout the central nervous system (<xref ref-type="bibr" rid="bib23">Dubois et al., 2006</xref>). <italic>Emx1-Cre</italic> expression is restricted to the mouse cerebral cortex (<xref ref-type="bibr" rid="bib36">Gorski et al., 2002</xref>). <italic>Nestin-Cre</italic> and <italic>Emx1-Cre</italic> recombinases demonstrate robust expression in the mouse cortex at E12.5, and the use of either one to mediate <italic>Smc5</italic> cKO was expected to result in a similar phenotype during cortex development (<xref ref-type="bibr" rid="bib47">Insolera et al., 2014</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Smc5</italic> conditional knockout (cKO) causes disruption of genomic integrity and apoptosis of neural progenitor cells (NPCs).</title><p>(<bold>A</bold>) The scheme of mouse <italic>Smc5</italic> floxed allele and Cre recombinase-mediated exon four excision. Arrows with numbers above represent genotyping primers (see Materials and methods). (<bold>B</bold>) PCR genotyping of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 tissues. Abbreviations: wt, wild type; flox, floxed allele; del, deletion. (<bold>C</bold>) Western blot analysis of SMC5 and SMC6 protein expression in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 tissues. β-actin was used as a loading control (n = 3). (<bold>D</bold>) Representative images of cleaved caspase 3 (CASP3) (red) staining in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 sagittal brain sections; DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>E</bold>) Quantification of CASP3+ cells within 300 µm columns in brain sections related to (<bold>D</bold>). Data represent mean ± S.E.M. (control animals n = 3, <italic>Smc5</italic> cKO animals n = 3; see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>F</bold>) Representative images of TUNEL+ nuclei (red) in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 coronal brain sections; DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>G</bold>) Quantification of the number of TUNEL+ nuclei within 800 µm columns in brain sections related to (<bold>F</bold>). Data represent mean ± S.E.M. (control animals: n = 3, <italic>Smc5</italic> cKO animals: n = 3; see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>H</bold>) Representative images of normal and abnormal mitotic E16.5 NPCs in anaphase, stained with an antibody against phospho-histone H3Ser10 (H3P) (red); DAPI (blue). Scale bar: 5 µm. (<bold>I</bold>) Quantification of percentage of normal and abnormal mitotic E16.5 NPCs in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) brain sections. Data represent weighted mean ± weighted S.D. (control anaphase cells n = 85 from three animals, <italic>Smc5</italic> cKO anaphase cells n = 79 from three animals, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Pearson's chi-squared test with Yates’ continuity correction, ****p&lt;0.0001. (<bold>J</bold>) Images of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) P1 brains. Metric ruler is provided for scale. (<bold>K</bold>) Quantification of control (n = 8) and <italic>Smc5</italic> cKO (n = 16) (<italic>Nestin-Cre</italic>) P0/1 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>L</bold>) Images of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) P56 brains. Metric ruler is provided for scale. (<bold>M</bold>) Quantification of control (n = 11) and <italic>Smc5</italic> cKO (n = 6) (<italic>Nestin-Cre</italic>) P56-59 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, ***p=0.0002. (<bold>N</bold>) Images of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) P56 brains. Metric ruler is provided for scale. (<bold>O</bold>) Quantification of control (n = 11) and <italic>Smc5</italic> cKO (n = 8) (<italic>Emx1-Cre</italic>) P55-56 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Evaluation of SMC5 depletion phenotype in embryonic cortices.</title><p>(<bold>A</bold>) PCR genotyping of <italic>Smc5</italic> conditional knockout (cKO; <italic>Nestin-Cre</italic>) E13.5 tissues. Abbreviations: wt, wild type; flox, floxed allele; del, deletion. (<bold>B</bold>) Western blot analysis of SMC5 and SMC6 protein expression in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E13.5 tissues. β-actin was used as a loading control (n = 2). (<bold>C</bold>) Representative cleaved caspase 3 (CASP3) staining of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E13.5 sagittal brain sections; DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>D</bold>) Quantification of CASP3+ cells within 300 µm in brain sections related to (<bold>C</bold>). Data represent mean ± S.E.M. (control animals n = 2, <italic>Smc5</italic> cKO animals n = 2; see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>E</bold>) Representative images of TUNEL+ nuclei (red) in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E13.5 sagittal brain sections; DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>F</bold>) Quantification of the number of TUNEL+ nuclei within 300 µm columns in the ventricular zone (VZ) in brain sections related to (<bold>E</bold>). Data represent mean ± S.E.M. (control animals n = 3; <italic>Smc5</italic> cKO animals n = 2; see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ns, not significant, p=0.0540. (<bold>G</bold>) Representative images of normal and abnormal mitotic E13.5 NPCs in anaphase, stained with an antibody against phospho-histone H3Ser10 (H3P) (red); DAPI (blue). Scale bar: 5 µm. (<bold>H</bold>) Quantification of percentage of normal and abnormal mitotic E13.5 NPCs in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) brain sections. Data represent weighted mean ± weighted S.D. (control anaphase cells n = 191 from two animals, <italic>Smc5</italic> cKO anaphase cells n = 126 from two animals, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Pearson's chi-squared test with Yates’ continuity correction, **p=0.0020. (<bold>I</bold>) Representative images of normal and abnormal mitotic E16.5 NPCs in anaphase (related to <xref ref-type="fig" rid="fig1">Figure 1H</xref>), stained with an antibody against phospho-histone H3Ser10 (H3P) (red); DAPI (blue). Scale bar: 5 µm. (<bold>J</bold>) Quantification of the cleavage plane orientation (defined as the angle between the cleavage plane and VZ surface) of E16.5 apical progenitors from control (n = 85 from three animals) and <italic>Smc5</italic> cKO (n = 82 from four animals) brain sections (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Pearson's chi-squared test with Yates’ continuity correction, *p=0.0124. Each filled circle represents one normal (blue) or abnormal (pink) anaphase (top panel). Representative images of apical progenitors in anaphase in E16.5 cortices. Anaphase cells are outlined by dashed lines, and cleavage plane is indicated by arrow. Scale bar: 5 µm (bottom panel).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title><italic>Smc5</italic> conditional knockout (cKO) results in reduced cortex and brain size.</title><p>(<bold>A</bold>) Images of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) P1 brains with outlined cortical area in control (blue) and <italic>Smc5</italic> cKO (red). Metric ruler is provided for scale. (<bold>B</bold>) Quantification of the cortical area in control (n = 4) and <italic>Smc5</italic> cKO (n = 4) (<italic>Nestin-Cre)</italic> P0/1 brains. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, *p=0.0286. (<bold>C</bold>) Brain images (top panel) and hematoxylin and eosin (H and E) staining of sagittal brain sections (bottom panel) of control and Smc5 cKO (Nestin-Cre) P55 mice. Scale bar: 100 μm. (<bold>D</bold>) Representative H and E staining of coronal sections from three brain regions of control (n = 2) and Smc5 cKO (n = 2) (Nestin-Cre) P56 mice. Scale bar: 1000 µm. (<bold>E</bold>) Images of control and Smc5 cKO (Emx1-Cre) P1 brains with outlined cortical area in control (blue) and Smc5 cKO (red). Metric ruler is used for scale. (<bold>F</bold>) Quantification of the cortical area in control (n = 14) and Smc5 cKO (n = 6) (Emx1-Cre) P0/1 brains. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>G</bold>) Quantification of the brain weight in control (n = 23) and Smc5 cKO (n = 15) (Emx1-Cre) P0/1 brains. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, *p=0.0188. (<bold>H</bold>) Images of control and Smc5 cKO (Emx1-Cre) P56 brains with outlined cortical area in control (blue) and Smc5 cKO (red). Metric ruler is provided for scale. (<bold>I</bold>) Quantification of the cortical area in control (n = 5) and Smc5 cKO (n = 7) (Emx1-Cre) P55-56 brains. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, **p=0.0025. (<bold>J</bold>) Images of control (P300) and Smc5 cKO (Emx1-Cre) (P283) brains. Metric ruler is provided for scale. (<bold>K</bold>) Quantification of the cortical area in control (n = 12) and Smc5 cKO (n = 11) (Emx1-Cre) P278-344 brains. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>L</bold>) Quantification of control (n = 12) and Smc5 cKO (n = 11) (Emx1-Cre) P278-344 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Reduced brain size in <italic>Smc5</italic> conditional knockout (cKO; <italic>Nestin-Cre</italic>) mice affects sensorimotor activity.</title><p>(<bold>A</bold>) Adhesive patch test. Quantification of the adhesive contact time of control (n = 2) and <italic>Smc5</italic> cKO (n = 2) (<italic>Nestin-Cre</italic>) male mice. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ***p=0.0002. (<bold>B</bold>) Inverted screen test. Quantification of the time control (n = 2) and <italic>Smc5</italic> cKO (n = 2) (<italic>Nestin-Cre</italic>) female mice held onto the screen once it was inverted. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ***p=0.0004. (<bold>C</bold>) Cylinder test. Quantification of the ratio of rears with no paws touching the cylinder wall to the total number of rears of control (n = 4) and <italic>Smc5</italic> cKO (n = 4) (<italic>Nestin-Cre</italic>) male and female mice. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ***p=0.0002. (<bold>D</bold>) Cylinder test. Quantification of the ratio of rears with two paws touching the cylinder wall to the total number of rears of control (n = 4) and <italic>Smc5</italic> cKO (n = 4) (<italic>Nestin-Cre</italic>) male and female mice. Data represent mean ± S.E.M., unpaired two-tailed Mann–Whitney test, ***p=0.0003. (<bold>E</bold>) Images of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) P295 brains. Metric ruler is provided for scale. (<bold>F</bold>) Representative H and E-stained control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre)</italic> P295 coronal brain sections. Scale bar: 1000 µm. (<bold>G</bold>) Quantification of the cortical thickness in P293/295 brains of control (n = 2) and <italic>Smc5</italic> cKO (n = 2) (<italic>Nestin-Cre</italic>) mice, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, **p=0.0037. (<bold>H</bold>) Quantification of control (n = 4) and <italic>Smc5</italic> cKO (n = 4) (<italic>Nestin-Cre</italic>) P293/295 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, *p=0.0286.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig1-figsupp3-v2.tif"/></fig></fig-group><p>First, we evaluated the efficiency and associated phenotype of <italic>Nestin-Cre</italic>-mediated <italic>Smc5</italic> cKO and depletion of SMC5 protein in E13.5 and E16.5 embryos (<xref ref-type="fig" rid="fig1">Figure 1A–G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Although we observed conditional mutation of <italic>Smc5</italic> in E13.5 brains, the protein levels of SMC5 and SMC6 were only partially diminished (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). In contrast, the deletion in <italic>Smc5</italic> was accompanied by a substantial reduction in SMC5 and SMC6 protein levels in E16.5 embryos (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). Since Nestin is expressed in progenitor cells of tissues other than neural, some degree of DNA excision was also observed in kidneys and muscles in our samples (<xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib12">Bernal and Arranz, 2018</xref>; <xref ref-type="bibr" rid="bib113">Sakairi et al., 2007</xref>). SMC5 depletion in the developing mouse cortex resulted in a significant increase in cleaved caspase 3 (CASP3)-positive cells in <italic>Smc5</italic> cKO compared to controls in both E13.5 and E16.5 cortices (<xref ref-type="fig" rid="fig1">Figure 1D,E</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C,D</xref>). The increase in the number of cells undergoing apoptotic DNA fragmentation was most pronounced in E16.5 cortices (<xref ref-type="fig" rid="fig1">Figure 1F,G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E,F</xref>).</p><p>We have previously shown that the depletion of SMC5 in mESCs causes chromosome segregation defects during mitosis (<xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). Thus, we analyzed VZ and SVZ mitotic progenitors in cortical sections of E13.5 and E16.5 embryos in detail (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G–I</xref>). The percentage of NPCs undergoing abnormal mitosis with characteristic DNA bridges and lagging chromosomes at anaphase was elevated in <italic>Smc5</italic> cKO compared to control (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G–I</xref>). We observed an increase in abnormal anaphase cells when comparing <italic>Smc5</italic> cKO cortices from E13.5 to E16.5 (9% versus 38%, respectively; <xref ref-type="fig" rid="fig1">Figure 1I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>).</p><p>NPCs residing at the VZ apical surface undergo two modes of cell division, symmetric for self-renewal and asymmetric for differentiation (<xref ref-type="bibr" rid="bib60">Lancaster and Knoblich, 2012</xref>; <xref ref-type="bibr" rid="bib123">Shitamukai and Matsuzaki, 2012</xref>). It has been shown that NPC mitotic spindle orientation determines the positioning of two daughter cells and, thus, cell fate (<xref ref-type="bibr" rid="bib60">Lancaster and Knoblich, 2012</xref>). During normal cortical development, cleavage plane orientation is close to vertical relative to the VZ surface (60–90°). Disruption of mitotic spindle positioning can cause imbalance in IP and neuron production, which can affect cerebral cortex expansion (<xref ref-type="bibr" rid="bib60">Lancaster and Knoblich, 2012</xref>; <xref ref-type="bibr" rid="bib123">Shitamukai and Matsuzaki, 2012</xref>). Thus, we analyzed cleavage plane orientation in apical mitotic NPCs of control and <italic>Smc5</italic> cKO cortices at E16.5. Depletion of SMC5 in NPCs caused a significant increase in the number of anaphase cells with oblique division axis (&lt;60°) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>).</p><p>Our observations demonstrate that SMC5 depletion in NPCs results in the disruption of genomic integrity, abnormal mitosis, and cell death (<xref ref-type="fig" rid="fig1">Figure 1D–I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–J</xref>). Elimination of NPCs during neurodevelopment can cause decreased cortex size and lead to microcephaly (<xref ref-type="bibr" rid="bib47">Insolera et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib73">Marthiens et al., 2013</xref>; <xref ref-type="bibr" rid="bib74">Martin et al., 2016</xref>; <xref ref-type="bibr" rid="bib86">Mullegama et al., 2017</xref>). Therefore, we investigated the <italic>Smc5</italic> cKO phenotype in newborn and adult brains. Tissue-specific depletion of SMC5 did not affect overall embryonic development and mice survived to adulthood without additional morphological abnormalities. The difference in brain weight and cortex size in <italic>Smc5</italic> cKO mediated by <italic>Nestin-Cre</italic> was significant at postnatal day 0/1 (P0/1) and became more prominent in adults (P55) (<xref ref-type="fig" rid="fig1">Figure 1J–M</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–D</xref>). <italic>Emx1-Cre</italic>-mediated <italic>Smc5</italic> cKO also led to reduced brain weight and cortex size in newborn and adult mice compared to littermate controls (<xref ref-type="fig" rid="fig1">Figure 1N,O</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E–L</xref>).</p><p>Reduced mammalian cortex size can significantly affect behavioral performance (<xref ref-type="bibr" rid="bib66">Leingärtner et al., 2007</xref>). To investigate if smaller cortex size affected sensorimotor activity in <italic>Smc5</italic> cKO mice, we performed three longitudinal sensorimotor assays (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–D</xref>). The adhesive patch test allows for objective evaluation of sensory and motor activity, which is commonly used as an assessment following brain injury (<xref ref-type="bibr" rid="bib16">Bouet et al., 2009</xref>; <xref ref-type="bibr" rid="bib27">Fleming et al., 2013</xref>). This test consists of applying an adhesive patch on the mouse hind paw, and recording time spent to sense and remove the adhesive (<xref ref-type="bibr" rid="bib16">Bouet et al., 2009</xref>). We observed a significant delay in the time taken to contact the adhesive in <italic>Smc5</italic> cKO mice compared to control mice, which is evidence of impaired sensory activity (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). The inverted screen test measures the time spent upside down on the wire mesh screen and is indicative of muscle strength in all four limbs and brain motor activity (<xref ref-type="bibr" rid="bib21">Deacon, 2013</xref>; <xref ref-type="bibr" rid="bib38">Grady et al., 2006</xref>). <italic>Smc5</italic> cKO mice underperformed in this test compared to control mice (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). The cylinder test allows for evaluation of exploratory behavior in a new environment, when mice rear and use their forelimbs against glass cylinder walls to support the body (<xref ref-type="bibr" rid="bib27">Fleming et al., 2013</xref>; <xref ref-type="bibr" rid="bib69">Magno et al., 2019</xref>). <italic>Smc5</italic> cKO mice displayed less forelimb use during vertical exploration compared to controls, as demonstrated by the elevated ratio of rears with no paws touching the cylinder wall and the reduced ratio of rears with two paws touching the cylinder wall (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C,D</xref>). Collectively, these behavioral tests revealed that the reduced cortex size mediated by SMC5 depletion results in impaired sensorimotor function in mice. Following conclusion of the sensorimotor assays, the aged adult (P293/295) <italic>Smc5</italic> cKO brains were assessed and showed reduced cortex size and thickness, as well as decreased brain weight, compared to the control mice (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E–H</xref>).</p></sec><sec id="s2-2"><title>Apoptosis of NPCs in <italic>Smc5</italic> cKO mice is mediated by p53 and CHEK2</title><p>We previously showed that <italic>Smc5</italic> cKO mouse embryonic fibroblasts (MEFs) accumulate RAD51 foci in the presence of replicative stress (<xref ref-type="bibr" rid="bib29">Gaddipati et al., 2019</xref>). RAD51 nucleoprotein filament formation at stalled replication forks and on damaged DNA is critical for fork reversal and homology search and repair, respectively (<xref ref-type="bibr" rid="bib106">Quinet et al., 2017</xref>; <xref ref-type="bibr" rid="bib128">Sullivan and Bernstein, 2018</xref>; <xref ref-type="bibr" rid="bib140">Wright et al., 2018</xref>). As NPCs are highly proliferative and have elevated propensity for endogenous replication stress and DNA damage, we assessed RAD51 levels during neurodevelopment (<xref ref-type="bibr" rid="bib40">Harley et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">McKinnon, 2017</xref>; <xref ref-type="bibr" rid="bib91">O'Driscoll, 2017</xref>; <xref ref-type="bibr" rid="bib109">Reynolds et al., 2017</xref>). Analysis of E16.5 embryonic tissues revealed upregulation of RAD51 in the neural cortex of <italic>Smc5</italic> cKO mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). DDR is controlled by ATM and ATR kinases, and in cases when DNA repair is not possible, these kinases activate p53 apoptotic signaling (<xref ref-type="bibr" rid="bib25">Enriquez-Rios et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Maréchal and Zou, 2013</xref>; <xref ref-type="bibr" rid="bib120">Sengupta and Harris, 2005</xref>). We have previously demonstrated that p53 is upregulated and activated in MEFs and mESCs following <italic>Smc5</italic> cKO (<xref ref-type="bibr" rid="bib29">Gaddipati et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). Similarly, we observe p53 activation in the progenitor zone of E16.5 <italic>Smc5</italic> cKO cortices (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Therefore, we explored whether knockout of <italic>Trp53</italic> in the mouse cortex can alleviate the <italic>Smc5</italic> cKO phenotype. Brain weight was not affected in mice that were <italic>Trp</italic>53 KO alone (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). The analysis of <italic>Smc5</italic>, <italic>Trp53</italic> double knockout (dKO) adult mice revealed that the brain weight, cortex area, and cortical thickness size were comparable to littermate controls (<xref ref-type="fig" rid="fig2">Figure 2B–E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). However, significant differences were observed compared to <italic>Smc5</italic> cKO mouse brain parameters (<xref ref-type="fig" rid="fig2">Figure 2B–E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). These data confirm that <italic>Smc5</italic> cKO in the mouse brain causes a p53-dependent apoptosis of neural cells.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Apoptosis of neural progenitor cells in <italic>Smc5</italic> conditional knockout (cKO) mice is mediated by p53 and CHEK2 pathways.</title><p>(<bold>A</bold>) Western blot analysis of RAD51 levels in control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 tissues. β-actin was used as a loading control (n = 2). (<bold>B</bold>) Representative hematoxylin and eosin-stained control; <italic>Smc5</italic> cKO; <italic>Smc5, Trp53</italic> double knockout (dKO); and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre)</italic> P55 coronal brain sections. Red line represents cortical thickness of <italic>Smc5</italic> cKO. Scale bar: 1000 µm. (<bold>C</bold>) Quantification of cortical thickness (mm) in control (n = 3); <italic>Smc5</italic> cKO (n = 4); <italic>Smc5, Trp53</italic> dKO (n = 4); and <italic>Smc5, Chek2</italic> dKO (n = 4) (<italic>Emx1-Cre</italic>) P54-57 brains. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>D</bold>) Quantification of control (n = 13); <italic>Smc5</italic> cKO (n = 12); <italic>Smc5, Trp53</italic> dKO (n = 6); <italic>Smc5, Chek2</italic> dKO (n = 5); and <italic>Smc5, 53</italic> bp1 dKO (n = 4) (<italic>Emx1-Cre</italic>) P55-57 brain weight. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>E–G</bold>) Representative images of (<bold>E</bold>) control; <italic>Smc5</italic> cKO; and <italic>Smc5, Trp53</italic> dKO; (<bold>F</bold>) control; <italic>Smc5</italic> cKO; and <italic>Smc5 Chek2</italic> dKO; and (<bold>G</bold>) control; <italic>Smc5, Trp53bp1</italic> dKO; and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) P55 brains. Metric ruler is provided for scale. (<bold>H</bold>) Representative images of TUNEL+ nuclei (red) in control; <italic>Smc5</italic> cKO; <italic>Smc5, Trp53</italic> dKO; and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre</italic>) P0/1 sagittal brain sections prepared from heads; DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>I</bold>) Quantification of the number of TUNEL+ nuclei within 800 µm columns in brain sections related to (<bold>H</bold>). Data represent mean ± S.E.M. (control animals n = 2; <italic>Smc5</italic> cKO animals n = 2; <italic>Smc5, Trp53</italic> dKO animals n = 2; <italic>Smc5, Chek2</italic> dKO animals n = 2). Unpaired two-tailed Mann–Whitney test, p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cortical size in <italic>Smc5</italic> conditional knockout (cKO) mice can be restored by inhibition of p53 and CHEK2 pathways.</title><p>(<bold>A</bold>) Quantification of the relative RAD51 protein levels from <xref ref-type="fig" rid="fig2">Figure 2A</xref> in E16.5 control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre)</italic> cortices. RAD51 protein levels were normalized to β-actin. Data represent unpaired two-tailed Student’s t-test, **p=0.0078 (n = 2). (<bold>B</bold>) Images of sagittal E16.5 cortical sections of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) mice stained for acetyl-p53 (red) and DAPI (blue). Scale bar: 500 µm. (<bold>C</bold>) Quantification of control (n = 5), <italic>Trp53</italic> KO (n = 5), and <italic>Chek2</italic> KO (n = 5) (<italic>Emx1-Cre</italic>) P55-57 brain weight. Data represent mean ± S.E.M. Difference is not significant. All p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>D</bold>) Quantification of the cortical area in control (n = 13); <italic>Smc5</italic> cKO (n = 12); <italic>Smc5, Trp53</italic> dKO (n = 6); <italic>Smc5, Chek2</italic> dKO (n = 5); and <italic>Smc5, Trp53bp1</italic> dKO (n = 4) (<italic>Emx1-Cre</italic>) P55-57 brains. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>E</bold>) Representative H and E staining of control; <italic>Smc5</italic> cKO; <italic>Smc5, Trp53</italic> dKO and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre</italic>) P1 sagittal head sections. Scale bar: 1000 µm. (<bold>F</bold>) Quantification of the cortical thickness in P0/1 heads of control (n = 4), <italic>Smc5</italic> cKO (n = 4), <italic>Smc5, Trp53</italic> dKO (n = 4), and <italic>Smc5, Chek2</italic> dKO (n = 4) (<italic>Emx1-Cre</italic>) mice, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>G</bold>) Representative images of TUNEL+ nuclei (red) in control; <italic>Smc5</italic> cKO; <italic>Smc5, Trp53</italic> dKO and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre</italic>) P0/1 sagittal cortex sections prepared from heads, related to figure (2H); DAPI (blue). Scale bar: 500 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Studies in <italic>Drosophila</italic>, budding yeast, and fission yeast have implied that aberrancies in SMC5/6 complex functions can result in the upregulation of a CHEK2 kinase-mediated DDR (<xref ref-type="bibr" rid="bib3">Ampatzidou et al., 2006</xref>; <xref ref-type="bibr" rid="bib98">Pebernard et al., 2008b</xref>; <xref ref-type="bibr" rid="bib129">Torres-Rosell et al., 2005</xref>; <xref ref-type="bibr" rid="bib130">Tran et al., 2016</xref>; <xref ref-type="bibr" rid="bib139">Winczura et al., 2019</xref>). We reasoned that if NPC apoptosis in <italic>Smc5</italic> cKO brain is mediated by CHEK2 signaling pathway, <italic>Chek2</italic> knockout would rescue the reduced cortex size in <italic>Smc5</italic> cKO mice. Indeed, adult <italic>Smc5</italic>, <italic>Chek2</italic> dKO mouse brain weight, cortical thickness, and cortex area were significantly larger than <italic>Smc5</italic> cKO mice (<xref ref-type="fig" rid="fig2">Figure 2B–D,F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). However, the brain weight and cortex area were not restored to levels equivalent to the control or <italic>Chek2</italic> KO mice (<xref ref-type="fig" rid="fig2">Figure 2B,D,F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C,D</xref>). This is likely because the p53-dependent apoptosis pathway is functional in <italic>Smc5</italic>, <italic>Chek2</italic> dKO mice, and defects that arise due to <italic>Smc5</italic> mutation still result in a degree of cell death. Taken together, these data suggest that abrogation of SMC5/6 functions results in DNA damage induced by DSBs and p53-mediated apoptosis likely through the ATM-CHEK2-p53 DDR signaling pathway.</p><p>A previous study in budding yeast suggested that the CHEK2 (Rad53) activation observed following SMC5/6 depletion was dependent on p53 binding protein 1 (53BP1) homolog, Rad9 (<xref ref-type="bibr" rid="bib129">Torres-Rosell et al., 2005</xref>). 53BP1 interacts with ATM and plays a role in ATM and CHEK2 activation (<xref ref-type="bibr" rid="bib82">Mirza-Aghazadeh-Attari et al., 2019</xref>). Earlier studies in 53BP1-deficient mice suggested that 53BP1 functions in DDR are regulated by ATM, and 53BP1 acts upstream of CHEK2 (<xref ref-type="bibr" rid="bib138">Ward et al., 2003</xref>). Thus, we analyzed <italic>Smc5</italic>, <italic>Trp53bp1</italic> dKO adult mice and revealed that the brain weight and cortex size were not restored (<xref ref-type="fig" rid="fig2">Figure 2D,G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). These results demonstrate that the loss of SMC5/6 complex functions induces a DDR independent of or epistatic with 53BP1-mediated signaling.</p><p>Next, we investigated if the loss of p53 or CHEK2 can alleviate apoptosis in SMC5-deficient NPCs. In contrast to <italic>Smc5</italic> cKO, increased DNA fragmentation was not evident in <italic>Smc5, Trp53</italic> dKO and <italic>Smc5, Chek2</italic> dKO P0/1 cortices (<xref ref-type="fig" rid="fig2">Figure 2H,I</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). From analysis of P0/1 sagittal head cross-sections, we observed rescue of the cortex thickness defect caused by <italic>Smc5</italic> cKO when <italic>Trp53</italic> or <italic>Chek2</italic> are also mutated (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E,F</xref>).</p></sec><sec id="s2-3"><title>SMC5 loss causes abnormal cortical development</title><p>Congenital microcephaly is often associated with abnormal cortical development due to NPC and cortical layer-specific neuron loss and their ectopic localization (<xref ref-type="bibr" rid="bib47">Insolera et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Jiang and Nardelli, 2016</xref>). Depletion of SMC5 in the developing mouse cortex caused the displacement of apical NPCs marked by SOX2 and PAX6 into the area outside VZ (<xref ref-type="fig" rid="fig3">Figure 3A–F</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>; <xref ref-type="bibr" rid="bib24">Englund et al., 2005</xref>; <xref ref-type="bibr" rid="bib26">Ferri et al., 2004</xref>; <xref ref-type="bibr" rid="bib115">Sansom et al., 2009</xref>). This tendency was even more pronounced in <italic>Smc5, Trp53</italic> dKO and <italic>Smc5, Chek2</italic> dKO cortices (<xref ref-type="fig" rid="fig3">Figure 3A–F</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>). Interestingly, we observed an increase in the total number of SOX2+ and PAX6+ NPCs in both <italic>Smc5</italic>, <italic>Trp53</italic> dKO and <italic>Smc5</italic>, <italic>Chek2</italic> dKO compared to the control (<xref ref-type="fig" rid="fig3">Figure 3A–F</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>). The increase in NPCs and their ectopic localization may be due to a compensatory mechanism in response to the mitotic defects and apoptosis observed in SMC5-depleted NPCs, which may lead to perturbed differentiation (<xref ref-type="bibr" rid="bib30">Gaitanou et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Lakomá et al., 2011</xref>; <xref ref-type="bibr" rid="bib116">Savchenko et al., 2017</xref>). In contrast to apical NPCs, we observed a significant decrease in the number of TBR2+ IPs located in the SVZ of <italic>Smc5</italic> cKO cortices compared to control (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref>; <xref ref-type="bibr" rid="bib8">Arnold et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Englund et al., 2005</xref>). The cortical area occupied by TBR2+ progenitors in <italic>Smc5</italic>, <italic>Trp53</italic> dKO and <italic>Smc5</italic>, <italic>Chek2</italic> dKO cortices was increased compared to the control (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). These results demonstrate that <italic>Smc5</italic> cKO leads to ectopic localization of NPCs and significant loss of IPs. Mutation of <italic>Trp53</italic> or <italic>Chek2</italic> in conjunction with <italic>Smc5</italic> cKO alleviates the loss of IPs but exacerbates NPC ectopic localization.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>SMC5 loss causes abnormal cortical development.</title><p>Representative immunostaining of control; <italic>Smc5</italic> conditional knockout (cKO); <italic>Smc5, Trp53</italic> double knockout (dKO) and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre</italic>) E16.5 sagittal brain sections and quantification for: (<bold>A</bold>) SOX2 (red) (ventricular zone [VZ]), DAPI (blue). Bracket on the right shows extra-VZ (ex-VZ). (<bold>B</bold>) Quantification of SOX2+ cells in 150 µm columns in the VZ and extra-VZ from brain sections related to (<bold>A</bold>). (<bold>C</bold>) Percentage of SOX2+ cells in the VZ and extra-VZ within 150 µm columns in brain sections related to (<bold>A</bold>). (<bold>D</bold>) PAX6 (green) (VZ); DAPI (blue). Bracket on the right shows extra-VZ (ex-VZ). (<bold>E</bold>) Quantification of PAX6+ cells within 150 µm columns in the VZ and extra-VZ in brain sections related to (<bold>D</bold>). (<bold>F</bold>) Percentage of PAX6+ cells in the VZ and extra-VZ within 150 µm columns in brain sections related to (<bold>D</bold>). (<bold>G</bold>) TBR2 (red) (SVZ); DAPI (blue). (<bold>H</bold>) Quantification of TBR2+ cells within 150 µm columns in the SVZ in brain sections related to (<bold>G</bold>). (<bold>I</bold>) Quantification of TBR2-stained area thickness to cortical thickness ratio in brain sections related to (<bold>G</bold>). (<bold>J</bold>) TBR1 (red) (layer VI); DAPI (blue). (<bold>K</bold>) Quantification of TBR1+ cells within 150 µm columns in brain sections related to (<bold>J</bold>). (<bold>L</bold>) Quantification of TBR1-stained area thickness to cortical thickness ratio in brain sections related to (<bold>J</bold>). (<bold>M</bold>) CTIP2 (yellow) (layer V) and SATB2 (red) (layer II-V); DAPI (blue). (<bold>N</bold>) Quantification of CTIP+ cells within 300 µm columns in brain sections related to (<bold>M</bold>). (<bold>O</bold>) Quantification of SATB2+ cells within 300 µm columns in brain sections related to (<bold>M</bold>). For images A, D, G, J, and M column width: 500 µm, scale bar: 100 µm. For all graphs data represent mean ± S.E.M. Control animals n = 3; <italic>Smc5</italic> cKO animals n = 3; <italic>Smc5, Trp53</italic> dKO animals n = 3; <italic>Smc5, Chek2</italic> dKO animals n = 3. For all graphs except C and F p-values were determined using unpaired two-tailed Mann–Whitney test. Pearson's chi-squared test with Yates’ continuity correction was applied to determine p-value for graphs C and F. All p-values are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Representative staining of E16.5 brains for cortical layer markers.</title><p>Images of whole sagittal cortical sections of control; <italic>Smc5</italic> conditional knockout; <italic>Smc5, Trp53</italic> double knockout (dKO), and <italic>Smc5, Chek2</italic> dKO (<italic>Emx1-Cre</italic>) brains stained for (<bold>A</bold>) SOX2 (red), related to <xref ref-type="fig" rid="fig3">Figure 3A</xref>; (<bold>B</bold>) PAX6 (green), related to <xref ref-type="fig" rid="fig3">Figure 3D</xref>; (<bold>C</bold>) TBR2 (red), related to <xref ref-type="fig" rid="fig3">Figure 3G</xref>; (<bold>D</bold>) TBR1 (red), related to <xref ref-type="fig" rid="fig3">Figure 3J</xref>; (<bold>E</bold>) SATB2 (red) and CTIP2 (yellow), related to <xref ref-type="fig" rid="fig3">Figure 3M</xref>. DAPI (blue). Scale bar: 500 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig3-figsupp1-v2.tif"/></fig></fig-group><p>We also investigated whether the lack of SMC5 affects the development of cortical layers. We observed a significant decrease in TBR1+ (layer VI), CTIP2+ (layer V), and SATB2+ (layers II–V) cells in <italic>Smc5</italic> cKO cortices compared to control (<xref ref-type="fig" rid="fig3">Figure 3J–O</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D,E</xref>). Assessment of the <italic>Smc5, Trp53</italic> dKO and <italic>Smc5, Chek2</italic> dKO cortices demonstrated that the development of early- and late-born neuron populations were restored (<xref ref-type="fig" rid="fig3">Figure 3J–O</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D,E</xref>).</p><p>Taken together, SMC5 depletion causes abnormal positioning of apical NPCs and reduction in the populations of IPs, as well as deep and upper cortical layer neurons, suggesting a global impact on cortical development. We also provide evidence that absence of p53 and CHEK2 prevents the loss of IPs and restores cortical layer-specific neuron numbers. These results imply that underlying reasons of affected corticogenesis are likely associated with functionality of apical NPCs. The fact that we do not observe a decrease in apical progenitors despite increased apoptosis in <italic>Smc5</italic> cKO cortices also implies impaired differentiation capability. Self-renewing NPCs have extended S-phase compared to progenitors committed to neuron production and can be subject to increased DNA replication stress (<xref ref-type="bibr" rid="bib6">Arai et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Lavado et al., 2018</xref>). Therefore, we next investigated DNA replication processes following depletion of SMC5.</p></sec><sec id="s2-4"><title>SMC5-deficient NPCs exhibit DNA replication stress</title><p>To investigate whether NPCs accumulated at specific stage of the cell cycle, we quantified proliferative Ki67+ cells, mitotic cells (phospho-histone H3 at serine 10, H3P+) and cells undergoing DNA replication (5-chloro-2'-deoxyuridine incorporation, CldU+) within the E16.5 cortex. <italic>Smc5</italic> cKO cortical sections had 20.2% less Ki67+ proliferating and 35.7% less H3P+ mitotic cells compared to control (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). We evaluated cells undergoing DNA synthesis by performing a 4-hr CldU pulse and analyzing the populations of CldU+ and H3P+ cells (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E,F</xref>). We observed a 34.7% decrease in CldU+ populations in <italic>Smc5</italic> cKO cortices compared to control (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E,F</xref>). The higher level of reduction in CldU+ and H3P+ populations compared to the reduction in total number of Ki67+ proliferating cells in <italic>Smc5</italic> cKO cortices indicates that there is an accumulation of cells in G1 phase of the cell cycle that are blocked from entering S phase (<xref ref-type="fig" rid="fig4">Figure 4B,C,F,G</xref>). The accumulation of cells in G1 phase may be a consequence of the DNA bridges and lagging chromosomes observed in <italic>Smc5</italic> cKO NPCs at anaphase (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>). CHEK2 is the primary checkpoint kinase during G1 phase that mediates p53 stabilization and cell cycle arrest (<xref ref-type="bibr" rid="bib121">Shaltiel et al., 2015</xref>). These observations complement the fact that the <italic>Smc5</italic> cKO microcephaly phenotype is rescued by mutation of <italic>Chek2</italic> or <italic>Trp53</italic> (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>DNA replication stress is a possible reason forSMC5-deficient neural progenitor cell death.</title><p>(<bold>A</bold>) Representative Ki67 (green) and H3P (red) staining of control and <italic>Smc5</italic> conditional knockout (cKO; <italic>Emx1-Cre</italic>) E16.5 sagittal cortical sections, DAPI (blue). Column width: 250 µm, scale bar: 100 µm. (<bold>B</bold>) Quantification of Ki67+ cells within 300 µm columns in brain sections related to (<bold>A</bold>). Data represent mean ± S.E.M. (control animals n = 3, <italic>Smc5</italic> cKO animals n = 3, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, *p=0.0443. (<bold>C</bold>) Quantification of H3P+ cells within 300 μm columns in brain sections related to (<bold>A</bold>). Data represent mean ± S.E.M. (control animals n = 3, <italic>Smc5</italic> cKO animals n = 3, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>D</bold>) Quantification of H3P+Ki67+/Ki67+ cell ratio within 300 μm columns in brain sections related to (<bold>A</bold>). Data represent mean ± S.E.M. (control animals n = 3, <italic>Smc5</italic> cKO animals n = 3, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, *p=0.0130. (<bold>E</bold>) Representative CldU (red) and H3P (green) staining of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) E16.5 sagittal brain sections. Column width 300 µm, scale bar: 100 µm. (<bold>F</bold>) Quantification of CldU+ cells within 300 µm columns in brain sections related to (<bold>E</bold>). Data represent mean ± S.E.M. (control animals n = 2; <italic>Smc5</italic> cKO animals n = 2, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, *p=0.0286. (<bold>G</bold>) Quantification of CldU+H3P+/CldU+ cell ratio within 300 µm columns in brain sections related to (<bold>E</bold>). Data represent mean ± S.E.M. (control animals n = 2; <italic>Smc5</italic> cKO animals n = 2, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ns, not significant. (<bold>H</bold>) Representative images of normal and abnormal anaphase cells from E16.5 <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) cortices stained with CldU (red) and H3P (green). Dashed rectangle outlines CldU+ chromatin bridge. Scale bar: 5 µm. (<bold>I</bold>) Representative FANCD2 (green) and CEN (red) staining of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 cortical cell spreads; DAPI (white). Insets depict magnified individual chromosomes. Scale bar: 5 µm. (<bold>J</bold>) Quantification of average number of FANCD2 foci in cortical cells related to (<bold>I</bold>). Data represent mean ± S.D. (control animals n = 2; control cells n = 21; <italic>Smc5</italic> cKO animals n = 2; <italic>Smc5</italic> cKO cells n = 27). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>K</bold>) Quantification of average number of FANCD2+CEN+ foci in cortical cells related to (<bold>I</bold>). Data represent mean ± S.D. (control animals n = 2; control cells n = 20; <italic>Smc5</italic> cKO animals n = 2; <italic>Smc5</italic> cKO cells n = 27). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>L</bold>) Representative H4K20me (red) and centromere (CEN) (green) staining of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 cortical cell chromosome spreads; DAPI (blue). Insets depict magnified individual chromosomes. Scale bar: 10 µm. (<bold>M</bold>) Quantification of average width of pericentromeric H4K20me signal in cortical cells related to (<bold>L</bold>). Data represent mean ± S.D. (control animals n = 2; control cells n = 32; <italic>Smc5</italic> cKO animals n = 2; <italic>Smc5</italic> cKO cells n = 43). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>N</bold>) Quantification of average intensity of pericentromeric H4K20me signal in cortical cells related to (<bold>L</bold>). Data represent mean ± S.D. (control animals n = 2; control cells n = 32; <italic>Smc5</italic> cKO animals n = 2; <italic>Smc5</italic> cKO cells n = 43). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Representative staining of E16.5 cortices for proliferative cell markers.</title><p>(<bold>A</bold>) Images of whole sagittal cortical sections of control and <italic>Smc5</italic> conditional knockout (cKO; <italic>Emx1-Cre</italic>) mice stained for Ki67 (green), H3P (red), and DAPI (blue) related to <xref ref-type="fig" rid="fig4">Figure 4A</xref>. Scale bar: 500 µm. (<bold>B</bold>) Representative H3P (red) staining of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) sagittal cortical sections, DAPI (blue). Column width: 500 µm, scale bar: 100 µm. (<bold>C</bold>) Quantification of H3P<sup>+</sup> cells in 300 µm columns represented in (<bold>B</bold>). Data represent mean ± S.E.M. (control animals n = 3, <italic>Smc5</italic> cKO animals n = 3, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>D</bold>) Images of whole sagittal cortical sections of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) mice stained for H3P (red), DAPI (blue) related to (<bold>B</bold>). Scale bar: 500 µm. (<bold>E</bold>) Representative images of whole sagittal cortical sections of control and <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) mice stained for CldU (red). Scale bar: 300 µm. (<bold>F</bold>) Quantification of CldU+H3P+ cells within 300 µm columns in brain sections related to Figure 4E. Data represent mean ± S.E.M. (control animals n = 2; <italic>Smc5</italic> cKO animals n = 2, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). Unpaired two-tailed Mann–Whitney test, *p=0.0286. (<bold>G</bold>) Representative images of normal and abnormal anaphase cells from E16.5 <italic>Smc5</italic> cKO (<italic>Emx1-Cre</italic>) cortices stained with CldU (red) and H3P (green). Scale bar: 10 µm. (<bold>H</bold>) Representative H4K20me (red) and centromere (CEN) (green) staining of control and <italic>Smc5</italic> cKO (<italic>Nestin-Cre</italic>) E16.5 cortical cell chromosome spreads; DAPI (blue). Scale bar: 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig4-figsupp1-v2.tif"/></fig></fig-group><p>From our in vivo CldU pulse experiments, we observed NPCs with extensive incorporation of CldU that were undergoing aberrant chromosome segregation (<xref ref-type="fig" rid="fig4">Figure 4H</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>). Further, we observed accumulation of two intensely stained H3P+ chromatin foci on both sides of the segregating chromosomes that also contained CldU (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). However, no CldU signal was observed between either of the two intensely stained H3P+ foci. As we observed NPCs within the <italic>Smc5</italic> cKO cortex with aberrant DNA bridges during anaphase (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>), we postulated that these events may be due to an inability to complete DNA replication prior to chromosome segregation. The detection of ultrafine DNA bridges formed by under-replicated DNA on histological sections is technically challenging, and our data require further support. Thus, we next focused on the analysis of chromosome spreads prepared using cells dissociated from E16.5 cortices.</p><p>Segregation of under-replicated chromosomes is generally coupled with a DNA replication stress response (<xref ref-type="bibr" rid="bib13">Berti and Vindigni, 2016</xref>). Fanconi anemia (FA) components, such as FANCD2, are known to accumulate at sites of DNA replication stress and, particularly, at common fragile sites (<xref ref-type="bibr" rid="bib20">Datta and Brosh Jr., 2019</xref>). Furthermore, late-replicating regions, such as pericentromeric heterochromatin, are additional sites prone to DNA replication stress (<xref ref-type="bibr" rid="bib77">Mendez-Bermudez et al., 2018</xref>; <xref ref-type="bibr" rid="bib114">Saksouk et al., 2015</xref>). Therefore, we assessed FANCD2 signal on chromosome spreads of prometaphase stage NPCs isolated from control and <italic>Smc5</italic> cKO E16.5 cortices. In all chromosome spreads prepared from control and <italic>Smc5</italic> cKO NPCs, we observed a large FANCD2 signal, which likely corresponds to the centrosome, as previously reported for FA proteins, including FANCD2 (<xref ref-type="bibr" rid="bib87">Nalepa et al., 2013</xref>). In addition, we observed increased number of FANCD2+ foci in <italic>Smc5</italic> cKO compared to control cells, particularly at pericentromeric regions (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>). The number of FANCD2+ foci in <italic>Smc5</italic> cKO cells was increased by 6.5-fold compared to control, while pericentromeric FANCD2+ foci were increased by 8.1-fold (<xref ref-type="fig" rid="fig4">Figure 4J,K</xref>).</p><p>We have previously shown that SMC5/6 components accumulate at pericentromeric heterochromatin regions of chromosomes (<xref ref-type="bibr" rid="bib46">Hwang et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). Therefore, we wondered whether the absence of SMC5/6 may disrupt the heterochromatic features of this region of the genome. Previous studies have indicated that histone H4 lysine 20 trimethylation (H4K20me3) is enriched at pericentromeric heterochromatin (<xref ref-type="bibr" rid="bib35">Gonzalo et al., 2005</xref>; <xref ref-type="bibr" rid="bib118">Schotta et al., 2004</xref>). H4K20 methylation regulates heterochromatin compaction during mitosis and is particularly important for regulating DNA replication and maintaining genome integrity (<xref ref-type="bibr" rid="bib52">Jørgensen et al., 2013</xref>; <xref ref-type="bibr" rid="bib114">Saksouk et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Schotta et al., 2008</xref>; <xref ref-type="bibr" rid="bib124">Shoaib et al., 2018</xref>). Assessment of chromosome spreads prepared from control and <italic>Smc5</italic> cKO E16.5 cortical cells revealed a decrease in average width and intensity of pericentromeric H4K20 signal by 1.3- and 2.0-fold, respectively, in <italic>Smc5</italic> cKO cells compared to control (<xref ref-type="fig" rid="fig4">Figure 4L–N</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>). H4K20 methylation is reduced in response to DNA damage allowing for decompaction of chromatin structure, DNA synthesis, and efficient DNA repair (<xref ref-type="bibr" rid="bib52">Jørgensen et al., 2013</xref>). Reduction in H4K20 methylation is also associated with increased replication origin licensing (<xref ref-type="bibr" rid="bib124">Shoaib et al., 2018</xref>). Therefore, the reduction in methylated pericentromeric H4K20 in <italic>Smc5</italic> cKO cells may reflect under-replicated DNA and increased DNA damage.</p></sec><sec id="s2-5"><title>Perturbed proliferation of SMC5-depleted mESCs can be alleviated by CHEK2 or p53 inhibition</title><p>Similar to NPCs, mESCs are rapidly proliferating stem cells subject to high levels of replication stress (<xref ref-type="bibr" rid="bib2">Ahuja et al., 2016</xref>). To further investigate potential causes of genome instability, we assessed SMC5-depleted mESCs in detail. In a previous study, we showed that tamoxifen-induced knockout of <italic>Smc5</italic> in mESCs causes a dramatic decrease in cell growth and p53 signaling is upregulated (<xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). In this study, we utilized a mESC line harboring the AID system, which allows for rapid depletion of SMC5 upon addition of indole-3-acetic acid (IAA) (hereafter referred to as Smc5-AID mESCs) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref ref-type="bibr" rid="bib88">Natsume et al., 2016</xref>; <xref ref-type="bibr" rid="bib90">Nishimura et al., 2009</xref>; <xref ref-type="bibr" rid="bib104">Pryzhkova et al., 2020</xref>). We observed the reduction of SMC5 levels as early as 30 min after IAA addition, with robust depletion occurring after 1 hr of IAA treatment (<xref ref-type="fig" rid="fig5">Figure 5B</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Depletion of SMC5 in mESCs perturbs cell growth and causes increased replication stress.</title><p>(<bold>A</bold>) Schematic of AID system. Upon addition of IAA, SMC5-AID is ubiquitinated by the SKP1, CULLIN1, F-box (SCF) complex and degraded by the proteasome. (<bold>B</bold>) Western blot analysis of SMC5-AID protein levels over a time course of IAA (100 µM) treatment (Unt, untreated, 30 min, 1 hr, 2 hr) in <italic>Smc5-AID</italic> homozygous mESCs. Asterisk marks nonspecific band. 2,2,2-Trichloroethanol (TCE) was incorporated in the gel to visualize total loaded protein. (<bold>C</bold>) Western blot analysis of acetyl-p53 (K379) protein levels over a time course of IAA (100 µM) treatment (Unt, untreated, 1 hr, 2 hr, 3 hr, 12 hr, 24 hr, 48 hr) in <italic>Smc5-AID</italic> homozygous mESCs. A separate western blot of acetyl-p53 (K379) in <italic>Smc5-AID</italic> homozygous mESCs treated with 20 Gy of gamma-irradiation is shown on the right. 2,2,2-Trichloroethanol (TCE) was incorporated in the gel to visualize total loaded protein. (<bold>D</bold>) Western blot analysis of phospho-p53 (S389) protein levels over a time course of IAA (100 µM) treatment (Unt, untreated, 3 hr, 12 hr, 24 hr, 48 hr), and with 20 Gy of gamma-irradiation , in <italic>Smc5-AID</italic> homozygous mESCs. 2,2,2-Trichloroethanol (TCE) was incorporated in the gel to visualize total loaded protein. (<bold>E</bold>) <italic>Smc5-AID</italic> mESC number fold change over 48 hr of cell culture without treatment (Unt), and in the presence of IAA (100 µM), CHEK2 inhibitor (CHEK2i) (10 µM), or IAA and CHEK2 inhibitor (CHEK2i + IAA). Data represent mean ± S.E.M. (n = 3). Unpaired two-tailed t-test, untreated versus CHEK2i *p=0.0289, untreated versus IAA **p=0.0019; IAA versus CHEK2i **p=0.0042; IAA versus CHEK2i+IAA **p=0.0086 (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). (<bold>F</bold>) DNA labeling scheme and representative images of DNA fibers labeled with CldU (30 µM) (magenta) and IdU (250 µM) (green) depicting ongoing forks, double-stalled converging forks, stalled forks, and new origins. (<bold>G</bold>) Quantification of replication events in <italic>Smc5-AID</italic> mESCs treated for 12 hr with CHEK2i and IAA or CHEK2i alone. Data represent mean ± S.E.M. (CHEK2i condition: n = 354 fibers from three experiments, CHEK2i + IAA condition: n = 429 fibers from three experiments). Pearson’s chi-squared test with Yates’ continuity correction, *p=0.0436, **p=0.0025, ****p&lt;0.0001 (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). (<bold>H</bold>) Quantification of replication events in control <italic>Smc5-AID</italic> mESCs or <italic>Smc5-AID</italic> mESCs treated for 12 hr with IAA. Data represent mean ± S.E.M. (control condition: n = 334 fibers from three experiments, IAA condition: n = 558 fibers from three experiments). Pearson’s chi-squared test with Yates’ continuity correction, ****p&lt;0.0001 (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details). (<bold>I</bold>) Quantification of DNA fiber track length in <italic>Smc5-AID</italic> mESCs treated for 12 hr with CHEK2i and IAA or CHEK2i alone. Data represent mean ± 95% C.I. (confidence interval) (CHEK2i condition: n = 142 fibers from three experiments, CHEK2i + IAA condition: n = 107 fibers from three experiments). Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>J</bold>) Quantification of DNA fiber CldU/IdU ratio in <italic>Smc5-AID</italic> mESCs treated for 12 hr with CHEK2i and IAA or CHEK2i alone. Data represent mean ± 95% C.I. (CHEK2i condition: n = 142 fibers from three experiments, CHEK2i + IAA condition: n = 107 fibers from three experiments). Unpaired two-tailed Mann–Whitney test ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Depletion of SMC5 in mESCs perturbs cell growth and causes increased replication stress.</title><p>(<bold>A</bold>) Western blot analysis of SMC5-AID and TIR-HA protein expression in <italic>TIR1</italic>-only mESCs and <italic>Smc5-AID</italic> homozygous mESCs over a time course of IAA (100 µM) treatment (Unt, untreated, 30 min, 1 hr, 2 hr, 3 hr). Asterisk marks nonspecific band. (<bold>B</bold>) <italic>Smc5-AID</italic> mESC number fold change over 48 hr of cell culture without treatment (Unt), in the presence of p53 inhibitor (10 µM) (p53i), IAA (100 µM) or p53 inhibitor and IAA (p53i + IAA). Data represent mean ± S.E.M. (n = 2). (<bold>C</bold>) <italic>Smc5-AID</italic> mESC number fold change over 48 hr of cell culture without treatment (Unt), in the presence of CHEK1 inhibitor (3 µM) (CHEK1i), IAA (100 µM) or CHEK1 inhibitor and IAA (CHEK1i + IAA). Data represent mean ± S.E.M. (n = 2). (<bold>D</bold>) Representative images of phospho-p53 (P-p53) (red) and H3P (green) staining of control and IAA-treated <italic>Smc5-AID</italic> mESCs; DAPI (blue). Magnified images of cells in punctate squares are shown on the right. Scale bar: 50 µm, scale bar (zoom): 10 µm. (<bold>E</bold>) Quantification of P-p53+ cell percentage and total cell percentage in G1, S/G2, prophase (Pro) and other mitotic (Other M) stages. Data represent mean ± S.E.M. (control condition: n = 1452 cells from three experiments; IAA condition: n = 913 cells from three experiments). Pearson's chi-squared test with Yates’ continuity correction, ***p=0.0001, ****p&lt;0.0001. (<bold>F</bold>) Quantification of the percentage of G1, S/G2, and prophase cells in the P-p53+ cell population. Data represent mean ± S.E.M. (control condition: n = 96 cells from three experiments; IAA condition: n = 473 cells from three experiments). Pearson's chi-squared test with Yates’ continuity correction, *p=0.0143, ****p&lt;0.0001. (<bold>G</bold>) Quantification of replication events in <italic>Smc5-AID</italic> mESCs treated for 12 hr with p53 inhibitor (p53i) alone or p53 inhibitor and IAA (p53i + IAA). Data represent mean ± S.E.M. (p53i condition: n = 173 fibers from two experiments, p53i + IAA condition: n = 114 fibers from two experiments). Pearson’s chi-squared test with Yates’ continuity correction, ongoing forks *p=0.0112, converging forks *p=0.0471, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for details. (<bold>H</bold>) Quantification of DNA fiber track length in <italic>Smc5-AID</italic> mESCs treated for 12 hr with IAA, and control <italic>Smc5-AID</italic> mESCs. Data represent mean ± S.E.M. (control condition: n = 80 fibers from three experiments, IAA condition: n = 127 fibers from three experiments). Unpaired two-tailed Mann–Whitney test, *p=0.0134. (<bold>I</bold>) Quantification of DNA fiber CldU/IdU ratio in <italic>Smc5-AID</italic> mESCs treated for 12 hr with IAA, and control <italic>Smc5-AID</italic> mESCs. Data represent mean ± S.E.M. (control condition: n = 63 fibers from three experiments, IAA condition: n = 64 fibers from three experiments). Unpaired two-tailed Mann–Whitney test ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Immunoblotting analysis showed that IAA treatment triggered upregulation of acetyl-p53 (K379) and phospho-p53 (S389) by 2 hr and 48 hr, respectively (<xref ref-type="fig" rid="fig5">Figure 5C,D</xref>). This is consistent with the fact that Smc5-AID mESCs undergo severe cell growth perturbations within 48 hr after SMC5 depletion (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><p>In addition, we performed immunofluorescence analysis of phospho-p53 (p-p53) (S389) expression at various cell cycle stages (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). To define proliferative cells, we performed immunostaining for Ki67 and H3P at the 48 hr time point. Nearly 100% of control and IAA-treated mESCs were Ki67+, and we never observed p-p53 signal in Ki67- cells. Previous reports demonstrate that H3P is first detectable in mESCs during S phase and reaches a maximum during mitosis (<xref ref-type="bibr" rid="bib70">Mallm and Rippe, 2015</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). H3P is not detectable in G1 phase mESCs. Greater than 90% of S phase mESCs exhibit H3P foci, that become more prominent by G2, colocalizing with the pericentromeric heterochromatin. By prophase H3P stains the entire chromatin of the cell. Thus, we defined the H3P- population as containing primarily G1 phase cells and classified the H3P+ population as non-mitotic (S/G2 phase), prophase or cells in other mitotic stages. We observed a global increase in the percentage of p-p53+ cells in both H3P+ and H3P- populations after 48 hr of IAA treatment. Specifically, 38.2% of G1 phase cells, 26.2% of S/G2 phase cells, and 40.8% of prophase cells were positive for p-p53 in the IAA-treated group compared to 11.9%, 11.8%, and 7.0% of the control in respective stages (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). The relative abundance of p-p53+ cells in G1 and prophase populations compared to S/G2 cells suggests that p53 (S389) phosphorylation is most likely to occur in G1 phase or prophase upon SMC5 depletion. Further reaffirming this, the majority of p-p53+ cells were in G1 phase in the IAA-treated group, while the majority of p-p53+ cells in the control population were in S/G2 phase (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). We also observed a 1.5-fold increase in the percentage of total G1 phase cells, a 1.5-fold decrease in the percentage of total S/G2 phase cells, and a 2.1-fold increase in the percentage of total prophase cells in the IAA-treated group compared to control (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). The activation of a DDR during G1 or prophase, leading to activation of p53 and cell death, might explain the increase in proportion of cells in these cell cycle stages. These observations are consistent with the apparent accumulation of cells in G1 phase in <italic>Smc5</italic> cKO cortices (<xref ref-type="fig" rid="fig4">Figure 4B,C,F,G</xref>). Furthermore, the accumulation of cells in prophase recapitulates our previous findings in <italic>Smc5</italic> knockout mESCs (<xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>).</p><p>The <italic>Smc5</italic> cKO reduced cortex size can be alleviated by knockout of <italic>Trp53</italic> or <italic>Chek2</italic> (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). CHEK1 and CHEK2 kinases are key transducers of DNA damage signaling that lead to DNA repair, p53-mediated cell cycle arrest, or p53-mediated apoptosis (<xref ref-type="bibr" rid="bib121">Shaltiel et al., 2015</xref>; <xref ref-type="bibr" rid="bib125">Smith et al., 2010</xref>). We tested whether the phenotype of SMC5-depletion in mESCs can be rescued by inhibition of CHEK1, CHEK2, or p53 (<xref ref-type="fig" rid="fig5">Figure 5E</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). Chk2 inhibitor II and LY2603618 (LCI-1) are potent and selective inhibitors of CHEK2 and CHEK1, respectively (<xref ref-type="bibr" rid="bib7">Arienti et al., 2005</xref>; <xref ref-type="bibr" rid="bib19">Dai et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">King et al., 2014</xref>). Concurrent treatment with IAA and CHEK2 inhibitor restored cell numbers similar to the CHEK2 inhibitor-only control (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Similar results were obtained when mESCs were incubated with a commonly used p53 inhibitor, pifithrin-α, although potential off-target effects of this compound cannot be excluded (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib126">Sohn et al., 2009</xref>; <xref ref-type="bibr" rid="bib144">Zhu et al., 2020</xref>). In contrast, CHEK1 inhibition did not rescue cell growth defects after IAA treatment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Collectively, these results suggest that the main pathway triggering p53 activation, cell cycle arrest, and apoptosis upon SMC5 depletion in mESCs is CHEK2-mediated. This is consistent with our in vivo findings, which demonstrate that the <italic>Smc5</italic> cKO neurodevelopmental defects can be alleviated by mutation of <italic>Trp53</italic> or <italic>Chek2</italic> (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p></sec><sec id="s2-6"><title>Depletion of SMC5 causes increased DNA replication stress</title><p>The CHEK2 pathway largely responds to DSBs, which are commonly formed during replication stress, the primary source of DNA damage in rapidly proliferating stem cells (<xref ref-type="bibr" rid="bib2">Ahuja et al., 2016</xref>; <xref ref-type="bibr" rid="bib141">Zeman and Cimprich, 2014</xref>). Based on studies using budding and fission yeast, it is proposed that the SMC5/6 complex is important for maintaining replication fork stability and avoiding accumulation of toxic recombination intermediates (<xref ref-type="bibr" rid="bib5">Aragón, 2018</xref>). Therefore, we reasoned that perturbed DNA replication could be responsible for genome instability and cell death in SMC5-deficient stem cells. To assess the effect of SMC5 depletion on replication fork progression, we performed DNA fiber assays, in which mESCs were pulse-labeled with CldU and then IdU (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). We found that SMC5 depletion in CHEK2-inhibited mESCs resulted in 1.5-fold decrease in ongoing unidirectional forks compared to the inhibitor-only control (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). In addition, converging forks and stalled forks were increased by 1.6- and 2.2-fold, respectively, compared to control (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). These observations suggest that replication stress is increased upon SMC5 depletion, perhaps due to an impaired ability to restart stalled replication forks or resolve replication intermediates. This may lead to licensing of nearby dormant replication origins, which can increase the prevalence of converging forks (<xref ref-type="bibr" rid="bib15">Blow and Ge, 2009</xref>; <xref ref-type="bibr" rid="bib79">Merrick et al., 2004</xref>). Increased converging fork frequency in SMC5-depleted cells could also be indicative of an inability to resolve joint molecules formed upon collision of two replication forks (<xref ref-type="bibr" rid="bib22">Dewar and Walter, 2017</xref>). SMC5 depletion in p53-inhibited mESCs yielded similar results (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1G</xref>). The same trend was observed in SMC5-depleted mESCs in the absence of inhibitors (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). We also observed 1.3-fold reduced track length and 1.5-fold elevated CldU/IdU ratio in unidirectional dual-labeled forks upon SMC5 depletion with CHEK2 inhibition (<xref ref-type="fig" rid="fig5">Figure 5I,J</xref>). This further affirms that fork stalling is increased, and replication is perturbed in SMC5-depleted cells. The decrease in track length and increase in CldU/IdU ratio upon SMC5 depletion were also recapitulated in the absence of inhibitors (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H,I</xref>). However, the track length reduction, while significant, was not as pronounced in these conditions. The slightly less severe phenotypes in the absence of inhibitors could be attributed to increased death of SMC5-deficient cells when CHEK2 and p53 are active.</p></sec><sec id="s2-7"><title>SMC5 depletion leads to increased mitotic DNA synthesis</title><p>The prevalence of stalled and converging forks in SMC5-depleted mESCs suggests their inability to restart stalled forks or resolve replication intermediates (<xref ref-type="bibr" rid="bib13">Berti and Vindigni, 2016</xref>). Unresolved replication intermediates could persist into mitosis, where they can be repaired via HDR (termed mitotic DNA synthesis, MiDAS) (<xref ref-type="bibr" rid="bib71">Mankouri et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Minocherhomji et al., 2015</xref>; <xref ref-type="bibr" rid="bib127">Sonneville et al., 2019</xref>). MiDAS often occurs at common fragile sites, AT-rich DNA sequences that are particularly prone to replication stress and subsequent breakage during mitosis, as well as at late-replicating heterochromatin regions (<xref ref-type="bibr" rid="bib28">Fungtammasan et al., 2012</xref>; <xref ref-type="bibr" rid="bib33">Glover et al., 2005</xref>; <xref ref-type="bibr" rid="bib77">Mendez-Bermudez et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Özer and Hickson, 2018</xref>; <xref ref-type="bibr" rid="bib114">Saksouk et al., 2015</xref>). Sites of MiDAS are generally accompanied by foci of FANCD2, which is required for DNA crosslink repair and regulation of MiDAS (<xref ref-type="bibr" rid="bib14">Bhowmick et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Datta and Brosh Jr., 2019</xref>; <xref ref-type="bibr" rid="bib37">Graber-Feesl et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Okamoto et al., 2018</xref>). Thus, we evaluated the frequency of MiDAS in synchronized mESCs during mitosis (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Replication stress in SMC5-depleted mESCs leads to MiDAS.</title><p>(<bold>A</bold>) Schematic of IAA treatment, cell synchronization with RO3306 (8 µM) and STLC (10 µM), and labeling with EdU (10 µM) for assessment of MiDAS foci. (<bold>B</bold>) Representative images of EdU (magenta), FANCD2 (red), and centromere (CEN) (green) staining of metaphase chromosomes from control and IAA-treated <italic>Smc5-AID</italic> mESCs; DAPI (white). Insets depict magnified individual chromosomes with combined channels and separate channels. Scale bar: 5 µm. (<bold>C</bold>) Quantification of EdU+ foci per chromosome in control (n = 34) and IAA-treated (n = 37) mESCs. Data represent mean and range. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>D</bold>) Quantification of EdU+FANCD2+ foci per chromosome in control (n = 34) and IAA-treated (n = 37) mESCs. Data represent mean and range. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>E</bold>) Quantification of EdU+CEN+ foci per chromosome in control (n = 34) and IAA-treated (n = 37) mESCs. Data represent mean and range. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001. (<bold>F</bold>) Quantification of EdU+FANCD2+CEN+ foci per chromosome in control (n = 34) and IAA-treated (n = 37) mESCs. Data represent mean and range. Unpaired two-tailed Mann–Whitney test, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Quantification of EdU+ and FANCD2+ foci in mESCs.</title><p>(<bold>A</bold>) Quantification of percentage of EdU+FANCD2- foci (out of total EdU+ foci) in control (n = 29) and IAA-treated (n = 33) mESCs. Data represent mean ± S.E.M. (<bold>B</bold>) Quantification of percentage of EdU-FANCD2+ foci (out of total FANCD2+ foci) in control (n = 32) and IAA-treated (n = 33) mESCs. Data represent mean ± S.E.M. Unpaired two-tailed Mann–Whitney test, ***p=0.0002. (<bold>C</bold>) Quantification of number of acrocentric/non-acrocentric (acro./non-acro.) EdU+ foci in control (n = 19) and IAA-treated (n = 31) mESCs. Data represent mean and range.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig6-figsupp1-v2.tif"/></fig></fig-group><p>IAA-treated and untreated mESCs were arrested in G2 phase using the CDK1 inhibitor RO3306, released, and subsequently arrested in mitosis using the Eg5 inhibitor S-trityl-L-cysteine (STLC) in the presence of thymidine analogue EdU (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Higher frequency of MiDAS was observed in SMC5-depleted mESCs, indicated by EdU+ and dual EdU+FANCD2+ foci (<xref ref-type="fig" rid="fig6">Figure 6B–D</xref>). The mean number of EdU+ and dual EdU+FANCD2+ foci per chromosome was increased by 3.6- and 4.3-fold, respectively, in SMC5-depleted mESCs compared to control (<xref ref-type="fig" rid="fig6">Figure 6B–D</xref>). The percentage of EdU foci that did not co-localize with FANCD2 was 59.4% and 56.2%, respectively, for control and IAA-treated cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). We also found that 81.3% and 64.5% of FANCD2 foci were EdU- in control and IAA-treated cells, respectively (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). Thus, FANCD2 foci are less frequently found outside of MiDAS foci upon SMC5 depletion, consistent with the increased number of EdU+FANCD2+ foci seen in IAA-treated cells (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Loss of SMC5 also caused elevated MiDAS at pericentromeric regions, as indicated by dual EdU+CEN+ foci and triple EdU+FANCD2+CEN+ foci, which were increased by 4.7- and 6.2-fold, respectively (<xref ref-type="fig" rid="fig6">Figure 6B,E,F</xref>). To note, EdU foci positioning at telomeres and centromeres on the acrocentric end of mouse chromosomes is difficult to distinguish due to their proximity. Therefore, we also quantified the ratio of ‘acrocentric’ EdU foci (that is, foci present on the end of the chromosome containing the centromere) to ‘non-acrocentric’ EdU foci (foci present on the opposite chromosomal end). This ratio was 1.47 and 1.91 in control and IAA-treated mESCs, respectively (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). The enrichment of acrocentric compared to non-acrocentric foci suggests that features unique to the pericentromeric DNA may confer increased MiDAS susceptibility and complements our findings in <italic>Smc5</italic> cKO NPCs compared to control NPCs (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>).</p><p>Our data suggest that the depletion of SMC5 in stem cells results in increased DNA replication stress (<xref ref-type="fig" rid="fig5">Figure 5F-J</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1G-I</xref>). This could lead to the formation of under-replicated DNA and replication intermediates that can persist into mitosis, particularly at sites prone to replication stress. Inability to resolve and repair these forms of DNA joint molecules can cause chromosome segregation errors, which we have observed in NPCs of <italic>Smc5</italic> cKO mice and mESCs (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>, <xref ref-type="fig" rid="fig4">Figure 4H</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>The SMC5/6 complex is critical for normal brain development and function</title><p>The SMC5/6 complex plays a crucial role in preserving genome integrity of somatic and stem cells (<xref ref-type="bibr" rid="bib31">Gallego-Paez et al., 2014</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>; <xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). Mutation of <italic>NSMCE2</italic> causes primordial dwarfism and primary congenital microcephaly in humans and promotes cancer development and premature aging in mice (<xref ref-type="bibr" rid="bib48">Jacome et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Payne et al., 2014</xref>). Our study provides the first insight toward understanding what neurodevelopmental processes are likely to be aberrant in humans harboring SMC5/6 mutations. The major neurodevelopmental defects we observed in our <italic>Smc5</italic> cKO model during embryogenesis were the displacement of apical NPCs into the cortical area outside the VZ and reduction in IPs and neurons of all cortical layers. However, the NPC population was not decreased by <italic>Smc5</italic> cKO. Therefore, our data suggest that a proportion of NPCs in the <italic>Smc5</italic> cKO cortex do not contribute to the development of IPs and fail to differentiate into layer-specific neurons. In mouse models, NPC genome instability often leads to lethality during development in utero or shortly after birth (<xref ref-type="bibr" rid="bib55">Katyal et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">McKinnon, 2017</xref>; <xref ref-type="bibr" rid="bib89">Nishide and Hirano, 2014</xref>; <xref ref-type="bibr" rid="bib111">Rosin et al., 2015</xref>). In contrast, cKO of <italic>Smc5</italic> within the developing cortex does not affect animal survival into adulthood and can be used for longitudinal behavioral, sensorimotor, and neuronal activity analyses. We have shown that <italic>Smc5</italic> cKO mice have sensorimotor defects, and they may prove to be an instrumental model for more comprehensive studies in the future.</p></sec><sec id="s3-2"><title>SMC5/6 absence triggers activation of CHEK2- and p53-mediated apoptosis</title><p>It has been well documented that a major source of DNA damage during neurogenesis is DNA replication stress (<xref ref-type="bibr" rid="bib63">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Magdalou et al., 2014</xref>; <xref ref-type="bibr" rid="bib75">McKinnon, 2013</xref>; <xref ref-type="bibr" rid="bib91">O'Driscoll, 2017</xref>; <xref ref-type="bibr" rid="bib141">Zeman and Cimprich, 2014</xref>). ATR kinase and its downstream substrate CHEK1 mediate a checkpoint response in the presence of aberrant replication fork structures containing ssDNA (<xref ref-type="bibr" rid="bib141">Zeman and Cimprich, 2014</xref>). <italic>Smc5</italic> cKO during neurodevelopment did not result in accumulation of NPCs in S phase, which indicated that the ATR-CHEK1 S phase checkpoint pathway did not trigger cell cycle arrest. In contrast, we observed <italic>Smc5</italic> cKO NPCs undergoing mitosis with DNA bridges and lagging chromosomes at anaphase. Despite the chromosome segregation defects, <italic>Smc5</italic> cKO NPCs did not undergo mitotic delay (<xref ref-type="bibr" rid="bib100">Phan et al., 2020</xref>). These data suggested that a DNA damage checkpoint was not being activated during G2 or M phase. DNA bridges can lead to the inheritance of DNA breaks in G1 daughter cells; therefore, it is likely that NPCs in G1 are subject to a DNA damage checkpoint response.</p><p>ATM together with CHEK2 are the primary DNA damage signaling proteins during G1 and result in the stabilization of p53 (<xref ref-type="bibr" rid="bib121">Shaltiel et al., 2015</xref>). We demonstrated that p53- and CHEK2-mediated apoptosis were major drivers for the reduced cortex size following <italic>Smc5</italic> cKO in NPCs. The depletion of SMC5 in mESCs resulted in upregulation of phospho- and acetyl-p53, consistent with the phenotype observed in mice. We further showed that the acetylation of p53 occurs within 2 hr after IAA treatment, while p53 phosphorylation occurs significantly later, presumably after multiple rounds of cell division. Given that complete SMC5 depletion occurs only after 1–2 hr of IAA treatment, the upregulation of acetyl-p53 at this early time point reveals that a DDR occurs nearly immediately upon SMC5 depletion. By contrast, previous studies in human cancer cells demonstrated an increase in unmodified p53 levels only within 2 days after SMC5/6 depletion by the AID system (<xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). Immunofluorescence microscopy analyses demonstrated that p-p53 was most frequently present in G1 phase and prophase cells, suggesting that aberrancies caused by SMC5 depletion lead to a DDR during G1 and prophase. As we observed perturbed replication in SMC5-depleted cells, it is conceivable that the phosphorylation of p53 during prophase could be a consequence of late replication defects during G2 or the presence of under-replicated DNA, while the accumulation of p-p53 during G1 phase may be caused by the inheritance of unresolved DNA damage by G1 daughter cells.</p><p>Furthermore, we showed that the proliferation defect following AID-mediated depletion of SMC5 in mESCs was alleviated by inhibiting p53 or CHEK2, but not CHEK1. It was recently shown that depletion of SMC5/6 components in human cancer cells (HCT116) or hTERT immortalized non-cancer cells (RPE1) caused activation of CHEK2 and stabilization of p53 (<xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). However, inactivation of <italic>TP53</italic> did not alleviate the cell-cycle arrest, cell death, and senescence observed following SMC5/6 degradation in either HCT116 or RPE1 cells (<xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). This discrepancy may be attributed to the fact that our studies were performed in vivo in multipotent NPCs or in pluripotent mESC cultures, whereas HCT116 and RPE1 are tissue-specific cell lines.</p></sec><sec id="s3-3"><title>SMC5/6 is critical for completion of DNA replication</title><p>Although an earlier study using human RPE1 cells showed slower progression of DNA replication upon RNAi-mediated depletion of SMC6, our previous work demonstrated timely entry and exit from S phase in SMC5-deficient mESCs (<xref ref-type="bibr" rid="bib31">Gallego-Paez et al., 2014</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). However, our DNA fiber analyses indicate that replication forks encounter more perturbations upon SMC5 depletion. Perturbed replication fork progression may be partially counteracted by CHEK1-mediated activation of compensatory mechanisms, such as increased firing of dormant origins. Indeed, new origin firing was slightly elevated in SMC5-depleted mESCs. In our studies, apoptosis was shown to be primarily mediated by CHEK2. This does not rule out the possibility that CHEK1 could play a role, although no rescue of cell growth was observed with CHEK1 inhibition. Increased replication stress suggests that mESCs and NPCs likely proceed through anaphase with under-replicated DNA, potentially causing mitotic DNA damage (<xref ref-type="bibr" rid="bib71">Mankouri et al., 2013</xref>; <xref ref-type="bibr" rid="bib136">Voutsinos et al., 2018</xref>).</p><p>DNA fiber studies in budding yeast have shown disrupted replication fork progression in <italic>Smc6</italic> mutant cells under exogenous replication stress, but with no effects under unstressed conditions (<xref ref-type="bibr" rid="bib11">Bermúdez-López et al., 2010</xref>). This suggests that SMC5/6 may be particularly important when replicative DNA damage levels are elevated. In contrast to the results presented here, a recent study using HCT116 cancer cells observed that the depletion of SMC5/6 complex components did not affect replication fork speed or CldU/IdU ratio (<xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). However, mESCs and NPCs have higher levels of intrinsic replication stress due to their rapid rate of proliferation (<xref ref-type="bibr" rid="bib2">Ahuja et al., 2016</xref>; <xref ref-type="bibr" rid="bib6">Arai et al., 2011</xref>; <xref ref-type="bibr" rid="bib32">Ge et al., 2015</xref>; <xref ref-type="bibr" rid="bib137">Waisman et al., 2019</xref>). Indeed, the cell cycle duration of mESCs and NPCs is approximately twofold shorter than that of HCT116 cells (<xref ref-type="bibr" rid="bib49">Jensen et al., 2015</xref>; <xref ref-type="bibr" rid="bib137">Waisman et al., 2019</xref>). Another study reported that the Saos2 alternative lengthening of telomeres (ALT) cancer cell line requires SMC5/6 to promote telomere clustering and MiDAS at telomeres (<xref ref-type="bibr" rid="bib80">Min et al., 2017</xref>). Although our findings in mESCs and NPCs demonstrate that SMC5/6 suppresses MiDAS, it is important to note that the ALT mechanism is a unique circumstance that requires distinct HR-mediated processes (<xref ref-type="bibr" rid="bib18">Cho et al., 2014</xref>). SMC5/6 has previously been shown to be critical for telomere clustering, and NSMCE2-mediated SUMOylation of shelterin components is important for ALT (<xref ref-type="bibr" rid="bib102">Potts and Yu, 2007</xref>).</p><p>The consequences of perturbed replication in SMC5-depleted NPCs and mESCs clearly manifest later in the cell cycle. This is evidenced by the increased formation of EdU+ and FANCD2+ foci during mitosis, particularly at late-replicating regions such as pericentromeric heterochromatin. Notably, SMC5/6 localizes to pericentromeric heterochromatin, as revealed by our previous work in mESCs, MEFs, and germ cells, suggesting that it may play a direct role at these sites (<xref ref-type="bibr" rid="bib34">Gómez et al., 2013</xref>; <xref ref-type="bibr" rid="bib46">Hwang et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>; <xref ref-type="bibr" rid="bib134">Verver et al., 2013</xref>). The relatively large percentage of EdU-FANCD2+ foci in both control and IAA-treated cells diverges from previous findings in U2OS cells, in which only one-third of FANCD2+ foci were EdU- (<xref ref-type="bibr" rid="bib14">Bhowmick et al., 2016</xref>). This could be related to differences in the functions of FANCD2 in mESCs compared to human cancer cells. Interestingly, it has been shown that FANCD2 is particularly important for promoting MiDAS in non-cancer cells (<xref ref-type="bibr" rid="bib37">Graber-Feesl et al., 2019</xref>). It has been shown that FANCD2 is highly expressed in mESCs, though no comparison has been made with human cancer cells, and detailed studies of FANCD2 localization in mESCs have not been conducted (<xref ref-type="bibr" rid="bib142">Zhang et al., 2017</xref>). Moreover, the absence of FANCD2 in a large percentage of EdU+ foci suggests that other non-FANCD2-mediated pathways could be at play during MiDAS. However, little is currently known about the factors involved in MiDAS in mESCs.</p><p>FA factors were recently shown to function upstream of SMC5/6 in the repair of exogenously induced inter-strand crosslinks (ICLs) (<xref ref-type="bibr" rid="bib112">Rossi et al., 2020</xref>). Among other roles, FA factors are important for MiDAS and the resolution of replication termination regions, which resemble ICLs and are also genomic fragile sites (<xref ref-type="bibr" rid="bib22">Dewar and Walter, 2017</xref>). . The increased prevalence of double-stalled converging forks in DNA fibers from SMC5-depleted cells likely reflects destabilization of these termination sites. These observations highlight an important role for SMC5/6 in fragile site replication. This is further reaffirmed by the fact that Smc5/6 is telomere-associated and involved in ribosomal DNA (rDNA) replication in yeast and human cells, with Smc5/6 deficiency leading to rDNA segregation errors during mitosis (<xref ref-type="bibr" rid="bib84">Moradi-Fard et al., 2016</xref>; <xref ref-type="bibr" rid="bib99">Peng et al., 2018</xref>; <xref ref-type="bibr" rid="bib133">Venegas et al., 2020</xref>). Notably, SMC5 has also been identified at early replicating fragile sites in murine B lymphocytes via ChIP-seq studies (<xref ref-type="bibr" rid="bib9">Barlow et al., 2013</xref>).</p><p>Although its precise role in replication fork stabilization is yet unknown, SMC5/6 is likely involved in the late steps of HR, as it functions downstream of FA factors and RAD51, of which we see an accumulation in <italic>Smc5</italic> cKO NPCs. RAD51 can mediate the formation of toxic recombination intermediates, and deletion of <italic>RAD51</italic> has been shown to rescue the lethality of <italic>SMC6</italic> mutants in fission and budding yeast (<xref ref-type="bibr" rid="bib3">Ampatzidou et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">Lehmann et al., 1995</xref>; <xref ref-type="bibr" rid="bib78">Menolfi et al., 2015</xref>). We previously showed that RAD51 foci are increased in <italic>Smc5</italic> cKO MEFs following hydroxyurea treatment (<xref ref-type="bibr" rid="bib29">Gaddipati et al., 2019</xref>). Together, these observations suggest that SMC5/6 is necessary for the stabilization of stalled replication forks, rescue of collapsed replication forks, and repair of replication and recombination intermediates. The impairment of HR completion during replication leads to under-replicated DNA and unresolved replication intermediates. The presence of EdU+ foci on chromosomes of SMC5-depleted mitotic mESCs reflects an attempt to repair these intermediates. However, in the absence of SMC5, late stages of DNA repair cannot be completed, rendering these regions prone to chromatin missegregation. Under-replicated regions that persist in anaphase manifest as DNA bridges and can lead to DNA breaks in G1 daughter cells and subsequent CHEK2-mediated DDR (<xref ref-type="bibr" rid="bib121">Shaltiel et al., 2015</xref>; <xref ref-type="bibr" rid="bib136">Voutsinos et al., 2018</xref>). Collectively, these findings provide a molecular mechanism for the increased genome instability and chromosome segregation defects observed in SMC5/6-deficient cells. Future experiments will determine whether ablation of CHEK2 alleviates the accumulation of RAD51 or exacerbates this defect. Furthermore, it will be valuable to explore whether inhibition of HR can also alleviate the consequences of SMC5 depletion.</p></sec><sec id="s3-4"><title>Conclusions</title><p>We demonstrate that loss of SMC5/6 functions in the developing cortex leads to a reduction in cortex size, mislocalization of NPCs, reduced numbers of IPs and cortical layer neurons, and increased cell apoptosis. These developmental defects are attributed to SMC5/6 being required for proficient DNA replication, particularly at pericentromeric heterochromatin. SMC5/6 depletion causes NPCs to enter mitosis with regions of under-replicated DNA, which results in chromosome segregation defects. These defects stimulate a CHEK2-mediated DNA damage checkpoint response and result in elevated p53-mediated apoptosis (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Proposed SMC5/6 complex functions in mammalian cortical development.</title><p>SMC5/6 complex depletion in developing mouse cortex causes increased DNA replication stress at fragile sites, such as late-replicating heterochromatin. Unrepaired DNA and DNA intermediates persist into mitosis resulting in chromosome segregation defects. Acquired DNA damage triggers DNA damage response (DDR) and CHEK2- and p53-mediated apoptosis, resulting in reduced cortex size. Abrogation of p53 and CHEK2 functions alleviates SMC5 depletion phenotype. RF = replication fork; DDR = DNA damage response.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61171-fig7-v2.tif"/></fig></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animal use and care</title><p>All mice were bred at Johns Hopkins University (JHU, Baltimore, MD) in accordance with the National Institutes of Health and U.S. Department of Agriculture criteria and protocols for their care and use were approved by the Institutional Animal Care and Use Committees (IACUC) of JHU.</p><p>Mice of following strains were used: C57BL/6J (B6/J), stock number 000664 (Jackson Laboratory (JAX)); B6.129S2-<italic>Emx1</italic><sup>tm1(cre)Krj</sup>/J (<italic>Emx1-Cre</italic>), stock number 005628 (JAX); B6.Cg-Tg(<italic>Nes-Cre</italic>)1Kln/J (<italic>Nestin-Cre</italic>), stock number 003771 (JAX); B6.129S2-<italic>Trp53<sup>tm1Tyj</sup></italic>/J (<italic>p53<sup>del</sup></italic>allele), stock number 002101 (JAX); <italic>Chek2<sup>tm1b(EUCOMM)Hmgu</sup></italic> (<italic>Chek2<sup>del</sup></italic> allele), stock number 047089-UCD (University California Davis); B6;129-<italic>Trp53bp1<sup>tm1Jc</sup></italic>/J (<italic>Trp53bp1<sup>del</sup></italic> allele), stock number 006495 (JAX). Mice harboring <italic>Smc5</italic> with a floxed exon 4 (designated <italic>Smc5<sup>flox</sup></italic>) and deleted exon 4 (designated <italic>Smc5<sup>del</sup></italic>) have been previously described (<xref ref-type="bibr" rid="bib46">Hwang et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Hwang et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>).</p><p>These mice were bred to obtain the following genotypes: <italic>Smc5<sup>flox/flox</sup></italic>, <italic>Emx1-Cre tg/0</italic> (hemizygous transgene); Smc5<italic><sup>flox/flox</sup></italic>, <italic>Nestin-Cre tg/0; Smc5<sup>flox/flox</sup></italic>, <italic>Trp53<sup>del/del</sup></italic>, <italic>Emx1-Cre tg/0; Smc5<sup>flox/flox</sup></italic>, <italic>Trp53bp1<sup>del/del</sup></italic>, <italic>Emx1-Cre tg/0; Smc5<sup>flox/flox</sup></italic>, <italic>Chk2<sup>del/del</sup></italic>, <italic>Emx1-Cre tg/0</italic>. Mice from both genders were included in the study for all ages. Genotypes not resulting in homozygous gene knockout were used as controls.</p></sec><sec id="s4-2"><title>Mouse genotyping</title><p>PCR genotyping was performed using AccuStart II PCR SuperMix (Quanta BioSciences).</p><p>Primers used are described in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. PCR reaction conditions were as follows: initial denaturation at 94°C for 2 min (denaturation at 94°C for 20 s, annealing at 58°C for 30 s, amplification at 72°C for 30 s) × 34 cycles, and final extension at 72°C for 10 min. For <italic>Trp53bp1</italic>, PCR conditions were as follows: initial denaturation at 94°C for 2 min (denaturation at 94°C for 20 s, annealing at 65°C for 15 s with 0.5°C per cycle decrease) × 10 cycles; (denaturation at 94°C for 15 s, annealing at 60°C for 15 s, amplification at 72°C for 10 s) × 28 cycles, and final extension at 72°C for 2 min.</p></sec><sec id="s4-3"><title>Behavioral studies</title><sec id="s4-3-1"><title>Adhesive patch test</title><p>The test was performed as previously described (<xref ref-type="bibr" rid="bib27">Fleming et al., 2013</xref>). A half of circular paper adhesive (9.5 mm diameter) was placed on right rare paw and time to contact was recorded. Each mouse was given up to 60 s to remove the paper adhesive. The mice were alternated to have three trials each for every age time point assessed.</p></sec><sec id="s4-3-2"><title>Inverted screen test</title><p>The test was performed as previously described (<xref ref-type="bibr" rid="bib38">Grady et al., 2006</xref>). A mouse was placed in the middle of wire mesh grid (16 squares per 10 cm), and screen was inverted to 180°. A mouse was timed for how long it remained upside down on the screen. Two trials were administered for each animal with 20–30 min interval between trials. Means were calculated across the trials for each mouse.</p></sec><sec id="s4-3-3"><title>Cylinder test</title><p>The test was performed as previously described (<xref ref-type="bibr" rid="bib27">Fleming et al., 2013</xref>). A mouse was placed into glass cylinder (15 cm diameter) and video recorded for 3 min. Videos were analyzed, and the number of rears with forelimbs touching the glass wall or not touching it was scored.</p></sec></sec><sec id="s4-4"><title>Western blot analysis</title><p>Cell lysates were prepared in RIPA buffer (Santa Cruz Biotechnology) supplemented with protease inhibitor cocktail (Roche). Equal amounts of proteins were fractionated by SDS-PAGE and transferred to PVDF membrane (Bio-Rad). Primary and secondary antibody information is provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. We used horseradish peroxidase (HRP)-conjugated goat anti-mouse-IgG and anti-rabbit-IgG secondary antibodies (Invitrogen). Signal was detected using Clarity Western ECL Substrate (Bio-Rad) and imaged using Syngene XR5 system.</p></sec><sec id="s4-5"><title>Immunohistochemistry</title><p>Mouse brains and heads were collected and fixed in 10% of formalin solution (Sigma-Aldrich): E13.5 brains were fixed for 1.5 hr, E16.5 brains for 3 hr, P0/1 brains for 6 hr, P0/1 heads and adult P55-58 brains overnight at 4°C. Following fixation, tissues were transferred to a 20% sucrose solution in PBS and left overnight at 4°C. Tissues were then transferred into O.C.T. compound (Scigen) and frozen at −80°C. Coronal or sagittal sectioning of frozen O.C.T. blocks was performed at 16 µm thickness using the Cryo3 (Sakura Tissue-Tek). All sections were mounted on TruBOND 380 (Matsunami) or Selectfrost Adhesion (Fisher) microscope slides. Sections were kept at −80°C until further processing.</p><p>Immunohistochemistry was carried out with or without antigen retrieval (see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Antigen retrieval was performed in sodium citrate buffer (10 mM sodium citrate, 0.05% Tween-20, pH 6.0) in a 70°C water bath for 20 min. All sections (regardless of antigen retrieval status) were incubated with permeabilizing and blocking solution (0.25% Triton X-100, 10% horse serum in PBS) for 1 hr at room temperature in a humidified slide box. Sections were incubated with primary antibodies diluted in blocking solution (10% horse serum in PBS) overnight at 4°C in a humidified slide box. Sections were washed three times with TBS-T rinse buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween-20) and incubated with secondary antibodies for 1 hr at room temperature in a humidified slide box. After washing with TBS-T buffer sections were mounted using Vectashield with DAPI (Vector Laboratories). Antibody information is provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-6"><title>TUNEL assay</title><p>Identification of apoptotic cells in brain cryosections was performed using In Situ BrdU-Red DNA fragmentation (TUNEL) assay kit (Abcam). Sections were mounted using Vectashield with DAPI (Vector Laboratories).</p></sec><sec id="s4-7"><title>CldU labeling</title><p>Pregnant females at 16.5-day post-coitum were injected intraperitoneally with 50 µg/g of body weight CldU (Sigma). Mice were sacrificed 4 hr after injection, and embryonic brains were collected and processed for cryosectioning as described above. For CldU immunostaining, frozen sections were subject to antigen retrieval as described above, followed by permeabilization with 0.25% Triton X-100, 10% horse serum in PBS for 30 min at room temperature, 30 min 2 M HCl treatment at 37°C, then blocking and incubation with primary and secondary antibodies for 2 hr at room temperature each. After washing with TBS-T buffer sections were mounted using Vectashield with DAPI (Vector Laboratories). Antibody information is provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-8"><title>Mouse cortical cell immunocytochemistry</title><p>E16.5 cortices were dissociated with 0.05% trypsin-EDTA (Gibco) into single cells and placed into cell culture medium in the presence of 10 µM STLC (Tocris) for 1 hr to enrich mitotic cells and then collected for analysis. Chromosome spread preparation from E16.5 primary cortical cell cultures was performed as described previously (<xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). Immunocytochemistry was performed as described previously (<xref ref-type="bibr" rid="bib103">Pryzhkova et al., 2014</xref>). Antibodies used are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Samples were mounted using Vectashield with DAPI (Vector Laboratories).</p></sec><sec id="s4-9"><title>mESC culture and analysis</title><p>B6 mESCs used in this study were established and maintained in 2i/LIF medium as described in <xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>; <xref ref-type="bibr" rid="bib104">Pryzhkova et al., 2020</xref>. mESCs were verified to be negative for mycoplasma using the PCR Mycoplasma Test Kit I/C (PromoCell). For cell growth analysis mESCs were cultured in the presence of 10 µM CHEK2 inhibitor II (Cayman), 3 µM CHEK1 inhibitor LY2603618 (Cayman), or p53 inhibitor cyclic pifithrin-alpha hydrobromide (Cayman), with or without 100 µM IAA for 48 hr. Drugs were added 18–20 hr after passaging. mESCs were counted at the time of passaging and after 48 hr of growth in the presence of drugs.</p></sec><sec id="s4-10"><title>DNA fiber assay</title><p>For DNA fiber assay, mESCs were treated with CHEK2 inhibitor, CHEK2 inhibitor and IAA, p53 inhibitor, or p53 inhibitor and IAA 16–18 hr after passaging. After 12 hr of treatment, mESCs were incubated in culture with 30 µM CldU (Sigma) for 20 min, washed twice with PBS, and incubated with 250 µM iododeoxyuridine (IdU) (Sigma) for 20 min. Labeled mESCs were resuspended in PBS at 2 × 10<sup>5</sup> cells/ml. DNA fiber spreading and immunostaining were performed as previously described (<xref ref-type="bibr" rid="bib44">Huang et al., 2013</xref>). Primary antibodies used were rat anti-BrdU (CldU) (Abcam) and mouse anti-BrdU (IdU) (Becton Dickinson). Secondary antibodies used were Alexa Fluor anti-rat 568 and Alexa Fluor anti-mouse 488. Antibody information is provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-11"><title>mESC immunocytochemistry</title><p>For MiDAS assessment, mESCs were treated with IAA 16–18 hr after passaging. After 18 hr of IAA treatment, mESCs were incubated with 8 µM RO-3306 (Sigma) for 6 hr, washed twice in PBS, and cultured in the presence of 10 µM STLC (Tocris) and 10 µM ethynyl-deoxyuridine (EdU) (Sigma) for 1 hr. mESCs were washed and collected. Chromosome spread preparation was performed as described previously (<xref ref-type="bibr" rid="bib105">Pryzhkova and Jordan, 2016</xref>). For EdU detection, chromosome spreads were washed three times in PBS and incubated with ‘click’ reaction cocktail containing 0.1 M Tris (pH 8.5), 10 µM cyanine 5-azide (Lumiprobe), 1 mM CuSO<sub>4</sub>, and 0.1 M L-ascorbic acid (Sigma) added last. All reaction components were dissolved in 20% dimethylsulfoxide (DMSO) (Sigma) in PBS. Chromosome spreads were incubated with the reaction cocktail for 20 min and washed in PBS with 0.5% Triton three times for 10 min each. Immunocytochemistry was performed as described previously (<xref ref-type="bibr" rid="bib103">Pryzhkova et al., 2014</xref>). Antibodies used are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Samples were mounted using Vectashield with DAPI (Vector Laboratories).</p></sec><sec id="s4-12"><title>Microscopy</title><p>Images were captured using a Zeiss Cell Observer Z1 fluorescence microscope linked to an ORCA-Flash 4.0 CMOS camera (Hamamatsu), or Zeiss AxioImager A2 linked to AxioCam ERc 5 s camera (Zeiss), or Keyence BZ-X800 fluorescence microscope. Images were analyzed and processed using ZEN 2012 blue edition imaging software (Zeiss) or with BZ-X800 Viewer and Analyzer software (Keyence). Photoshop (Adobe) was used to prepare figure images.</p></sec><sec id="s4-13"><title>Image data quantification</title><sec id="s4-13-1"><title>Brain section analysis</title><p>The measurements of cortical area were made using Fiji (ImageJ) (<xref ref-type="bibr" rid="bib117">Schneider et al., 2012</xref>). To determine the ratio of cortical layers to cortex thickness, we measured the thickness of the cortical layer being analyzed and the thickness of the neural cortex (from the apical ventricular surface to the basal surface). This was performed at 90° to the ventricular surface using the angle tool in Fiji (ImageJ). The thickness of hematoxylin and eosin-stained cortical sections was measured at 90° to the ventricular surface using the angle tool in Fiji (ImageJ). For counts of cells expressing specific marker, cells were counted within the defined area. Similar regions of the cortex were compared between representative genotypes.</p><p>Anaphase-stage mitotic cells were classified in the VZ area. The cleavage plane orientation of anaphase cells in the VZ was defined by the angle between the cleavage plane and the ventricular surface. For cleavage plane orientation, mitotic cells were scored as vertical (60–90°), oblique (30–60°), and horizontal (0–30°). Cells were quantified using Fiji (ImageJ). Detailed information about cortical section analysis is provided in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-13-2"><title>Chromosome spreads analysis</title><p>For measurements of H4K20 signal width on cortical cell spreads, a line was drawn across the widest part of the pericentromeric H4K20 signal, and an additional line was drawn perpendicular to this line. The length of both lines was measured and averaged. This was performed for three pericentromeric H4K20 signals per cell, and the average of the three measurements was calculated to determine the average width of the pericentromeric H4K20 signal in each cell. For H4K20 signal intensity, the H4K20 channel image was converted to grayscale, the pericentromeric H4K20 signal was outlined, and the average pixel intensity was measured within the outlined area. This was performed for three pericentromeric H4K20 signals per cell, and the average of the three measurements was calculated to determine the average intensity of the pericentromeric H4K20 signal in each cell. The average intensity was normalized to the background intensity of the image, which was determined by measuring the average pixel intensity of the grayscale image in the area where there were no chromosome spreads. Image data quantification was performed using Fiji (ImageJ).</p><p>For FANCD2, EdU, and CEN assessments in cortical cells and mESCs, foci were counted using the multi-point tool in Fiji (ImageJ).</p></sec><sec id="s4-13-3"><title>DNA fiber analysis</title><p>For measurements of DNA fiber length, a line was drawn along each dual-labeled DNA fiber. The length of the line was measured. For assessment of DNA fiber CldU/IdU ratio, a line was drawn along the CldU-labeled section and the IdU-labeled section of each dual-labeled fiber, and the length of the lines measured. The ratio of CldU length to IdU length was calculated. Image data quantification was performed using Fiji (ImageJ).</p></sec></sec><sec id="s4-14"><title>Statistical analysis</title><p>Statistical analyses were performed using GraphPad Prism V5/8 software and RStudio. For anaphase counts, cleavage plane orientation, and NPC percentage in VZ and outside of VZ statistical significance was assessed using a chi-squared test with Yates’ correction for continuity. For quantification of the western blot intensity in <xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref> the significance was assessed using an unpaired two-tailed Student’s t-test. For all other assessments, a non-parametric unpaired two-tailed Mann–Whitney U-test was used. p-values of less than 0.05 were considered significant. All data represent the means ± S.E.M. unless noted otherwise. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001, ****p&lt;0.0001 and ns (not significant) indicates &gt;0.05. Individual p-values for all graphs presented in each figure are available in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Ewelina Bolcun-Filas for the <italic>Chek2</italic> KO mouse, Thao Phan and Andrew Holland for discussion and reagents, and Jing Zhang and Michael Seidman for guidance with DNA fiber assay.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were bred at Johns Hopkins University (JHU, Baltimore, MD) in accordance with the National Institutes of Health and U.S. Department of Agriculture criteria and protocols for their care and use were approved by the Institutional Animal Care and Use Committees (IACUC) of JHU (Protocol number = MO19H08).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers used in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61171-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Antibodies used in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61171-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Statistics and p-values.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61171-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61171-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamus</surname> <given-names>M</given-names></name><name><surname>Lelkes</surname> <given-names>E</given-names></name><name><surname>Potesil</surname> <given-names>D</given-names></name><name><surname>Ganji</surname> <given-names>SR</given-names></name><name><surname>Kolesar</surname> <given-names>P</given-names></name><name><surname>Zabrady</surname> <given-names>K</given-names></name><name><surname>Zdrahal</surname> <given-names>Z</given-names></name><name><surname>Palecek</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular insights into the architecture of the human SMC5/6 complex</article-title><source>Journal of Molecular Biology</source><volume>432</volume><fpage>3820</fpage><lpage>3837</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2020.04.024</pub-id><pub-id pub-id-type="pmid">32389690</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahuja</surname> <given-names>AK</given-names></name><name><surname>Jodkowska</surname> <given-names>K</given-names></name><name><surname>Teloni</surname> <given-names>F</given-names></name><name><surname>Bizard</surname> <given-names>AH</given-names></name><name><surname>Zellweger</surname> <given-names>R</given-names></name><name><surname>Herrador</surname> <given-names>R</given-names></name><name><surname>Ortega</surname> <given-names>S</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name><name><surname>Altmeyer</surname> <given-names>M</given-names></name><name><surname>Mendez</surname> <given-names>J</given-names></name><name><surname>Lopes</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10660</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10660</pub-id><pub-id pub-id-type="pmid">26876348</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ampatzidou</surname> <given-names>E</given-names></name><name><surname>Irmisch</surname> <given-names>A</given-names></name><name><surname>O'Connell</surname> <given-names>MJ</given-names></name><name><surname>Murray</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Smc5/6 is required for repair at collapsed replication forks</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>9387</fpage><lpage>9401</lpage><pub-id pub-id-type="doi">10.1128/MCB.01335-06</pub-id><pub-id pub-id-type="pmid">17030601</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname> <given-names>EA</given-names></name><name><surname>Palecek</surname> <given-names>J</given-names></name><name><surname>Sergeant</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>E</given-names></name><name><surname>Lehmann</surname> <given-names>AR</given-names></name><name><surname>Watts</surname> <given-names>FZ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>185</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.1.185-196.2005</pub-id><pub-id pub-id-type="pmid">15601841</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragón</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Smc5/6 complex: new and old functions of the enigmatic Long-Distance relative</article-title><source>Annual Review of Genetics</source><volume>52</volume><fpage>89</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-120417-031353</pub-id><pub-id pub-id-type="pmid">30476445</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname> <given-names>Y</given-names></name><name><surname>Pulvers</surname> <given-names>JN</given-names></name><name><surname>Haffner</surname> <given-names>C</given-names></name><name><surname>Schilling</surname> <given-names>B</given-names></name><name><surname>Nüsslein</surname> <given-names>I</given-names></name><name><surname>Calegari</surname> <given-names>F</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural stem and progenitor cells shorten S-phase on commitment to neuron production</article-title><source>Nature Communications</source><volume>2</volume><elocation-id>154</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms1155</pub-id><pub-id pub-id-type="pmid">21224845</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arienti</surname> <given-names>KL</given-names></name><name><surname>Brunmark</surname> <given-names>A</given-names></name><name><surname>Axe</surname> <given-names>FU</given-names></name><name><surname>McClure</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>A</given-names></name><name><surname>Blevitt</surname> <given-names>J</given-names></name><name><surname>Neff</surname> <given-names>DK</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Crawford</surname> <given-names>S</given-names></name><name><surname>Pandit</surname> <given-names>CR</given-names></name><name><surname>Karlsson</surname> <given-names>L</given-names></name><name><surname>Breitenbucher</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Checkpoint kinase inhibitors: sar and radioprotective properties of a series of 2-arylbenzimidazoles</article-title><source>Journal of Medicinal Chemistry</source><volume>48</volume><fpage>1873</fpage><lpage>1885</lpage><pub-id pub-id-type="doi">10.1021/jm0495935</pub-id><pub-id pub-id-type="pmid">15771432</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname> <given-names>SJ</given-names></name><name><surname>Huang</surname> <given-names>GJ</given-names></name><name><surname>Cheung</surname> <given-names>AF</given-names></name><name><surname>Era</surname> <given-names>T</given-names></name><name><surname>Nishikawa</surname> <given-names>S</given-names></name><name><surname>Bikoff</surname> <given-names>EK</given-names></name><name><surname>Molnár</surname> <given-names>Z</given-names></name><name><surname>Robertson</surname> <given-names>EJ</given-names></name><name><surname>Groszer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The T-box transcription factor eomes/Tbr2 regulates neurogenesis in the cortical subventricular zone</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>2479</fpage><lpage>2484</lpage><pub-id pub-id-type="doi">10.1101/gad.475408</pub-id><pub-id pub-id-type="pmid">18794345</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname> <given-names>JH</given-names></name><name><surname>Faryabi</surname> <given-names>RB</given-names></name><name><surname>Callén</surname> <given-names>E</given-names></name><name><surname>Wong</surname> <given-names>N</given-names></name><name><surname>Malhowski</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>HT</given-names></name><name><surname>Gutierrez-Cruz</surname> <given-names>G</given-names></name><name><surname>Sun</surname> <given-names>HW</given-names></name><name><surname>McKinnon</surname> <given-names>P</given-names></name><name><surname>Wright</surname> <given-names>G</given-names></name><name><surname>Casellas</surname> <given-names>R</given-names></name><name><surname>Robbiani</surname> <given-names>DF</given-names></name><name><surname>Staudt</surname> <given-names>L</given-names></name><name><surname>Fernandez-Capetillo</surname> <given-names>O</given-names></name><name><surname>Nussenzweig</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of early replicating fragile sites that contribute to genome instability</article-title><source>Cell</source><volume>152</volume><fpage>620</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.01.006</pub-id><pub-id pub-id-type="pmid">23352430</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batty</surname> <given-names>P</given-names></name><name><surname>Gerlich</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitotic chromosome mechanics: how cells segregate their genome</article-title><source>Trends in Cell Biology</source><volume>29</volume><fpage>717</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2019.05.007</pub-id><pub-id pub-id-type="pmid">31230958</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bermúdez-López</surname> <given-names>M</given-names></name><name><surname>Ceschia</surname> <given-names>A</given-names></name><name><surname>de Piccoli</surname> <given-names>G</given-names></name><name><surname>Colomina</surname> <given-names>N</given-names></name><name><surname>Pasero</surname> <given-names>P</given-names></name><name><surname>Aragón</surname> <given-names>L</given-names></name><name><surname>Torres-Rosell</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Smc5/6 complex is required for dissolution of DNA-mediated sister chromatid linkages</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>6502</fpage><lpage>6512</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq546</pub-id><pub-id pub-id-type="pmid">20571088</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal</surname> <given-names>A</given-names></name><name><surname>Arranz</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nestin-expressing progenitor cells: function, identity and therapeutic implications</article-title><source>Cellular and Molecular Life Sciences</source><volume>75</volume><fpage>2177</fpage><lpage>2195</lpage><pub-id pub-id-type="doi">10.1007/s00018-018-2794-z</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berti</surname> <given-names>M</given-names></name><name><surname>Vindigni</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Replication stress: getting back on track</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>23</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3163</pub-id><pub-id pub-id-type="pmid">26840898</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmick</surname> <given-names>R</given-names></name><name><surname>Minocherhomji</surname> <given-names>S</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RAD52 facilitates mitotic DNA synthesis following replication stress</article-title><source>Molecular Cell</source><volume>64</volume><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.10.037</pub-id><pub-id pub-id-type="pmid">27984745</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blow</surname> <given-names>JJ</given-names></name><name><surname>Ge</surname> <given-names>XQ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A model for DNA replication showing how dormant origins safeguard against replication fork failure</article-title><source>EMBO Reports</source><volume>10</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/embor.2009.5</pub-id><pub-id pub-id-type="pmid">19218919</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouet</surname> <given-names>V</given-names></name><name><surname>Boulouard</surname> <given-names>M</given-names></name><name><surname>Toutain</surname> <given-names>J</given-names></name><name><surname>Divoux</surname> <given-names>D</given-names></name><name><surname>Bernaudin</surname> <given-names>M</given-names></name><name><surname>Schumann-Bard</surname> <given-names>P</given-names></name><name><surname>Freret</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice</article-title><source>Nature Protocols</source><volume>4</volume><fpage>1560</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.125</pub-id><pub-id pub-id-type="pmid">19798088</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>MI</given-names></name><name><surname>Jespersgaard</surname> <given-names>C</given-names></name><name><surname>Brøndum-Nielsen</surname> <given-names>K</given-names></name><name><surname>Bisgaard</surname> <given-names>AM</given-names></name><name><surname>Tümer</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cornelia De Lange syndrome</article-title><source>Clinical Genetics</source><volume>88</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/cge.12499</pub-id><pub-id pub-id-type="pmid">25209348</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>NW</given-names></name><name><surname>Dilley</surname> <given-names>RL</given-names></name><name><surname>Lampson</surname> <given-names>MA</given-names></name><name><surname>Greenberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interchromosomal homology searches drive directional ALT telomere movement and Synapsis</article-title><source>Cell</source><volume>159</volume><fpage>108</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.030</pub-id><pub-id pub-id-type="pmid">25259924</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>B</given-names></name><name><surname>Zhao</surname> <given-names>XF</given-names></name><name><surname>Mazan-Mamczarz</surname> <given-names>K</given-names></name><name><surname>Hagner</surname> <given-names>P</given-names></name><name><surname>Corl</surname> <given-names>S</given-names></name><name><surname>Bahassi</surname> <given-names>elM</given-names></name><name><surname>Lu</surname> <given-names>S</given-names></name><name><surname>Stambrook</surname> <given-names>PJ</given-names></name><name><surname>Shapiro</surname> <given-names>P</given-names></name><name><surname>Gartenhaus</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma</article-title><source>Nature Communications</source><volume>2</volume><elocation-id>402</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms1404</pub-id><pub-id pub-id-type="pmid">21772273</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname> <given-names>A</given-names></name><name><surname>Brosh Jr.</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Holding all the Cards—How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability</article-title><source>Genes</source><volume>10</volume><elocation-id>170</elocation-id><pub-id pub-id-type="doi">10.3390/genes10020170</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname> <given-names>RMJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Measuring the strength of mice</article-title><source>Journal of Visualized Experiments</source><volume>2013</volume><elocation-id>2610</elocation-id><pub-id pub-id-type="doi">10.3791/2610</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewar</surname> <given-names>JM</given-names></name><name><surname>Walter</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanisms of DNA replication termination</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>507</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.42</pub-id><pub-id pub-id-type="pmid">28537574</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname> <given-names>NC</given-names></name><name><surname>Hofmann</surname> <given-names>D</given-names></name><name><surname>Kaloulis</surname> <given-names>K</given-names></name><name><surname>Bishop</surname> <given-names>JM</given-names></name><name><surname>Trumpp</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues</article-title><source>Genesis</source><volume>44</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1002/dvg.20226</pub-id><pub-id pub-id-type="pmid">16847871</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Englund</surname> <given-names>C</given-names></name><name><surname>Fink</surname> <given-names>A</given-names></name><name><surname>Lau</surname> <given-names>C</given-names></name><name><surname>Pham</surname> <given-names>D</given-names></name><name><surname>Daza</surname> <given-names>RA</given-names></name><name><surname>Bulfone</surname> <given-names>A</given-names></name><name><surname>Kowalczyk</surname> <given-names>T</given-names></name><name><surname>Hevner</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pax6, Tbr2, and Tbr1 are expressed sequentially by radial Glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2899-04.2005</pub-id><pub-id pub-id-type="pmid">15634788</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enriquez-Rios</surname> <given-names>V</given-names></name><name><surname>Dumitrache</surname> <given-names>LC</given-names></name><name><surname>Downing</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Brown</surname> <given-names>EJ</given-names></name><name><surname>Russell</surname> <given-names>HR</given-names></name><name><surname>McKinnon</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DNA-PKcs, ATM, and ATR interplay maintains genome integrity during neurogenesis</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>893</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4213-15.2016</pub-id><pub-id pub-id-type="pmid">28123024</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferri</surname> <given-names>AL</given-names></name><name><surname>Cavallaro</surname> <given-names>M</given-names></name><name><surname>Braida</surname> <given-names>D</given-names></name><name><surname>Di Cristofano</surname> <given-names>A</given-names></name><name><surname>Canta</surname> <given-names>A</given-names></name><name><surname>Vezzani</surname> <given-names>A</given-names></name><name><surname>Ottolenghi</surname> <given-names>S</given-names></name><name><surname>Pandolfi</surname> <given-names>PP</given-names></name><name><surname>Sala</surname> <given-names>M</given-names></name><name><surname>DeBiasi</surname> <given-names>S</given-names></name><name><surname>Nicolis</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain</article-title><source>Development</source><volume>131</volume><fpage>3805</fpage><lpage>3819</lpage><pub-id pub-id-type="doi">10.1242/dev.01204</pub-id><pub-id pub-id-type="pmid">15240551</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>SM</given-names></name><name><surname>Ekhator</surname> <given-names>OR</given-names></name><name><surname>Ghisays</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Assessment of sensorimotor function in mouse models of Parkinson's disease</article-title><source>Journal of Visualized Experiments</source><volume>2013</volume><elocation-id>50303</elocation-id><pub-id pub-id-type="doi">10.3791/50303</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fungtammasan</surname> <given-names>A</given-names></name><name><surname>Walsh</surname> <given-names>E</given-names></name><name><surname>Chiaromonte</surname> <given-names>F</given-names></name><name><surname>Eckert</surname> <given-names>KA</given-names></name><name><surname>Makova</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome?</article-title><source>Genome Research</source><volume>22</volume><fpage>993</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1101/gr.134395.111</pub-id><pub-id pub-id-type="pmid">22456607</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaddipati</surname> <given-names>H</given-names></name><name><surname>Pryzhkova</surname> <given-names>MV</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conditional mutation of SMC5 in mouse embryonic fibroblasts</article-title><source>Methods in Molecular Biology</source><volume>2004</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9520-2_4</pub-id><pub-id pub-id-type="pmid">31147908</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaitanou</surname> <given-names>M</given-names></name><name><surname>Segklia</surname> <given-names>K</given-names></name><name><surname>Matsas</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cend1, a story with many tales: from regulation of cell cycle progression/Exit of neural stem cells to brain structure and function</article-title><source>Stem Cells International</source><volume>2019</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1155/2019/2054783</pub-id><pub-id pub-id-type="pmid">31191667</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallego-Paez</surname> <given-names>LM</given-names></name><name><surname>Tanaka</surname> <given-names>H</given-names></name><name><surname>Bando</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>M</given-names></name><name><surname>Nozaki</surname> <given-names>N</given-names></name><name><surname>Nakato</surname> <given-names>R</given-names></name><name><surname>Shirahige</surname> <given-names>K</given-names></name><name><surname>Hirota</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Smc5/6-mediated regulation of replication progression contributes to chromosome assembly during mitosis in human cells</article-title><source>Molecular Biology of the Cell</source><volume>25</volume><fpage>302</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1091/mbc.e13-01-0020</pub-id><pub-id pub-id-type="pmid">24258023</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname> <given-names>XQ</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Cheng</surname> <given-names>EC</given-names></name><name><surname>Yamaguchi</surname> <given-names>S</given-names></name><name><surname>Shima</surname> <given-names>N</given-names></name><name><surname>Thomas</surname> <given-names>JL</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Embryonic stem cells license a high level of dormant origins to protect the genome against replication stress</article-title><source>Stem Cell Reports</source><volume>5</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.06.002</pub-id><pub-id pub-id-type="pmid">26190528</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname> <given-names>TW</given-names></name><name><surname>Arlt</surname> <given-names>MF</given-names></name><name><surname>Casper</surname> <given-names>AM</given-names></name><name><surname>Durkin</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mechanisms of common fragile site instability</article-title><source>Human Molecular Genetics</source><volume>14</volume><fpage>R197</fpage><lpage>R205</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi265</pub-id><pub-id pub-id-type="pmid">16244318</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez</surname> <given-names>R</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name><name><surname>Viera</surname> <given-names>A</given-names></name><name><surname>Alsheimer</surname> <given-names>M</given-names></name><name><surname>Fukuda</surname> <given-names>T</given-names></name><name><surname>Jessberger</surname> <given-names>R</given-names></name><name><surname>Llano</surname> <given-names>E</given-names></name><name><surname>Pendás</surname> <given-names>AM</given-names></name><name><surname>Handel</surname> <given-names>MA</given-names></name><name><surname>Suja</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dynamic localization of SMC5/6 complex proteins during mammalian meiosis and mitosis suggests functions in distinct chromosome processes</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>4239</fpage><lpage>4252</lpage><pub-id pub-id-type="doi">10.1242/jcs.130195</pub-id><pub-id pub-id-type="pmid">23843628</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalo</surname> <given-names>S</given-names></name><name><surname>García-Cao</surname> <given-names>M</given-names></name><name><surname>Fraga</surname> <given-names>MF</given-names></name><name><surname>Schotta</surname> <given-names>G</given-names></name><name><surname>Peters</surname> <given-names>AH</given-names></name><name><surname>Cotter</surname> <given-names>SE</given-names></name><name><surname>Eguía</surname> <given-names>R</given-names></name><name><surname>Dean</surname> <given-names>DC</given-names></name><name><surname>Esteller</surname> <given-names>M</given-names></name><name><surname>Jenuwein</surname> <given-names>T</given-names></name><name><surname>Blasco</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin</article-title><source>Nature Cell Biology</source><volume>7</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1038/ncb1235</pub-id><pub-id pub-id-type="pmid">15750587</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorski</surname> <given-names>JA</given-names></name><name><surname>Talley</surname> <given-names>T</given-names></name><name><surname>Qiu</surname> <given-names>M</given-names></name><name><surname>Puelles</surname> <given-names>L</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Jones</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cortical excitatory neurons and Glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>6309</fpage><lpage>6314</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-15-06309.2002</pub-id><pub-id pub-id-type="pmid">12151506</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graber-Feesl</surname> <given-names>CL</given-names></name><name><surname>Pederson</surname> <given-names>KD</given-names></name><name><surname>Aney</surname> <given-names>KJ</given-names></name><name><surname>Shima</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitotic DNA synthesis is differentially regulated between Cancer and noncancerous cells</article-title><source>Molecular Cancer Research</source><volume>17</volume><fpage>1687</fpage><lpage>1698</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-19-0057</pub-id><pub-id pub-id-type="pmid">31113828</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname> <given-names>RM</given-names></name><name><surname>Wozniak</surname> <given-names>DF</given-names></name><name><surname>Ohlemiller</surname> <given-names>KK</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>2841</fpage><lpage>2851</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4823-05.2006</pub-id><pub-id pub-id-type="pmid">16540561</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagstrom</surname> <given-names>KA</given-names></name><name><surname>Meyer</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Condensin and cohesin: more than chromosome compactor and glue</article-title><source>Nature Reviews Genetics</source><volume>4</volume><fpage>520</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nrg1110</pub-id><pub-id pub-id-type="pmid">12838344</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname> <given-names>ME</given-names></name><name><surname>Murina</surname> <given-names>O</given-names></name><name><surname>Leitch</surname> <given-names>A</given-names></name><name><surname>Higgs</surname> <given-names>MR</given-names></name><name><surname>Bicknell</surname> <given-names>LS</given-names></name><name><surname>Yigit</surname> <given-names>G</given-names></name><name><surname>Blackford</surname> <given-names>AN</given-names></name><name><surname>Zlatanou</surname> <given-names>A</given-names></name><name><surname>Mackenzie</surname> <given-names>KJ</given-names></name><name><surname>Reddy</surname> <given-names>K</given-names></name><name><surname>Halachev</surname> <given-names>M</given-names></name><name><surname>McGlasson</surname> <given-names>S</given-names></name><name><surname>Reijns</surname> <given-names>MAM</given-names></name><name><surname>Fluteau</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>CA</given-names></name><name><surname>Sabbioneda</surname> <given-names>S</given-names></name><name><surname>Elcioglu</surname> <given-names>NH</given-names></name><name><surname>Altmüller</surname> <given-names>J</given-names></name><name><surname>Thiele</surname> <given-names>H</given-names></name><name><surname>Greenhalgh</surname> <given-names>L</given-names></name><name><surname>Chessa</surname> <given-names>L</given-names></name><name><surname>Maghnie</surname> <given-names>M</given-names></name><name><surname>Salim</surname> <given-names>M</given-names></name><name><surname>Bober</surname> <given-names>MB</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Jackson</surname> <given-names>SP</given-names></name><name><surname>Hurles</surname> <given-names>ME</given-names></name><name><surname>Wollnik</surname> <given-names>B</given-names></name><name><surname>Stewart</surname> <given-names>GS</given-names></name><name><surname>Jackson</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism</article-title><source>Nature Genetics</source><volume>48</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1038/ng.3451</pub-id><pub-id pub-id-type="pmid">26595769</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassler</surname> <given-names>M</given-names></name><name><surname>Shaltiel</surname> <given-names>IA</given-names></name><name><surname>Haering</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Towards a unified model of SMC complex function</article-title><source>Current Biology</source><volume>28</volume><fpage>R1266</fpage><lpage>R1281</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.08.034</pub-id><pub-id pub-id-type="pmid">30399354</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Condensin-Based chromosome organization from Bacteria to vertebrates</article-title><source>Cell</source><volume>164</volume><fpage>847</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.01.033</pub-id><pub-id pub-id-type="pmid">26919425</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homsy</surname> <given-names>J</given-names></name><name><surname>Zaidi</surname> <given-names>S</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Ware</surname> <given-names>JS</given-names></name><name><surname>Samocha</surname> <given-names>KE</given-names></name><name><surname>Karczewski</surname> <given-names>KJ</given-names></name><name><surname>DePalma</surname> <given-names>SR</given-names></name><name><surname>McKean</surname> <given-names>D</given-names></name><name><surname>Wakimoto</surname> <given-names>H</given-names></name><name><surname>Gorham</surname> <given-names>J</given-names></name><name><surname>Jin</surname> <given-names>SC</given-names></name><name><surname>Deanfield</surname> <given-names>J</given-names></name><name><surname>Giardini</surname> <given-names>A</given-names></name><name><surname>Porter</surname> <given-names>GA</given-names></name><name><surname>Kim</surname> <given-names>R</given-names></name><name><surname>Bilguvar</surname> <given-names>K</given-names></name><name><surname>López-Giráldez</surname> <given-names>F</given-names></name><name><surname>Tikhonova</surname> <given-names>I</given-names></name><name><surname>Mane</surname> <given-names>S</given-names></name><name><surname>Romano-Adesman</surname> <given-names>A</given-names></name><name><surname>Qi</surname> <given-names>H</given-names></name><name><surname>Vardarajan</surname> <given-names>B</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Daly</surname> <given-names>M</given-names></name><name><surname>Roberts</surname> <given-names>AE</given-names></name><name><surname>Russell</surname> <given-names>MW</given-names></name><name><surname>Mital</surname> <given-names>S</given-names></name><name><surname>Newburger</surname> <given-names>JW</given-names></name><name><surname>Gaynor</surname> <given-names>JW</given-names></name><name><surname>Breitbart</surname> <given-names>RE</given-names></name><name><surname>Iossifov</surname> <given-names>I</given-names></name><name><surname>Ronemus</surname> <given-names>M</given-names></name><name><surname>Sanders</surname> <given-names>SJ</given-names></name><name><surname>Kaltman</surname> <given-names>JR</given-names></name><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Brueckner</surname> <given-names>M</given-names></name><name><surname>Gelb</surname> <given-names>BD</given-names></name><name><surname>Goldmuntz</surname> <given-names>E</given-names></name><name><surname>Lifton</surname> <given-names>RP</given-names></name><name><surname>Seidman</surname> <given-names>CE</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies</article-title><source>Science</source><volume>350</volume><fpage>1262</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1126/science.aac9396</pub-id><pub-id pub-id-type="pmid">26785492</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Bellani</surname> <given-names>MA</given-names></name><name><surname>Thazhathveetil</surname> <given-names>AK</given-names></name><name><surname>Ling</surname> <given-names>C</given-names></name><name><surname>de Winter</surname> <given-names>JP</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Seidman</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks</article-title><source>Molecular Cell</source><volume>52</volume><fpage>434</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.09.021</pub-id><pub-id pub-id-type="pmid">24207054</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>G</given-names></name><name><surname>Sun</surname> <given-names>F</given-names></name><name><surname>O'Brien</surname> <given-names>M</given-names></name><name><surname>Eppig</surname> <given-names>JJ</given-names></name><name><surname>Handel</surname> <given-names>MA</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SMC5/6 is required for the formation of segregation-competent bivalent chromosomes during meiosis I in mouse oocytes</article-title><source>Development</source><volume>144</volume><fpage>1648</fpage><lpage>1660</lpage><pub-id pub-id-type="doi">10.1242/dev.145607</pub-id><pub-id pub-id-type="pmid">28302748</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>G</given-names></name><name><surname>Verver</surname> <given-names>DE</given-names></name><name><surname>Handel</surname> <given-names>MA</given-names></name><name><surname>Hamer</surname> <given-names>G</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Depletion of SMC5/6 sensitizes male germ cells to DNA damage</article-title><source>Molecular Biology of the Cell</source><volume>29</volume><fpage>3003</fpage><lpage>3016</lpage><pub-id pub-id-type="doi">10.1091/mbc.E18-07-0459</pub-id><pub-id pub-id-type="pmid">30281394</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insolera</surname> <given-names>R</given-names></name><name><surname>Bazzi</surname> <given-names>H</given-names></name><name><surname>Shao</surname> <given-names>W</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name><name><surname>Shi</surname> <given-names>S-H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cortical neurogenesis in the absence of centrioles</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>1528</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1038/nn.3831</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacome</surname> <given-names>A</given-names></name><name><surname>Gutierrez-Martinez</surname> <given-names>P</given-names></name><name><surname>Schiavoni</surname> <given-names>F</given-names></name><name><surname>Tenaglia</surname> <given-names>E</given-names></name><name><surname>Martinez</surname> <given-names>P</given-names></name><name><surname>Rodríguez-Acebes</surname> <given-names>S</given-names></name><name><surname>Lecona</surname> <given-names>E</given-names></name><name><surname>Murga</surname> <given-names>M</given-names></name><name><surname>Méndez</surname> <given-names>J</given-names></name><name><surname>Blasco</surname> <given-names>MA</given-names></name><name><surname>Fernandez-Capetillo</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>2604</fpage><lpage>2619</lpage><pub-id pub-id-type="doi">10.15252/embj.201591829</pub-id><pub-id pub-id-type="pmid">26443207</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>NF</given-names></name><name><surname>Stenvang</surname> <given-names>J</given-names></name><name><surname>Beck</surname> <given-names>MK</given-names></name><name><surname>Hanáková</surname> <given-names>B</given-names></name><name><surname>Belling</surname> <given-names>KC</given-names></name><name><surname>Do</surname> <given-names>KN</given-names></name><name><surname>Viuff</surname> <given-names>B</given-names></name><name><surname>Nygård</surname> <given-names>SB</given-names></name><name><surname>Gupta</surname> <given-names>R</given-names></name><name><surname>Rasmussen</surname> <given-names>MH</given-names></name><name><surname>Tarpgaard</surname> <given-names>LS</given-names></name><name><surname>Hansen</surname> <given-names>TP</given-names></name><name><surname>Budinská</surname> <given-names>E</given-names></name><name><surname>Pfeiffer</surname> <given-names>P</given-names></name><name><surname>Bosman</surname> <given-names>F</given-names></name><name><surname>Tejpar</surname> <given-names>S</given-names></name><name><surname>Roth</surname> <given-names>A</given-names></name><name><surname>Delorenzi</surname> <given-names>M</given-names></name><name><surname>Andersen</surname> <given-names>CL</given-names></name><name><surname>Rømer</surname> <given-names>MU</given-names></name><name><surname>Brünner</surname> <given-names>N</given-names></name><name><surname>Moreira</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Establishment and characterization of models of chemotherapy resistance in colorectal Cancer: towards a predictive signature of chemoresistance</article-title><source>Molecular Oncology</source><volume>9</volume><fpage>1169</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1016/j.molonc.2015.02.008</pub-id><pub-id pub-id-type="pmid">25759163</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Nardelli</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cellular and molecular introduction to brain development</article-title><source>Neurobiology of Disease</source><volume>92</volume><fpage>3</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2015.07.007</pub-id><pub-id pub-id-type="pmid">26184894</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>SC</given-names></name><name><surname>Homsy</surname> <given-names>J</given-names></name><name><surname>Zaidi</surname> <given-names>S</given-names></name><name><surname>Lu</surname> <given-names>Q</given-names></name><name><surname>Morton</surname> <given-names>S</given-names></name><name><surname>DePalma</surname> <given-names>SR</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Qi</surname> <given-names>H</given-names></name><name><surname>Chang</surname> <given-names>W</given-names></name><name><surname>Sierant</surname> <given-names>MC</given-names></name><name><surname>Hung</surname> <given-names>WC</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Knight</surname> <given-names>J</given-names></name><name><surname>Bjornson</surname> <given-names>RD</given-names></name><name><surname>Castaldi</surname> <given-names>C</given-names></name><name><surname>Tikhonoa</surname> <given-names>IR</given-names></name><name><surname>Bilguvar</surname> <given-names>K</given-names></name><name><surname>Mane</surname> <given-names>SM</given-names></name><name><surname>Sanders</surname> <given-names>SJ</given-names></name><name><surname>Mital</surname> <given-names>S</given-names></name><name><surname>Russell</surname> <given-names>MW</given-names></name><name><surname>Gaynor</surname> <given-names>JW</given-names></name><name><surname>Deanfield</surname> <given-names>J</given-names></name><name><surname>Giardini</surname> <given-names>A</given-names></name><name><surname>Porter</surname> <given-names>GA</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name><name><surname>Lo</surname> <given-names>CW</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Watkins</surname> <given-names>WS</given-names></name><name><surname>Yandell</surname> <given-names>M</given-names></name><name><surname>Yost</surname> <given-names>HJ</given-names></name><name><surname>Tristani-Firouzi</surname> <given-names>M</given-names></name><name><surname>Newburger</surname> <given-names>JW</given-names></name><name><surname>Roberts</surname> <given-names>AE</given-names></name><name><surname>Kim</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Kaltman</surname> <given-names>JR</given-names></name><name><surname>Goldmuntz</surname> <given-names>E</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Gelb</surname> <given-names>BD</given-names></name><name><surname>Seidman</surname> <given-names>CE</given-names></name><name><surname>Lifton</surname> <given-names>RP</given-names></name><name><surname>Brueckner</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1593</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1038/ng.3970</pub-id><pub-id pub-id-type="pmid">28991257</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jørgensen</surname> <given-names>S</given-names></name><name><surname>Schotta</surname> <given-names>G</given-names></name><name><surname>Sørensen</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>2797</fpage><lpage>2806</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt012</pub-id><pub-id pub-id-type="pmid">23345616</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname> <given-names>L</given-names></name><name><surname>Wing</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>E</given-names></name><name><surname>Brandt</surname> <given-names>R</given-names></name><name><surname>Slijepcevic</surname> <given-names>P</given-names></name><name><surname>Horsch</surname> <given-names>M</given-names></name><name><surname>Rathkolb</surname> <given-names>B</given-names></name><name><surname>Rácz</surname> <given-names>I</given-names></name><name><surname>Becker</surname> <given-names>L</given-names></name><name><surname>Hans</surname> <given-names>W</given-names></name><name><surname>Adler</surname> <given-names>T</given-names></name><name><surname>Beckers</surname> <given-names>J</given-names></name><name><surname>Rozman</surname> <given-names>J</given-names></name><name><surname>Klingenspor</surname> <given-names>M</given-names></name><name><surname>Wolf</surname> <given-names>E</given-names></name><name><surname>Zimmer</surname> <given-names>A</given-names></name><name><surname>Klopstock</surname> <given-names>T</given-names></name><name><surname>Busch</surname> <given-names>DH</given-names></name><name><surname>Gailus-Durner</surname> <given-names>V</given-names></name><name><surname>Fuchs</surname> <given-names>H</given-names></name><name><surname>de Angelis</surname> <given-names>MH</given-names></name><name><surname>van der Horst</surname> <given-names>G</given-names></name><name><surname>Lehmann</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SMC6 is an essential gene in mice, but a hypomorphic mutant in the ATPase domain has a mild phenotype with a range of subtle abnormalities</article-title><source>DNA Repair</source><volume>12</volume><fpage>356</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2013.02.006</pub-id><pub-id pub-id-type="pmid">23518413</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagami</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The functional role for condensin in the regulation of chromosomal organization during the cell cycle</article-title><source>Cellular and Molecular Life Sciences</source><volume>73</volume><fpage>4591</fpage><lpage>4598</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2305-z</pub-id><pub-id pub-id-type="pmid">27402120</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katyal</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Nitiss</surname> <given-names>KC</given-names></name><name><surname>Downing</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Shimada</surname> <given-names>M</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Russell</surname> <given-names>HR</given-names></name><name><surname>Petrini</surname> <given-names>JH</given-names></name><name><surname>Nitiss</surname> <given-names>JL</given-names></name><name><surname>McKinnon</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>813</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1038/nn.3715</pub-id><pub-id pub-id-type="pmid">24793032</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname> <given-names>C</given-names></name><name><surname>Diaz</surname> <given-names>H</given-names></name><name><surname>Barnard</surname> <given-names>D</given-names></name><name><surname>Barda</surname> <given-names>D</given-names></name><name><surname>Clawson</surname> <given-names>D</given-names></name><name><surname>Blosser</surname> <given-names>W</given-names></name><name><surname>Cox</surname> <given-names>K</given-names></name><name><surname>Guo</surname> <given-names>S</given-names></name><name><surname>Marshall</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor</article-title><source>Investigational New Drugs</source><volume>32</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1007/s10637-013-0036-7</pub-id><pub-id pub-id-type="pmid">24114124</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalczyk</surname> <given-names>T</given-names></name><name><surname>Pontious</surname> <given-names>A</given-names></name><name><surname>Englund</surname> <given-names>C</given-names></name><name><surname>Daza</surname> <given-names>RA</given-names></name><name><surname>Bedogni</surname> <given-names>F</given-names></name><name><surname>Hodge</surname> <given-names>R</given-names></name><name><surname>Attardo</surname> <given-names>A</given-names></name><name><surname>Bell</surname> <given-names>C</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name><name><surname>Hevner</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex</article-title><source>Cerebral Cortex</source><volume>19</volume><fpage>2439</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhn260</pub-id><pub-id pub-id-type="pmid">19168665</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kschonsak</surname> <given-names>M</given-names></name><name><surname>Haering</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Shaping mitotic chromosomes: from classical concepts to molecular mechanisms</article-title><source>BioEssays</source><volume>37</volume><fpage>755</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1002/bies.201500020</pub-id><pub-id pub-id-type="pmid">25988527</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakomá</surname> <given-names>J</given-names></name><name><surname>Garcia-Alonso</surname> <given-names>L</given-names></name><name><surname>Luque</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Reelin sets the pace of neocortical neurogenesis</article-title><source>Development</source><volume>138</volume><fpage>5223</fpage><lpage>5234</lpage><pub-id pub-id-type="doi">10.1242/dev.063776</pub-id><pub-id pub-id-type="pmid">22069190</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname> <given-names>MA</given-names></name><name><surname>Knoblich</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Spindle orientation in mammalian cerebral cortical development</article-title><source>Current Opinion in Neurobiology</source><volume>22</volume><fpage>737</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2012.04.003</pub-id><pub-id pub-id-type="pmid">22554882</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname> <given-names>MJ</given-names></name><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Benson</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>GR</given-names></name><name><surname>Chao</surname> <given-names>C</given-names></name><name><surname>Chitipiralla</surname> <given-names>S</given-names></name><name><surname>Gu</surname> <given-names>B</given-names></name><name><surname>Hart</surname> <given-names>J</given-names></name><name><surname>Hoffman</surname> <given-names>D</given-names></name><name><surname>Jang</surname> <given-names>W</given-names></name><name><surname>Karapetyan</surname> <given-names>K</given-names></name><name><surname>Katz</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Maddipatla</surname> <given-names>Z</given-names></name><name><surname>Malheiro</surname> <given-names>A</given-names></name><name><surname>McDaniel</surname> <given-names>K</given-names></name><name><surname>Ovetsky</surname> <given-names>M</given-names></name><name><surname>Riley</surname> <given-names>G</given-names></name><name><surname>Zhou</surname> <given-names>G</given-names></name><name><surname>Holmes</surname> <given-names>JB</given-names></name><name><surname>Kattman</surname> <given-names>BL</given-names></name><name><surname>Maglott</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D1062</fpage><lpage>D1067</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1153</pub-id><pub-id pub-id-type="pmid">29165669</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavado</surname> <given-names>A</given-names></name><name><surname>Park</surname> <given-names>JY</given-names></name><name><surname>Paré</surname> <given-names>J</given-names></name><name><surname>Finkelstein</surname> <given-names>D</given-names></name><name><surname>Pan</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>B</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Kumar</surname> <given-names>RP</given-names></name><name><surname>Neale</surname> <given-names>G</given-names></name><name><surname>Kwak</surname> <given-names>YD</given-names></name><name><surname>McKinnon</surname> <given-names>PJ</given-names></name><name><surname>Johnson</surname> <given-names>RL</given-names></name><name><surname>Cao</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The hippo pathway prevents YAP/TAZ-Driven hypertranscription and controls neural progenitor number</article-title><source>Developmental Cell</source><volume>47</volume><fpage>576</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.09.021</pub-id><pub-id pub-id-type="pmid">30523785</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Katyal</surname> <given-names>S</given-names></name><name><surname>Downing</surname> <given-names>SM</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Russell</surname> <given-names>HR</given-names></name><name><surname>McKinnon</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>819</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1038/nn.3097</pub-id><pub-id pub-id-type="pmid">22522401</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname> <given-names>AR</given-names></name><name><surname>Walicka</surname> <given-names>M</given-names></name><name><surname>Griffiths</surname> <given-names>DJ</given-names></name><name><surname>Murray</surname> <given-names>JM</given-names></name><name><surname>Watts</surname> <given-names>FZ</given-names></name><name><surname>McCready</surname> <given-names>S</given-names></name><name><surname>Carr</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The rad18 gene of <italic>Schizosaccharomyces pombe</italic> defines a new subgroup of the SMC superfamily involved in DNA repair</article-title><source>Molecular and Cellular Biology</source><volume>15</volume><fpage>7067</fpage><lpage>7080</lpage><pub-id pub-id-type="doi">10.1128/MCB.15.12.7067</pub-id><pub-id pub-id-type="pmid">8524274</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of SMC proteins in the responses to DNA damage</article-title><source>DNA Repair</source><volume>4</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2004.07.009</pub-id><pub-id pub-id-type="pmid">15661654</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leingärtner</surname> <given-names>A</given-names></name><name><surname>Thuret</surname> <given-names>S</given-names></name><name><surname>Kroll</surname> <given-names>TT</given-names></name><name><surname>Chou</surname> <given-names>SJ</given-names></name><name><surname>Leasure</surname> <given-names>JL</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>O'Leary</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cortical area size dictates performance at modality-specific behaviors</article-title><source>PNAS</source><volume>104</volume><fpage>4153</fpage><lpage>4158</lpage><pub-id pub-id-type="doi">10.1073/pnas.0611723104</pub-id><pub-id pub-id-type="pmid">17360492</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madabhushi</surname> <given-names>R</given-names></name><name><surname>Pan</surname> <given-names>L</given-names></name><name><surname>Tsai</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>DNA damage and its links to neurodegeneration</article-title><source>Neuron</source><volume>83</volume><fpage>266</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.06.034</pub-id><pub-id pub-id-type="pmid">25033177</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdalou</surname> <given-names>I</given-names></name><name><surname>Lopez</surname> <given-names>BS</given-names></name><name><surname>Pasero</surname> <given-names>P</given-names></name><name><surname>Lambert</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The causes of replication stress and their consequences on genome stability and cell fate</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>30</volume><fpage>154</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.04.035</pub-id><pub-id pub-id-type="pmid">24818779</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magno</surname> <given-names>LA</given-names></name><name><surname>Collodetti</surname> <given-names>M</given-names></name><name><surname>Tenza-Ferrer</surname> <given-names>H</given-names></name><name><surname>Romano-Silva</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cylinder test to assess Sensory-Motor function in a mouse model of Parkinson’s Disease</article-title><source>Bio-Protocol</source><volume>9</volume><elocation-id>3337</elocation-id><pub-id pub-id-type="doi">10.21769/BioProtoc.3337</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallm</surname> <given-names>JP</given-names></name><name><surname>Rippe</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Aurora kinase B regulates telomerase activity via a centromeric RNA in stem cells</article-title><source>Cell Reports</source><volume>11</volume><fpage>1667</fpage><lpage>1678</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.05.015</pub-id><pub-id pub-id-type="pmid">26051938</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mankouri</surname> <given-names>HW</given-names></name><name><surname>Huttner</surname> <given-names>D</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>How unfinished business from S-phase affects mitosis and beyond</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2661</fpage><lpage>2671</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.211</pub-id><pub-id pub-id-type="pmid">24065128</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maréchal</surname> <given-names>A</given-names></name><name><surname>Zou</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DNA damage sensing by the ATM and ATR kinases</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>5</volume><elocation-id>a012716</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a012716</pub-id><pub-id pub-id-type="pmid">24003211</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marthiens</surname> <given-names>V</given-names></name><name><surname>Rujano</surname> <given-names>MA</given-names></name><name><surname>Pennetier</surname> <given-names>C</given-names></name><name><surname>Tessier</surname> <given-names>S</given-names></name><name><surname>Paul-Gilloteaux</surname> <given-names>P</given-names></name><name><surname>Basto</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Centrosome amplification causes microcephaly</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>731</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1038/ncb2746</pub-id><pub-id pub-id-type="pmid">23666084</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>CA</given-names></name><name><surname>Murray</surname> <given-names>JE</given-names></name><name><surname>Carroll</surname> <given-names>P</given-names></name><name><surname>Leitch</surname> <given-names>A</given-names></name><name><surname>Mackenzie</surname> <given-names>KJ</given-names></name><name><surname>Halachev</surname> <given-names>M</given-names></name><name><surname>Fetit</surname> <given-names>AE</given-names></name><name><surname>Keith</surname> <given-names>C</given-names></name><name><surname>Bicknell</surname> <given-names>LS</given-names></name><name><surname>Fluteau</surname> <given-names>A</given-names></name><name><surname>Gautier</surname> <given-names>P</given-names></name><name><surname>Hall</surname> <given-names>EA</given-names></name><name><surname>Joss</surname> <given-names>S</given-names></name><name><surname>Soares</surname> <given-names>G</given-names></name><name><surname>Silva</surname> <given-names>J</given-names></name><name><surname>Bober</surname> <given-names>MB</given-names></name><name><surname>Duker</surname> <given-names>A</given-names></name><name><surname>Wise</surname> <given-names>CA</given-names></name><name><surname>Quigley</surname> <given-names>AJ</given-names></name><name><surname>Phadke</surname> <given-names>SR</given-names></name><name><surname>Wood</surname> <given-names>AJ</given-names></name><name><surname>Vagnarelli</surname> <given-names>P</given-names></name><name><surname>Jackson</surname> <given-names>AP</given-names></name><collab>Deciphering Developmental Disorders Study</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>2158</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.1101/gad.286351.116</pub-id><pub-id pub-id-type="pmid">27737959</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinnon</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Maintaining genome stability in the nervous system</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1523</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1038/nn.3537</pub-id><pub-id pub-id-type="pmid">24165679</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinnon</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome integrity and disease prevention in the nervous system</article-title><source>Genes &amp; Development</source><volume>31</volume><fpage>1180</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1101/gad.301325.117</pub-id><pub-id pub-id-type="pmid">28765160</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez-Bermudez</surname> <given-names>A</given-names></name><name><surname>Lototska</surname> <given-names>L</given-names></name><name><surname>Bauwens</surname> <given-names>S</given-names></name><name><surname>Giraud-Panis</surname> <given-names>MJ</given-names></name><name><surname>Croce</surname> <given-names>O</given-names></name><name><surname>Jamet</surname> <given-names>K</given-names></name><name><surname>Irizar</surname> <given-names>A</given-names></name><name><surname>Mowinckel</surname> <given-names>M</given-names></name><name><surname>Koundrioukoff</surname> <given-names>S</given-names></name><name><surname>Nottet</surname> <given-names>N</given-names></name><name><surname>Almouzni</surname> <given-names>G</given-names></name><name><surname>Teulade-Fichou</surname> <given-names>MP</given-names></name><name><surname>Schertzer</surname> <given-names>M</given-names></name><name><surname>Perderiset</surname> <given-names>M</given-names></name><name><surname>Londoño-Vallejo</surname> <given-names>A</given-names></name><name><surname>Debatisse</surname> <given-names>M</given-names></name><name><surname>Gilson</surname> <given-names>E</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide control of heterochromatin replication by the telomere capping protein TRF2</article-title><source>Molecular Cell</source><volume>70</volume><fpage>449</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.036</pub-id><pub-id pub-id-type="pmid">29727617</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menolfi</surname> <given-names>D</given-names></name><name><surname>Delamarre</surname> <given-names>A</given-names></name><name><surname>Lengronne</surname> <given-names>A</given-names></name><name><surname>Pasero</surname> <given-names>P</given-names></name><name><surname>Branzei</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Essential roles of the Smc5/6 complex in replication through natural pausing sites and endogenous DNA damage tolerance</article-title><source>Molecular Cell</source><volume>60</volume><fpage>835</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.023</pub-id><pub-id pub-id-type="pmid">26698660</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrick</surname> <given-names>CJ</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Diffley</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Visualization of altered replication dynamics after DNA damage in human cells</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>20067</fpage><lpage>20075</lpage><pub-id pub-id-type="doi">10.1074/jbc.M400022200</pub-id><pub-id pub-id-type="pmid">14982920</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname> <given-names>J</given-names></name><name><surname>Wright</surname> <given-names>WE</given-names></name><name><surname>Shay</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Alternative lengthening of telomeres mediated by mitotic DNA synthesis engages Break-Induced replication processes</article-title><source>Molecular and Cellular Biology</source><volume>37</volume><elocation-id>e00226-17</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00226-17</pub-id><pub-id pub-id-type="pmid">28760773</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minocherhomji</surname> <given-names>S</given-names></name><name><surname>Ying</surname> <given-names>S</given-names></name><name><surname>Bjerregaard</surname> <given-names>VA</given-names></name><name><surname>Bursomanno</surname> <given-names>S</given-names></name><name><surname>Aleliunaite</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Mankouri</surname> <given-names>HW</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Replication stress activates DNA repair synthesis in mitosis</article-title><source>Nature</source><volume>528</volume><fpage>286</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/nature16139</pub-id><pub-id pub-id-type="pmid">26633632</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirza-Aghazadeh-Attari</surname> <given-names>M</given-names></name><name><surname>Mohammadzadeh</surname> <given-names>A</given-names></name><name><surname>Yousefi</surname> <given-names>B</given-names></name><name><surname>Mihanfar</surname> <given-names>A</given-names></name><name><surname>Karimian</surname> <given-names>A</given-names></name><name><surname>Majidinia</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>53bp1: a key player of DNA damage response with critical functions in Cancer</article-title><source>DNA Repair</source><volume>73</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2018.11.008</pub-id><pub-id pub-id-type="pmid">30497961</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname> <given-names>BJ</given-names></name><name><surname>Arlotta</surname> <given-names>P</given-names></name><name><surname>Menezes</surname> <given-names>JR</given-names></name><name><surname>Macklis</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Neuronal subtype specification in the cerebral cortex</article-title><source>Nature Reviews Neuroscience</source><volume>8</volume><fpage>427</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1038/nrn2151</pub-id><pub-id pub-id-type="pmid">17514196</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi-Fard</surname> <given-names>S</given-names></name><name><surname>Sarthi</surname> <given-names>J</given-names></name><name><surname>Tittel-Elmer</surname> <given-names>M</given-names></name><name><surname>Lalonde</surname> <given-names>M</given-names></name><name><surname>Cusanelli</surname> <given-names>E</given-names></name><name><surname>Chartrand</surname> <given-names>P</given-names></name><name><surname>Cobb</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Smc5/6 is a Telomere-Associated complex that regulates Sir4 binding and TPE</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006268</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006268</pub-id><pub-id pub-id-type="pmid">27564449</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname> <given-names>C</given-names></name><name><surname>Losada</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Establishing and dissolving cohesion during the vertebrate cell cycle</article-title><source>Current Opinion in Cell Biology</source><volume>52</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2018.01.010</pub-id><pub-id pub-id-type="pmid">29433064</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullegama</surname> <given-names>SV</given-names></name><name><surname>Klein</surname> <given-names>SD</given-names></name><name><surname>Mulatinho</surname> <given-names>MV</given-names></name><name><surname>Senaratne</surname> <given-names>TN</given-names></name><name><surname>Singh</surname> <given-names>K</given-names></name><name><surname>Nguyen</surname> <given-names>DC</given-names></name><name><surname>Gallant</surname> <given-names>NM</given-names></name><name><surname>Strom</surname> <given-names>SP</given-names></name><name><surname>Ghahremani</surname> <given-names>S</given-names></name><name><surname>Rao</surname> <given-names>NP</given-names></name><name><surname>Martinez-Agosto</surname> <given-names>JA</given-names></name><collab>UCLA Clinical Genomics Center</collab></person-group><year iso-8601-date="2017">2017</year><article-title>De novo loss-of-function variants in <italic>STAG2</italic> are associated with developmental delay, microcephaly, and congenital anomalies</article-title><source>American Journal of Medical Genetics Part A</source><volume>173</volume><fpage>1319</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.38207</pub-id><pub-id pub-id-type="pmid">28296084</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalepa</surname> <given-names>G</given-names></name><name><surname>Enzor</surname> <given-names>R</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Marchal</surname> <given-names>C</given-names></name><name><surname>Park</surname> <given-names>SJ</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Tedeschi</surname> <given-names>L</given-names></name><name><surname>Kelich</surname> <given-names>S</given-names></name><name><surname>Hanenberg</surname> <given-names>H</given-names></name><name><surname>Clapp</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fanconi Anemia signaling network regulates the spindle assembly checkpoint</article-title><source>Journal of Clinical Investigation</source><volume>123</volume><fpage>3839</fpage><lpage>3847</lpage><pub-id pub-id-type="doi">10.1172/JCI67364</pub-id><pub-id pub-id-type="pmid">23934222</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natsume</surname> <given-names>T</given-names></name><name><surname>Kiyomitsu</surname> <given-names>T</given-names></name><name><surname>Saga</surname> <given-names>Y</given-names></name><name><surname>Kanemaki</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rapid protein depletion in human cells by Auxin-Inducible degron tagging with short homology donors</article-title><source>Cell Reports</source><volume>15</volume><fpage>210</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.001</pub-id><pub-id pub-id-type="pmid">27052166</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishide</surname> <given-names>K</given-names></name><name><surname>Hirano</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004847</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004847</pub-id><pub-id pub-id-type="pmid">25474630</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>K</given-names></name><name><surname>Fukagawa</surname> <given-names>T</given-names></name><name><surname>Takisawa</surname> <given-names>H</given-names></name><name><surname>Kakimoto</surname> <given-names>T</given-names></name><name><surname>Kanemaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>An auxin-based degron system for the rapid depletion of proteins in nonplant cells</article-title><source>Nature Methods</source><volume>6</volume><fpage>917</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1401</pub-id><pub-id pub-id-type="pmid">19915560</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Driscoll</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The pathological consequences of impaired genome integrity in humans; disorders of the DNA replication machinery</article-title><source>The Journal of Pathology</source><volume>241</volume><fpage>192</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1002/path.4828</pub-id><pub-id pub-id-type="pmid">27757957</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname> <given-names>Y</given-names></name><name><surname>Iwasaki</surname> <given-names>WM</given-names></name><name><surname>Kugou</surname> <given-names>K</given-names></name><name><surname>Takahashi</surname> <given-names>KK</given-names></name><name><surname>Oda</surname> <given-names>A</given-names></name><name><surname>Sato</surname> <given-names>K</given-names></name><name><surname>Kobayashi</surname> <given-names>W</given-names></name><name><surname>Kawai</surname> <given-names>H</given-names></name><name><surname>Sakasai</surname> <given-names>R</given-names></name><name><surname>Takaori-Kondo</surname> <given-names>A</given-names></name><name><surname>Yamamoto</surname> <given-names>T</given-names></name><name><surname>Kanemaki</surname> <given-names>MT</given-names></name><name><surname>Taoka</surname> <given-names>M</given-names></name><name><surname>Isobe</surname> <given-names>T</given-names></name><name><surname>Kurumizaka</surname> <given-names>H</given-names></name><name><surname>Innan</surname> <given-names>H</given-names></name><name><surname>Ohta</surname> <given-names>K</given-names></name><name><surname>Ishiai</surname> <given-names>M</given-names></name><name><surname>Takata</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Replication stress induces accumulation of FANCD2 at central region of large fragile genes</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>2932</fpage><lpage>2944</lpage><pub-id pub-id-type="doi">10.1093/nar/gky058</pub-id><pub-id pub-id-type="pmid">29394375</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özer</surname> <given-names>Ö</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pathways for maintenance of telomeres and common fragile sites during DNA replication stress</article-title><source>Open Biology</source><volume>8</volume><elocation-id>180018</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.180018</pub-id><pub-id pub-id-type="pmid">29695617</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palecek</surname> <given-names>J</given-names></name><name><surname>Vidot</surname> <given-names>S</given-names></name><name><surname>Feng</surname> <given-names>M</given-names></name><name><surname>Doherty</surname> <given-names>AJ</given-names></name><name><surname>Lehmann</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The Smc5-Smc6 DNA repair complex bridging of the Smc5-Smc6 heads by the KLEISIN, Nse4, and non-Kleisin subunits</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>36952</fpage><lpage>36959</lpage><pub-id pub-id-type="doi">10.1074/jbc.M608004200</pub-id><pub-id pub-id-type="pmid">17005570</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paridaen</surname> <given-names>JT</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neurogenesis during development of the vertebrate central nervous system</article-title><source>EMBO Reports</source><volume>15</volume><fpage>351</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1002/embr.201438447</pub-id><pub-id pub-id-type="pmid">24639559</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname> <given-names>F</given-names></name><name><surname>Colnaghi</surname> <given-names>R</given-names></name><name><surname>Rocha</surname> <given-names>N</given-names></name><name><surname>Seth</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>J</given-names></name><name><surname>Carpenter</surname> <given-names>G</given-names></name><name><surname>Bottomley</surname> <given-names>WE</given-names></name><name><surname>Wheeler</surname> <given-names>E</given-names></name><name><surname>Wong</surname> <given-names>S</given-names></name><name><surname>Saudek</surname> <given-names>V</given-names></name><name><surname>Savage</surname> <given-names>D</given-names></name><name><surname>O'Rahilly</surname> <given-names>S</given-names></name><name><surname>Carel</surname> <given-names>JC</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>O'Driscoll</surname> <given-names>M</given-names></name><name><surname>Semple</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistance</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>4028</fpage><lpage>4038</lpage><pub-id pub-id-type="doi">10.1172/JCI73264</pub-id><pub-id pub-id-type="pmid">25105364</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pebernard</surname> <given-names>S</given-names></name><name><surname>Perry</surname> <given-names>JJ</given-names></name><name><surname>Tainer</surname> <given-names>JA</given-names></name><name><surname>Boddy</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2008">2008a</year><article-title>Nse1 RING-like domain supports functions of the Smc5-Smc6 holocomplex in genome stability</article-title><source>Molecular Biology of the Cell</source><volume>19</volume><fpage>4099</fpage><lpage>4109</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-02-0226</pub-id><pub-id pub-id-type="pmid">18667531</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pebernard</surname> <given-names>S</given-names></name><name><surname>Schaffer</surname> <given-names>L</given-names></name><name><surname>Campbell</surname> <given-names>D</given-names></name><name><surname>Head</surname> <given-names>SR</given-names></name><name><surname>Boddy</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2008">2008b</year><article-title>Localization of Smc5/6 to centromeres and telomeres requires heterochromatin and SUMO, respectively</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>3011</fpage><lpage>3023</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.220</pub-id><pub-id pub-id-type="pmid">18923417</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>XP</given-names></name><name><surname>Lim</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Marjavaara</surname> <given-names>L</given-names></name><name><surname>Chabes</surname> <given-names>A</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Acute Smc5/6 depletion reveals its primary role in rDNA replication by restraining recombination at fork pausing sites</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007129</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007129</pub-id><pub-id pub-id-type="pmid">29360860</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname> <given-names>TP</given-names></name><name><surname>Maryniak</surname> <given-names>AL</given-names></name><name><surname>Boatwright</surname> <given-names>CA</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Atkins</surname> <given-names>A</given-names></name><name><surname>Tijhuis</surname> <given-names>A</given-names></name><name><surname>Spierings</surname> <given-names>DC</given-names></name><name><surname>Bazzi</surname> <given-names>H</given-names></name><name><surname>Foijer</surname> <given-names>F</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name><name><surname>Stracker</surname> <given-names>TH</given-names></name><name><surname>Holland</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Centrosome defects cause microcephaly by activating the 53BP1-USP28-TP53 mitotic surveillance pathway</article-title><source>The EMBO Journal</source><pub-id pub-id-type="doi">10.15252/embj.2020106118</pub-id><pub-id pub-id-type="pmid">33226141</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piché</surname> <given-names>J</given-names></name><name><surname>Van Vliet</surname> <given-names>PP</given-names></name><name><surname>Pucéat</surname> <given-names>M</given-names></name><name><surname>Andelfinger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The expanding phenotypes of cohesinopathies: one ring to rule them all!</article-title><source>Cell Cycle</source><volume>18</volume><fpage>2828</fpage><lpage>2848</lpage><pub-id pub-id-type="doi">10.1080/15384101.2019.1658476</pub-id><pub-id pub-id-type="pmid">31516082</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname> <given-names>PR</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The SMC5/6 complex maintains telomere length in ALT Cancer cells through SUMOylation of telomere-binding proteins</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>14</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/nsmb1259</pub-id><pub-id pub-id-type="pmid">17589526</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryzhkova</surname> <given-names>MV</given-names></name><name><surname>Aria</surname> <given-names>I</given-names></name><name><surname>Cheng</surname> <given-names>Q</given-names></name><name><surname>Harris</surname> <given-names>GM</given-names></name><name><surname>Zan</surname> <given-names>X</given-names></name><name><surname>Gharib</surname> <given-names>M</given-names></name><name><surname>Jabbarzadeh</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Carbon nanotube-based substrates for modulation of human pluripotent stem cell fate</article-title><source>Biomaterials</source><volume>35</volume><fpage>5098</fpage><lpage>5109</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.03.011</pub-id><pub-id pub-id-type="pmid">24690530</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryzhkova</surname> <given-names>MV</given-names></name><name><surname>Xu</surname> <given-names>MJ</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Adaptation of the AID system for stem cell and transgenic mouse research</article-title><source>Stem Cell Research</source><volume>49</volume><elocation-id>102078</elocation-id><pub-id pub-id-type="doi">10.1016/j.scr.2020.102078</pub-id><pub-id pub-id-type="pmid">33202307</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryzhkova</surname> <given-names>MV</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Conditional mutation of <italic>Smc5</italic> in mouse embryonic stem cells perturbs condensin localization and mitotic progression</article-title><source>Journal of Cell Science</source><volume>129</volume><fpage>1619</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1242/jcs.179036</pub-id><pub-id pub-id-type="pmid">26919979</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinet</surname> <given-names>A</given-names></name><name><surname>Lemaçon</surname> <given-names>D</given-names></name><name><surname>Vindigni</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Replication fork reversal: players and guardians</article-title><source>Molecular Cell</source><volume>68</volume><fpage>830</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.11.022</pub-id><pub-id pub-id-type="pmid">29220651</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Räschle</surname> <given-names>M</given-names></name><name><surname>Smeenk</surname> <given-names>G</given-names></name><name><surname>Hansen</surname> <given-names>RK</given-names></name><name><surname>Temu</surname> <given-names>T</given-names></name><name><surname>Oka</surname> <given-names>Y</given-names></name><name><surname>Hein</surname> <given-names>MY</given-names></name><name><surname>Nagaraj</surname> <given-names>N</given-names></name><name><surname>Long</surname> <given-names>DT</given-names></name><name><surname>Walter</surname> <given-names>JC</given-names></name><name><surname>Hofmann</surname> <given-names>K</given-names></name><name><surname>Storchova</surname> <given-names>Z</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Bekker-Jensen</surname> <given-names>S</given-names></name><name><surname>Mailand</surname> <given-names>N</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>DNA repair proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links</article-title><source>Science</source><volume>348</volume><elocation-id>1253671</elocation-id><pub-id pub-id-type="doi">10.1126/science.1253671</pub-id><pub-id pub-id-type="pmid">25931565</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remeseiro</surname> <given-names>S</given-names></name><name><surname>Losada</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cohesin, a chromatin engagement ring</article-title><source>Current Opinion in Cell Biology</source><volume>25</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2012.10.013</pub-id><pub-id pub-id-type="pmid">23219370</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname> <given-names>JJ</given-names></name><name><surname>Bicknell</surname> <given-names>LS</given-names></name><name><surname>Carroll</surname> <given-names>P</given-names></name><name><surname>Higgs</surname> <given-names>MR</given-names></name><name><surname>Shaheen</surname> <given-names>R</given-names></name><name><surname>Murray</surname> <given-names>JE</given-names></name><name><surname>Papadopoulos</surname> <given-names>DK</given-names></name><name><surname>Leitch</surname> <given-names>A</given-names></name><name><surname>Murina</surname> <given-names>O</given-names></name><name><surname>Tarnauskaitė</surname> <given-names>Ž</given-names></name><name><surname>Wessel</surname> <given-names>SR</given-names></name><name><surname>Zlatanou</surname> <given-names>A</given-names></name><name><surname>Vernet</surname> <given-names>A</given-names></name><name><surname>von Kriegsheim</surname> <given-names>A</given-names></name><name><surname>Mottram</surname> <given-names>RM</given-names></name><name><surname>Logan</surname> <given-names>CV</given-names></name><name><surname>Bye</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Brean</surname> <given-names>A</given-names></name><name><surname>Maddirevula</surname> <given-names>S</given-names></name><name><surname>Challis</surname> <given-names>RC</given-names></name><name><surname>Skouloudaki</surname> <given-names>K</given-names></name><name><surname>Almoisheer</surname> <given-names>A</given-names></name><name><surname>Alsaif</surname> <given-names>HS</given-names></name><name><surname>Amar</surname> <given-names>A</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Bober</surname> <given-names>MB</given-names></name><name><surname>Duker</surname> <given-names>A</given-names></name><name><surname>Faqeih</surname> <given-names>E</given-names></name><name><surname>Seidahmed</surname> <given-names>MZ</given-names></name><name><surname>Al Tala</surname> <given-names>S</given-names></name><name><surname>Alswaid</surname> <given-names>A</given-names></name><name><surname>Ahmed</surname> <given-names>S</given-names></name><name><surname>Al-Aama</surname> <given-names>JY</given-names></name><name><surname>Altmüller</surname> <given-names>J</given-names></name><name><surname>Al Balwi</surname> <given-names>M</given-names></name><name><surname>Brady</surname> <given-names>AF</given-names></name><name><surname>Chessa</surname> <given-names>L</given-names></name><name><surname>Cox</surname> <given-names>H</given-names></name><name><surname>Fischetto</surname> <given-names>R</given-names></name><name><surname>Heller</surname> <given-names>R</given-names></name><name><surname>Henderson</surname> <given-names>BD</given-names></name><name><surname>Hobson</surname> <given-names>E</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Percin</surname> <given-names>EF</given-names></name><name><surname>Peron</surname> <given-names>A</given-names></name><name><surname>Spaccini</surname> <given-names>L</given-names></name><name><surname>Quigley</surname> <given-names>AJ</given-names></name><name><surname>Thakur</surname> <given-names>S</given-names></name><name><surname>Wise</surname> <given-names>CA</given-names></name><name><surname>Yoon</surname> <given-names>G</given-names></name><name><surname>Alnemer</surname> <given-names>M</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Yigit</surname> <given-names>G</given-names></name><name><surname>Taylor</surname> <given-names>AM</given-names></name><name><surname>Reijns</surname> <given-names>MA</given-names></name><name><surname>Simpson</surname> <given-names>MA</given-names></name><name><surname>Cortez</surname> <given-names>D</given-names></name><name><surname>Alkuraya</surname> <given-names>FS</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Jackson</surname> <given-names>AP</given-names></name><name><surname>Stewart</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutations in DONSON disrupt replication fork stability and cause microcephalic dwarfism</article-title><source>Nature Genetics</source><volume>49</volume><fpage>537</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1038/ng.3790</pub-id><pub-id pub-id-type="pmid">28191891</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigue</surname> <given-names>A</given-names></name><name><surname>Coulombe</surname> <given-names>Y</given-names></name><name><surname>Jacquet</surname> <given-names>K</given-names></name><name><surname>Gagné</surname> <given-names>JP</given-names></name><name><surname>Roques</surname> <given-names>C</given-names></name><name><surname>Gobeil</surname> <given-names>S</given-names></name><name><surname>Poirier</surname> <given-names>G</given-names></name><name><surname>Masson</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>348</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1242/jcs.114595</pub-id><pub-id pub-id-type="pmid">23108668</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosin</surname> <given-names>N</given-names></name><name><surname>Elcioglu</surname> <given-names>NH</given-names></name><name><surname>Beleggia</surname> <given-names>F</given-names></name><name><surname>Isgüven</surname> <given-names>P</given-names></name><name><surname>Altmüller</surname> <given-names>J</given-names></name><name><surname>Thiele</surname> <given-names>H</given-names></name><name><surname>Steindl</surname> <given-names>K</given-names></name><name><surname>Joset</surname> <given-names>P</given-names></name><name><surname>Rauch</surname> <given-names>A</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Wollnik</surname> <given-names>B</given-names></name><name><surname>Yigit</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>3708</fpage><lpage>3717</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv115</pub-id><pub-id pub-id-type="pmid">25839420</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>F</given-names></name><name><surname>Helbling-Leclerc</surname> <given-names>A</given-names></name><name><surname>Kawasumi</surname> <given-names>R</given-names></name><name><surname>Jegadesan</surname> <given-names>NK</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Devulder</surname> <given-names>P</given-names></name><name><surname>Abe</surname> <given-names>T</given-names></name><name><surname>Takata</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>D</given-names></name><name><surname>Rosselli</surname> <given-names>F</given-names></name><name><surname>Branzei</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SMC5/6 acts jointly with fanconi Anemia factors to support DNA repair and genome stability</article-title><source>EMBO Reports</source><volume>21</volume><elocation-id>e48222</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201948222</pub-id><pub-id pub-id-type="pmid">31867888</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakairi</surname> <given-names>T</given-names></name><name><surname>Hiromura</surname> <given-names>K</given-names></name><name><surname>Yamashita</surname> <given-names>S</given-names></name><name><surname>Takeuchi</surname> <given-names>S</given-names></name><name><surname>Tomioka</surname> <given-names>M</given-names></name><name><surname>Ideura</surname> <given-names>H</given-names></name><name><surname>Maeshima</surname> <given-names>A</given-names></name><name><surname>Kaneko</surname> <given-names>Y</given-names></name><name><surname>Kuroiwa</surname> <given-names>T</given-names></name><name><surname>Nangaku</surname> <given-names>M</given-names></name><name><surname>Takeuchi</surname> <given-names>T</given-names></name><name><surname>Nojima</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nestin expression in the kidney with an obstructed ureter</article-title><source>Kidney International</source><volume>72</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5002277</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saksouk</surname> <given-names>N</given-names></name><name><surname>Simboeck</surname> <given-names>E</given-names></name><name><surname>Déjardin</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Constitutive heterochromatin formation and transcription in mammals</article-title><source>Epigenetics &amp; Chromatin</source><volume>8</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/1756-8935-8-3</pub-id><pub-id pub-id-type="pmid">25788984</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansom</surname> <given-names>SN</given-names></name><name><surname>Griffiths</surname> <given-names>DS</given-names></name><name><surname>Faedo</surname> <given-names>A</given-names></name><name><surname>Kleinjan</surname> <given-names>DJ</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Smith</surname> <given-names>J</given-names></name><name><surname>van Heyningen</surname> <given-names>V</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Livesey</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis</article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000511</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000511</pub-id><pub-id pub-id-type="pmid">19521500</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savchenko</surname> <given-names>E</given-names></name><name><surname>Singh</surname> <given-names>Y</given-names></name><name><surname>Konttinen</surname> <given-names>H</given-names></name><name><surname>Lejavova</surname> <given-names>K</given-names></name><name><surname>Mediavilla Santos</surname> <given-names>L</given-names></name><name><surname>Grubman</surname> <given-names>A</given-names></name><name><surname>Kärkkäinen</surname> <given-names>V</given-names></name><name><surname>Keksa-Goldsteine</surname> <given-names>V</given-names></name><name><surname>Naumenko</surname> <given-names>N</given-names></name><name><surname>Tavi</surname> <given-names>P</given-names></name><name><surname>White</surname> <given-names>AR</given-names></name><name><surname>Malm</surname> <given-names>T</given-names></name><name><surname>Koistinaho</surname> <given-names>J</given-names></name><name><surname>Kanninen</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Loss of <italic>Cln5</italic> causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>1089</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1242/dmm.029165</pub-id><pub-id pub-id-type="pmid">28733362</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schotta</surname> <given-names>G</given-names></name><name><surname>Lachner</surname> <given-names>M</given-names></name><name><surname>Sarma</surname> <given-names>K</given-names></name><name><surname>Ebert</surname> <given-names>A</given-names></name><name><surname>Sengupta</surname> <given-names>R</given-names></name><name><surname>Reuter</surname> <given-names>G</given-names></name><name><surname>Reinberg</surname> <given-names>D</given-names></name><name><surname>Jenuwein</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin</article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>1251</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1101/gad.300704</pub-id><pub-id pub-id-type="pmid">15145825</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schotta</surname> <given-names>G</given-names></name><name><surname>Sengupta</surname> <given-names>R</given-names></name><name><surname>Kubicek</surname> <given-names>S</given-names></name><name><surname>Malin</surname> <given-names>S</given-names></name><name><surname>Kauer</surname> <given-names>M</given-names></name><name><surname>Callén</surname> <given-names>E</given-names></name><name><surname>Celeste</surname> <given-names>A</given-names></name><name><surname>Pagani</surname> <given-names>M</given-names></name><name><surname>Opravil</surname> <given-names>S</given-names></name><name><surname>De La Rosa-Velazquez</surname> <given-names>IA</given-names></name><name><surname>Espejo</surname> <given-names>A</given-names></name><name><surname>Bedford</surname> <given-names>MT</given-names></name><name><surname>Nussenzweig</surname> <given-names>A</given-names></name><name><surname>Busslinger</surname> <given-names>M</given-names></name><name><surname>Jenuwein</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>2048</fpage><lpage>2061</lpage><pub-id pub-id-type="doi">10.1101/gad.476008</pub-id><pub-id pub-id-type="pmid">18676810</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname> <given-names>S</given-names></name><name><surname>Harris</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>p53: traffic cop at the crossroads of DNA repair and recombination</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>6</volume><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nrm1546</pub-id><pub-id pub-id-type="pmid">15688066</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaltiel</surname> <given-names>IA</given-names></name><name><surname>Krenning</surname> <given-names>L</given-names></name><name><surname>Bruinsma</surname> <given-names>W</given-names></name><name><surname>Medema</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>607</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1242/jcs.163766</pub-id><pub-id pub-id-type="pmid">25609713</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname> <given-names>M</given-names></name><name><surname>Gulden</surname> <given-names>FO</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>From trans to Cis: transcriptional regulatory networks in neocortical development</article-title><source>Trends in Genetics</source><volume>31</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2014.12.004</pub-id><pub-id pub-id-type="pmid">25624274</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shitamukai</surname> <given-names>A</given-names></name><name><surname>Matsuzaki</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Control of asymmetric cell division of mammalian neural progenitors</article-title><source>Development, Growth &amp; Differentiation</source><volume>54</volume><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1111/j.1440-169X.2012.01345.x</pub-id><pub-id pub-id-type="pmid">22524601</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoaib</surname> <given-names>M</given-names></name><name><surname>Walter</surname> <given-names>D</given-names></name><name><surname>Gillespie</surname> <given-names>PJ</given-names></name><name><surname>Izard</surname> <given-names>F</given-names></name><name><surname>Fahrenkrog</surname> <given-names>B</given-names></name><name><surname>Lleres</surname> <given-names>D</given-names></name><name><surname>Lerdrup</surname> <given-names>M</given-names></name><name><surname>Johansen</surname> <given-names>JV</given-names></name><name><surname>Hansen</surname> <given-names>K</given-names></name><name><surname>Julien</surname> <given-names>E</given-names></name><name><surname>Blow</surname> <given-names>JJ</given-names></name><name><surname>Sørensen</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Histone H4K20 methylation mediated chromatin compaction threshold ensures genome integrity by limiting DNA replication licensing</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3704</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06066-8</pub-id><pub-id pub-id-type="pmid">30209253</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>J</given-names></name><name><surname>Tho</surname> <given-names>LM</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Gillespie</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and Cancer</article-title><source>Advances in Cancer Research</source><volume>108</volume><fpage>73</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-380888-2.00003-0</pub-id><pub-id pub-id-type="pmid">21034966</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname> <given-names>D</given-names></name><name><surname>Graupner</surname> <given-names>V</given-names></name><name><surname>Neise</surname> <given-names>D</given-names></name><name><surname>Essmann</surname> <given-names>F</given-names></name><name><surname>Schulze-Osthoff</surname> <given-names>K</given-names></name><name><surname>Jänicke</surname> <given-names>RU</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pifithrin-alpha protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53</article-title><source>Cell Death &amp; Differentiation</source><volume>16</volume><fpage>869</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.17</pub-id><pub-id pub-id-type="pmid">19229248</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonneville</surname> <given-names>R</given-names></name><name><surname>Bhowmick</surname> <given-names>R</given-names></name><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Mailand</surname> <given-names>N</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name><name><surname>Labib</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TRAIP drives replisome disassembly and mitotic DNA repair synthesis at sites of incomplete DNA replication</article-title><source>eLife</source><volume>8</volume><elocation-id>e48686</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.48686</pub-id><pub-id pub-id-type="pmid">31545170</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>MR</given-names></name><name><surname>Bernstein</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RAD-ical new insights into RAD51 regulation</article-title><source>Genes</source><volume>9</volume><elocation-id>629</elocation-id><pub-id pub-id-type="doi">10.3390/genes9120629</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Rosell</surname> <given-names>J</given-names></name><name><surname>Machín</surname> <given-names>F</given-names></name><name><surname>Farmer</surname> <given-names>S</given-names></name><name><surname>Jarmuz</surname> <given-names>A</given-names></name><name><surname>Eydmann</surname> <given-names>T</given-names></name><name><surname>Dalgaard</surname> <given-names>JZ</given-names></name><name><surname>Aragón</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>SMC5 and SMC6 genes are required for the segregation of repetitive chromosome regions</article-title><source>Nature Cell Biology</source><volume>7</volume><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/ncb1239</pub-id><pub-id pub-id-type="pmid">15793567</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>M</given-names></name><name><surname>Tsarouhas</surname> <given-names>V</given-names></name><name><surname>Kegel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Early development of <italic>Drosophila</italic> embryos requires Smc5/6 function during oogenesis</article-title><source>Biology Open</source><volume>5</volume><fpage>928</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1242/bio.019000</pub-id><pub-id pub-id-type="pmid">27288507</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlmann</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SMC complexes: from DNA to chromosomes</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>17</volume><fpage>399</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.30</pub-id><pub-id pub-id-type="pmid">27075410</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Crabben</surname> <given-names>SN</given-names></name><name><surname>Hennus</surname> <given-names>MP</given-names></name><name><surname>McGregor</surname> <given-names>GA</given-names></name><name><surname>Ritter</surname> <given-names>DI</given-names></name><name><surname>Nagamani</surname> <given-names>SC</given-names></name><name><surname>Wells</surname> <given-names>OS</given-names></name><name><surname>Harakalova</surname> <given-names>M</given-names></name><name><surname>Chinn</surname> <given-names>IK</given-names></name><name><surname>Alt</surname> <given-names>A</given-names></name><name><surname>Vondrova</surname> <given-names>L</given-names></name><name><surname>Hochstenbach</surname> <given-names>R</given-names></name><name><surname>van Montfrans</surname> <given-names>JM</given-names></name><name><surname>Terheggen-Lagro</surname> <given-names>SW</given-names></name><name><surname>van Lieshout</surname> <given-names>S</given-names></name><name><surname>van Roosmalen</surname> <given-names>MJ</given-names></name><name><surname>Renkens</surname> <given-names>I</given-names></name><name><surname>Duran</surname> <given-names>K</given-names></name><name><surname>Nijman</surname> <given-names>IJ</given-names></name><name><surname>Kloosterman</surname> <given-names>WP</given-names></name><name><surname>Hennekam</surname> <given-names>E</given-names></name><name><surname>Orange</surname> <given-names>JS</given-names></name><name><surname>van Hasselt</surname> <given-names>PM</given-names></name><name><surname>Wheeler</surname> <given-names>DA</given-names></name><name><surname>Palecek</surname> <given-names>JJ</given-names></name><name><surname>Lehmann</surname> <given-names>AR</given-names></name><name><surname>Oliver</surname> <given-names>AW</given-names></name><name><surname>Pearl</surname> <given-names>LH</given-names></name><name><surname>Plon</surname> <given-names>SE</given-names></name><name><surname>Murray</surname> <given-names>JM</given-names></name><name><surname>van Haaften</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>2881</fpage><lpage>2892</lpage><pub-id pub-id-type="doi">10.1172/JCI82890</pub-id><pub-id pub-id-type="pmid">27427983</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venegas</surname> <given-names>AB</given-names></name><name><surname>Natsume</surname> <given-names>T</given-names></name><name><surname>Kanemaki</surname> <given-names>M</given-names></name><name><surname>Hickson</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inducible degradation of the human SMC5/6 complex reveals an essential role only during interphase</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107533</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107533</pub-id><pub-id pub-id-type="pmid">32320646</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verver</surname> <given-names>DE</given-names></name><name><surname>van Pelt</surname> <given-names>AM</given-names></name><name><surname>Repping</surname> <given-names>S</given-names></name><name><surname>Hamer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role for rodent Smc6 in pericentromeric heterochromatin domains during spermatogonial differentiation and meiosis</article-title><source>Cell Death &amp; Disease</source><volume>4</volume><elocation-id>e749</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2013.269</pub-id><pub-id pub-id-type="pmid">23907463</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verver</surname> <given-names>DE</given-names></name><name><surname>Hwang</surname> <given-names>GH</given-names></name><name><surname>Jordan</surname> <given-names>PW</given-names></name><name><surname>Hamer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Resolving complex chromosome structures during meiosis: versatile deployment of Smc5/6</article-title><source>Chromosoma</source><volume>125</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s00412-015-0518-9</pub-id><pub-id pub-id-type="pmid">25947290</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voutsinos</surname> <given-names>V</given-names></name><name><surname>Munk</surname> <given-names>SHN</given-names></name><name><surname>Oestergaard</surname> <given-names>VH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Common chromosomal fragile Sites—Conserved Failure Stories</article-title><source>Genes</source><volume>9</volume><elocation-id>580</elocation-id><pub-id pub-id-type="doi">10.3390/genes9120580</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waisman</surname> <given-names>A</given-names></name><name><surname>Sevlever</surname> <given-names>F</given-names></name><name><surname>Elías Costa</surname> <given-names>M</given-names></name><name><surname>Cosentino</surname> <given-names>MS</given-names></name><name><surname>Miriuka</surname> <given-names>SG</given-names></name><name><surname>Ventura</surname> <given-names>AC</given-names></name><name><surname>Guberman</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell cycle dynamics of mouse embryonic stem cells in the ground state and during transition to formative pluripotency</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>8051</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-44537-0</pub-id><pub-id pub-id-type="pmid">31142785</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>IM</given-names></name><name><surname>Minn</surname> <given-names>K</given-names></name><name><surname>van Deursen</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>p53 binding protein 53bp1 is required for DNA damage responses and tumor suppression in mice</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>2556</fpage><lpage>2563</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.7.2556-2563.2003</pub-id><pub-id pub-id-type="pmid">12640136</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winczura</surname> <given-names>A</given-names></name><name><surname>Appanah</surname> <given-names>R</given-names></name><name><surname>Tatham</surname> <given-names>MH</given-names></name><name><surname>Hay</surname> <given-names>RT</given-names></name><name><surname>De Piccoli</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The S phase checkpoint promotes the Smc5/6 complex dependent SUMOylation of Pol2, the catalytic subunit of DNA polymerase ε</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008427</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008427</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname> <given-names>WD</given-names></name><name><surname>Shah</surname> <given-names>SS</given-names></name><name><surname>Heyer</surname> <given-names>WD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Homologous recombination and the repair of DNA double-strand breaks</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>10524</fpage><lpage>10535</lpage><pub-id pub-id-type="doi">10.1074/jbc.TM118.000372</pub-id><pub-id pub-id-type="pmid">29599286</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeman</surname> <given-names>MK</given-names></name><name><surname>Cimprich</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Causes and consequences of replication stress</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ncb2897</pub-id><pub-id pub-id-type="pmid">24366029</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Du</surname> <given-names>W</given-names></name><name><surname>Wilson</surname> <given-names>AF</given-names></name><name><surname>Namekawa</surname> <given-names>SH</given-names></name><name><surname>Andreassen</surname> <given-names>PR</given-names></name><name><surname>Meetei</surname> <given-names>AR</given-names></name><name><surname>Pang</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>45626</elocation-id><pub-id pub-id-type="doi">10.1038/srep45626</pub-id><pub-id pub-id-type="pmid">28378742</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Blobel</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization</article-title><source>PNAS</source><volume>102</volume><fpage>4777</fpage><lpage>4782</lpage><pub-id pub-id-type="doi">10.1073/pnas.0500537102</pub-id><pub-id pub-id-type="pmid">15738391</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>M</given-names></name><name><surname>Selivanova</surname> <given-names>G</given-names></name><name><surname>Peuget</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>1049</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-58051-1</pub-id><pub-id pub-id-type="pmid">31974452</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61171.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>Thank you for submitting your article &quot;SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Kevin Struhl as the Senior and Reviewing Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>The reviewers have indicated a number of changes in the text to soften the conclusions, and these are required. In addition, the following experiments are strongly suggested to be done:</p><p>1) Show when p53/<italic>chek2</italic> are activated upon <italic>Smc5</italic> loss in mESC cells.</p><p>2) Show DNA fiber results for IAA treatment alone samples as an important control. The revised manuscript should be submitted with point-by-point answers.</p><p><italic>Reviewer #1:</italic></p><p>The authors developed two <italic>Smc5</italic> cKO mice lines to conditionally deplete <italic>Smc5</italic>/<italic>6</italic> in central cortex tissues using tissue specific Cre constructs. They verified the reduction of <italic>Smc5</italic> and <italic>6</italic> protein levels in E16.5 embryos and to a less degree in E13.5 embryos. The resultant mice exhibited increased apoptosis, mitotic DNA abnormalities, increase of Rad51 levels and oblique division axis in NPCs, and consequently reduced brain weight and cortex size in newborn and adult mice, as well as showed sensorimotor function defects. Deleting <italic>Chek2</italic> or p53, but not 53BP1, significantly improved various <italic>Smc5</italic> cKO mice defects regarding brain weight, cortex area, and cortical thickness, apoptosis, and DNA fragmentation, suggesting that the DSB-induced DDR mediated by the ATM-<italic>Chek2</italic>-p53 axis is activated in <italic>Smc5</italic> KO mice and responsible for many defects in these cells. p53/Check2 KO did not improve the ectopic localization of apical NPC cells marked by <italic>SOX2</italic>/PAX6 seen in <italic>Smc5</italic> KO mice. Both <italic>Smc5</italic> KO and combined KO with p53/<italic>Chek2</italic> increases total <italic>SOX2</italic>/PAX6+ NPC cells, which was interpreted as compensator effects. In contrast to apical NPCs, decrease in several other types of neuron in <italic>Smc5</italic> KO mice was rescued by p53/<italic>Chek2</italic> KO. How to explain this contrast effect of p53/<italic>Chek2</italic> KO in different type of cells should was not clear.</p><p>Staining assays suggests that <italic>Smc5</italic> KO NPCs tend to accumulate in G1, an effect reversible by <italic>Chek2</italic> KO. Image in Figure 4H suggests anaphase bridge with H3P marking ends of the DNA bridges. It is unclear how prominent this phenotype is. Levels of FACND2 foci, including those co-localizing with pericentrimeric regions, increased about 6 to 8-fold in the chromosome spread of <italic>Smc5</italic> KO cells. In addition, level of H4K20me3 at pericentromeric regions increased 2X in <italic>Smc5</italic> KO cells.</p><p>The rest of the paper describes studies in mESCs cells by acute <italic>Smc5</italic> depletion upon IAA addition. <italic>Smc5</italic> depletion retards cell growth, which is reversed by cotreatment by <italic>Chek2i</italic> or p53i, while later addition of <italic>Chek2i</italic> had no effect. DNA fiber results suggest that compared to <italic>Chek2i</italic> (or p53i) treated cells, IAA+<italic>Chek2i</italic> (or IAA+p53i) treatment reduced ongoing DNA synthesis but appears to increase stalled and converging replication. Experiments should be shown to address whether these effects can be seen upon IAA treatment compared with untreated conditions without <italic>Chek2i</italic>. The fact that <italic>Chek2i</italic> and IAA+ <italic>Chek2i</italic> treatment are comparable for cell growth but not for replication is puzzling. Additional data are provided to suggest increase MiDAS in +IAA conditions. Taken together, the authors conclude that <italic>Smc5</italic>/<italic>6</italic> helps to complete replication before mitosis and thus is critical in highly proliferative stem cells during development.</p><p>This work generates the first neuron specific <italic>Smc5</italic> KO mice and demonstrates that <italic>Smc5</italic> loss leads to multiple brain development defects, which can provide a nice explanation for NSMCE2 human patient microcephaly phenotype. This reviewer feels that the developmental data quality present here is quite high, though an expert in this area should be consulted. Another important conclusion of the paper is that many NPC defects associated with <italic>Smc5</italic> KO are caused by <italic>Chek2</italic>/p53 DDR mediated cell death. Phenotype of SMC5 KO mESC cells are largely expected from similar studies and can provide an explanation for <italic>Smc5</italic> NPC KO mice phenotype. In particular, this work shows that <italic>Smc5</italic> KO in mESCs and in mice can respond differently to p53/check2 loss than in cancer cell lines as recently reported by Vegengas et al., 2020. With this said, interpretations of mESC data here needs to be more carefully vetted, as most data are not causative. For example, increased levels of MiDAS may not necessarily be caused by S phase defects. Could <italic>Smc5</italic> depletion in mitosis or G2 phase be sufficient to cause increased MiDAS? Also, it is unclear whether increased Rad51 levels is one of the causes for replication defects seen in <italic>Smc5</italic> KO cells. Does p53 or <italic>chek2</italic> KO rescue the increased Rad51 levels of <italic>Smc5</italic> KO mice? What types of events initially trigger the p53/<italic>chek2</italic> signaling pathway in <italic>Smc5</italic>/<italic>6</italic> KO cells, are these replication-born DSBs? Standard analysis to directly measure p53/<italic>Chek2</italic> activation can help to pinpoint when cells evoke this pathway, thus help to formulate a model to tie various defects reported here.</p><p><italic>Reviewer #2:</italic></p><p>This article from the Jordan laboratory describes an extensive set of analyses on a new mouse model where the <italic>Smc5</italic> gene was conditionally inactivated. These analyses were complemented by studies on <italic>Smc5</italic> degron cells. There have been several previous reports of the effects of impairing <italic>Smc5</italic>/<italic>6</italic> functions in mouse or human cells, but the current study extends those analysis by focusing on effects in vivo and, more specifically, in the developing neocortex. Overall, I really liked the article and the clear manner in which the analyses were described. I think that it will be an important addition to the many times confusing array of studies on <italic>Smc5</italic>/<italic>6</italic> function. There were, however, some concerns with the cellular analyses in particular.</p><p>1) In several places it is discussed that pericentromeric heterochromatin is a common fragile site. My understanding is that, at least in human cells, this heterochromatic region very rarely, if at all, shows gaps or breaks on mitotic chromosomes. Further, the marker of fragile sites used here, FANCD2, also does not generally localize to pericentromeric regions. I found the discussion around this point quite contrived as if it was intended to link the fact that <italic>Smc5</italic>/<italic>6</italic> localizes to pericentromeric regions with some well recognized manifestation of replication stress like fragility (and MiDAS that they used) when there isn't such a clear association. The authors cite Bhowmick et al. as the reference for EdU foci (MiDAS) and FANCD2 being at centromeric heterochromatin (subsection “SMC5/6 is critical for completion of DNA replication”), but I could find no reference to pericentromeric regions in that paper.</p><p>2) Related to 1) it would be important to show that real gaps/breaks and MiDAS foci co-localize with at centromeric heterochromatin regions – and that they are distinct from the telomeres that are adjacent in mouse chromosomes. Telomeres are hotspots for fragility and MiDAS. On a related note, the red and pink staining in Figure 6 is really hard to distinguish – couldn't the authors pseudo-color the foci differently? It is important to see where the telomere is on the acrocentric chromosome end. The impression I get is that many of the FANCD2 and EdU foci are at telomeres. These images do not look very crisp either and the resolution could be improved by collecting better confocal images I would suggest.</p><p>3) Related to 2), what is the percentage of EdU foci in mitosis that co-localize with FANCD2? Unlike what has been shown in previous studies on human cancer cell lines, many of the EdU foci shown here don't seem to co-localize with FANCD2. This should be quantified and discussed in the context of the current literature.</p><p>4) The fiber analyses should be repeated with a new control where CHEK2 inhibition is not employed in all of the samples, including the so-called negative control. As things stand, it is hard to compare the current analysis with previous analyses done with controls lacking any added compounds.</p><p><italic>Reviewer #3:</italic></p><p>This is a nicely conducted analysis of conditional SMC5 deletion in mouse, with well executed and controlled experiments and robust data. The work does not uncover any major surprises or unexpected discoveries in terms of SMC5 function/cellular phenotypes, but does consolidate and demonstrate previously established and anticipated roles in an in vivo setting. The mice developed here have been carefully characterised and will be of use as disease models by this and other laboratories.</p><p>The primary finding is that SMC5/6 is needed for tolerance to replication stress and replication fork stability/restart, and consequently for normal neurogenesis. The authors also show convincingly that defects in SMC5 function elicit cellular and organismal pathology via the CHEK2/p53 pathway. I have no major criticisms. The work will be of broad interest to the chromosome structure and maintenance research fields, and particularly so to investigators interested in cohesion/condensin function/dysfunction.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61171.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>The reviewers have indicated a number of changes in the text to soften the conclusions, and these are required. In addition, the following experiments are strongly suggested to be done:</p><p>1) Show when p53/chek2 are activated upon Smc5 loss in mESC cells.</p></disp-quote><p>To investigate p53 and <italic>Chek2</italic> activation in <italic>Smc5</italic>-depleted mouse embryonic stem cells (mESCs) we performed following analyses:</p><p>(1a) western blot analyses of mESCs treated with IAA at multiple timepoints demonstrated that acetyl-p53 (K379) and phospho-p53 (S389) are upregulated after 2 hours and 48 hours of auxin treatment, respectively. These data are added to Figure 5C, D and discussed in the Results section. We were unable to obtain conclusive results with phospho-CHEK2 antibodies due to their non-specificity and non-reactivity in mESCs (see details in the response to reviewer 1).</p><p>(1b) using immunofluorescence analysis, we also assessed the cell cycle distribution of phospho-p53+ mESCs using proliferative cell markers Ki67 and H3P (H3 serine 10 phosphorylation). Ki67 staining demonstrated that close to 100% of cells were proliferative. H3P staining in mESCs has been previously characterized to show that H3P foci are present on DNA during S-phase adjacent to DAPI-dense regions that become more prominent by G2, colocalizing with the pericentromeric heterochromatin (Mallm and Rippe, 2015; Pryzhkova and Jordan, 2016). By M-phase H3P localizes throughout the condensed chromatin. Therefore, based on H3P expression, we defined G1 (H3P-), S/G2 and mitotic stages (H3P+) of cell cycle in mESCs and quantified the distribution of phospho-p53 positive cells. Details are provided in the Results section. We observed an increase in the percentage of phospho-p53+ cells in both H3P+ and H3P- populations after 48 hours of IAA treatment. The abundance of phospho-p53+ cells in prophase and G1 populations compared to S/G2 cells suggests that p53 (S389) phosphorylation is most likely to occur in prophase or G1 phases upon SMC5 depletion. Specifically, 38.2% of G1 phase cells, 26.2% of S/G2 phase cells and 40.8% of prophase cells were positive for p-p53 in the IAA-treated group compared to 11.9%, 11.8% and 7.0% in control, respectively. We also observed a 1.5-fold increase in the percentage of total G1 phase cells, a 1.5-fold decrease in the percentage of total S/G2 phase cells, and a 2.1-fold increase in the percentage of total prophase cells in the IAA-treated group compared to control. These data are shown in Figure 5—figure supplement 1D-F and discussed in the Results section.</p><p>Unfortunately, we did not see a discernible difference in acetyl-p53 intensity in mESCs treated with various durations of IAA, as a high degree of background staining was present in both control and treated cells. Also, we were unable to assess activation of CHEK2 in mESCs due to non-specificity and non-reactivity of the phospho-CHEK2 antibodies we tested (see details in the response to reviewer 1).</p><p>(1c) As an additional experiment, to validate the reactivity of phospho-CHEK2, phospho-p53 and acetyl-p53 antibodies used for mESC analyses and complement our data, we performed immunofluorescence assessments of mouse E16.5 cortical sections. We found that acetyl-p53 was upregulated in the progenitor zone of <italic>Smc5</italic> cKO cortical sections compared to control. We have added these data to Figure 2—figure supplement 1B and discussed it in the Results section. We did not observe any staining with phospho-CHEK2 and phospho-p53 antibody in <italic>Smc5</italic> cKO and control cortical sections due to non-reactivity.</p><p>In summary, we show the upregulation of acetyl-p53 in <italic>Smc5</italic> cKO cortices and of acetyl-p53 and phospho-p53 in SMC5-depleted mESCs. We demonstrate that acetylation of p53 is an early response to SMC5 depletion in mESCs. In addition, we show that p53 (S389) phosphorylation occurs significantly later than p53 acetylation and is most frequently present in G1 phase and prophase cells. This suggests that aberrancies caused by SMC5 depletion (for example, late replication defects during G2) lead to a DNA damage response during prophase and potentially, the inheritance of DNA damage by G1 daughter cells.</p><disp-quote content-type="editor-comment"><p>2) Show DNA fiber results for IAA treatment alone samples as an important control. The revised manuscript should be submitted with point-by-point answers.</p></disp-quote><p>We performed DNA fiber experiments in the presence of IAA alone (without CHEK2 inhibitor). We have included these results in Figure 5H and Figure 5—figure supplement 1H, I and discussed it in the Results section. In brief, we show that DNA fibers from IAA-treated mESCs exhibit increased frequency of converging forks and stalled forks, and reduced incidence of ongoing forks, which is similar to the results with CHEK2 inhibition. IAA-treated mESCs also have slightly shorter DNA fiber track length and increased CldU/IdU length ratio, similar to the results with CHEK2 inhibition.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>The authors developed two Smc5 cKO mice lines to conditionally deplete Smc5/6 in central cortex tissues using tissue specific Cre constructs. They verified the reduction of Smc5 and 6 protein levels in E16.5 embryos and to a less degree in E13.5 embryos. The resultant mice exhibited increased apoptosis, mitotic DNA abnormalities, increase of Rad51 levels and oblique division axis in NPCs, and consequently reduced brain weight and cortex size in newborn and adult mice, as well as showed sensorimotor function defects. Deleting Chek2 or p53, but not 53BP1, significantly improved various Smc5 cKO mice defects regarding brain weight, cortex area, and cortical thickness, apoptosis, and DNA fragmentation, suggesting that the DSB-induced DDR mediated by the ATM-Chek2-p53 axis is activated in Smc5 KO mice and responsible for many defects in these cells. p53/Check2 KO did not improve the ectopic localization of apical NPC cells marked by SOX2/PAX6 seen in Smc5 KO mice. Both Smc5 KO and combined KO with p53/Chek2 increases total SOX2/PAX6+ NPC cells, which was interpreted as compensator effects. In contrast to apical NPCs, decrease in several other types of neuron in Smc5 KO mice was rescued by p53/Chek2 KO. How to explain this contrast effect of p53/Chek2 KO in different type of cells should was not clear.</p></disp-quote><p>Firstly, we thank you for your time and effort in reviewing our manuscript. This is a very interesting question for further investigation. We speculate that <italic>Smc5</italic> depletion also causes perturbations in neuronal differentiation associated with increased mitotic defects and apoptosis (subsections “SMC5 loss causes abnormal cortical development” and “SMC5 depletion leads to increased mitotic DNA synthesis”). Neuronal differentiation in <italic>Smc5</italic> cKO is not completely abrogated, but corticogenesis is affected by apoptosis. In case of p53/<italic>Chek2</italic> KO rescue phenotypes, apoptosis is alleviated allowing for production of larger numbers of layer-specific neurons. However, all other affected developmental processes in rescue mice are not restored. This phenomenon might be difficult to investigate using mouse models, but possibly cell culture-based approaches can provide further information.</p><disp-quote content-type="editor-comment"><p>Staining assays suggests that Smc5 KO NPCs tend to accumulate in G1, an effect reversible by Chek2 KO. Image in Figure 4H suggests anaphase bridge with H3P marking ends of the DNA bridges. It is unclear how prominent this phenotype is.</p></disp-quote><p>H3P is always observed incorporated in the chromatin bridges in anaphase cells (see additional images included). However, detecting ultrafine DNA bridges on histological sections is technically challenging. Even a monolayer cell culture requires specific techniques to detect ultrafine DNA bridges successfully (Bizard et al., Genome Instability: Methods and Protocols, 2018). We attempted to perform immunostaining with anti-RAD51, PICH, FANCD2, RPA2 and BLM antibodies, albeit, unsuccessfully. The image shown in Figure 4H is a representative of cortical anaphase cell with very likely broken segments of chromosomes bound by fine DNA bridge, formed by under-replicated DNA, which is not detectable due to the scarce amount of chromatin. We incorporated these additional images in the manuscript to demonstrate the existence of these events. Nevertheless, improved techniques are required to be able to quantify defects such as these in an in vivo setting.</p><p>We included additional anaphase images into Figure 4—figure supplement 1G and the following text into the Results section: “The detection of ultrafine DNA bridges formed by under-replicated DNA on histological sections is technically challenging, and our data require further support. Thus, next we focused on the analysis of chromosome spreads prepared from dissociated E16.5 cortices.”</p><disp-quote content-type="editor-comment"><p>Levels of FACND2 foci, including those co-localizing with pericentrimeric regions, increased about 6 to 8-fold in the chromosome spread of Smc5 KO cells. In addition, level of H4K20me3 at pericentromeric regions increased 2X in Smc5 KO cells.</p><p>The rest of the paper describes studies in mESCs cells by acute Smc5 depletion upon IAA addition. Smc5 depletion retards cell growth, which is reversed by cotreatment by Chek2i or p53i, while later addition of Chek2i had no effect. DNA fiber results suggest that compared to Chek2i (or p53i) treated cells, IAA+Chek2i (or IAA+p53i) treatment reduced ongoing DNA synthesis but appears to increase stalled and converging replication. Experiments should be shown to address whether these effects can be seen upon IAA treatment compared with untreated conditions without Chek2i.</p></disp-quote><p>We performed additional DNA fiber experiments in the absence or presence of IAA alone (without CHEK2 inhibitor). We have included these results in Figure 5H and Figure 5—figure supplement 1H, I and discussed it in the Results section. In brief, we show that DNA fibers from IAA-treated mESCs exhibit increased frequency of converging forks and stalled forks, and reduced incidence of ongoing forks, which is similar to the results with CHEK2 inhibition. IAA-treated mESCs also have slightly shorter DNA fiber track length and increased CldU/IdU length ratio, similar to the results with CHEK2 inhibition.</p><disp-quote content-type="editor-comment"><p>The fact that Chek2i and IAA+ Chek2i treatment are comparable for cell growth but not for replication is puzzling.</p></disp-quote><p>We attribute this to the fact that CHEK2 inactivation may prevent cell death, despite perturbations that would normally induce CHEK2 activation. In other words, cells may bypass apoptosis, but still harbor defects.</p><disp-quote content-type="editor-comment"><p>Additional data are provided to suggest increase MiDAS in +IAA conditions. Taken together, the authors conclude that Smc5/6 helps to complete replication before mitosis and thus is critical in highly proliferative stem cells durning development.</p><p>This work generates the first neuron specific Smc5 KO mice and demonstrates that Smc5 loss leads to multiple brain development defects, which can provide a nice explanation for NSMCE2 human patient microcephaly phenotype. This reviewer feels that the developmental data quality present here is quite high, though an expert in this area should be consulted.</p></disp-quote><p>We received continual critique from Dr. Miho Iijima (Ph.D., Professor in Cell Biology, Johns Hopkins School of Medicine). Dr. Iijima together with Dr. Hiromi Sesaki (Ph.D., Professor in Cell Biology, Johns Hopkins School of Medicine) who specialize in studying neurodevelopment and neurodegenerative disorders. Furthermore, we communicated our research with our collaborators Dr. Mustafa Khokha (M.D., Professor of Pediatric Critical Care Medicine and Genetics, Yale School of Medicine), Dr. Laura Ment (M.D., Professor of Pediatrics Neurology) for additional feedback prior to submission.</p><disp-quote content-type="editor-comment"><p>Another important conclusion of the paper is that many NPC defects associated with Smc5 KO are caused by Chek2/p53 DDR mediated cell death. Phenotype of SMC5 KO mESC cells are largely expected from similar studies and can provide an explanation for Smc5 NPC KO mice phenotype. In particular, this work shows that Smc5 KO in mESCs and in mice can respond differently to p53/check2 loss than in cancer cell lines as recently reported by Vegengas et al., 2020. With this said, interpretations of mESC data here needs to be more carefully vetted, as most data are not causative. For example, increased levels of MiDAS may not necessarily be caused by S phase defects. Could Smc5 depletion in mitosis or G2 phase be sufficient to cause increased MiDAS?</p></disp-quote><p>We have edited the manuscript text to ensure we remove claims that may be construed that the phenotype observed in SMC5-depleted mESCs is specifically due to defects acquired in S phase.</p><disp-quote content-type="editor-comment"><p>Also, it is unclear whether increased Rad51 levels is one of the causes for replication defects seen in Smc5 KO cells.</p></disp-quote><p>We have not assessed the role of RAD51 in promoting or counteracting replication stress in <italic>Smc5</italic> cKO cells. However, RAD51 can mediate the formation of toxic recombination intermediates, and deletion of <italic>RAD51</italic> has been shown to rescue lethality in fission and budding yeast with <italic>SMC6</italic> mutations (Lehmann et al., 1995; Menolfi et al., 2015). We previously showed that RAD51 foci are increased in <italic>Smc5</italic> cKO MEFs following hydroxyurea treatment (Gaddipati, Pryzhkova, and Jordan, 2019). We have referenced these investigations in our Discussion and promote it as a promising avenue for further investigation.</p><disp-quote content-type="editor-comment"><p>Does p53 or chek2 KO rescue the increased Rad51 levels of Smc5 KO mice?</p></disp-quote><p>This is a question we agree warrants further investigation. However, it will require additional mice breeding and collection of embryos from multiple litters, as double KO mice only constitute a small proportion of embryos harvested. Under current COVID-19 restrictions it is very time-consuming task and would require at least half a year to answer this question. We will definitely be pursuing this line of questioning in the future and we reference this within our Discussion.</p><disp-quote content-type="editor-comment"><p>What types of events initially trigger the p53/chek2 signaling pathway in Smc5/6 KO cells, are these replication-born DSBs? Standard analysis to directly measure p53/Chek2 activation can help to pinpoint when cells evoke this pathway, thus help to formulate a model to tie various defects reported here.</p></disp-quote><p>First, we used western blot analysis to assess the acetylation and phosphorylation of p53 in mESCs at various timepoints of IAA treatment (Figure 5C, D). These experiments showed that acetyl-p53 and phospho-p53 are upregulated after 2 hours and 48 hours of auxin treatment, respectively. These data are added to Figure 5C, D and discussed in the Results section.</p><p>We also attempted to assess <italic>Chek2</italic> phosphorylation using two different phospho-<italic>Chek2</italic> antibodies (Abnova PAB25281, Cell Signalling #2661). However, we were unable to obtain conclusive results due to non-specificity and non-reactivity of these antibodies in mESCs. However, we clearly show that both, genetic ablation of <italic>Chek2</italic> in <italic>Smc5</italic> cKO mice and inhibition of CHEK2 in SMC-AID depleted mESCs, rescues the phenotypes mediated by SMC5/6 depletion. Thus, we feel that we have provided sufficient evidence that the p53-CHEK2 pathway is a primary response axis following SMC5/6 failure.</p><p>Using immunofluorescence analysis, we also assessed the cell cycle distribution of phospho-p53+ mESCs using proliferative cell markers Ki67 and H3P. Ki67 staining demonstrated that close to 100% of cells were proliferative. Based on a prior publication (Mallm and Rippe, 2015) we used H3P expression to define G1 (H3P-), S/G2 and mitotic stages (H3P+) of cell cycle in mESCs and quantified the distribution of phospho-p53 positive cells. Details are provided in the Results section. We observed a global increase in the percentage of phospho-p53+ cells in both H3P+ and H3P- populations after 48 hours of IAA treatment. The abundance of phospho-p53+ cells in prophase and G1 populations compared to S/G2 cells suggests that p53 (S389) phosphorylation is most likely to occur in prophase or G1 phases upon SMC5 depletion. Specifically, 38.2% of G1 phase cells, 26.2% of S/G2 phase cells and 40.8% of prophase cells were positive for p-p53 in the IAA-treated group compared to 11.9%, 11.8% and 7.0% in control, respectively. We also observed a 2.1-fold increase in the percentage of total prophase cells, a 1.5-fold decrease in the percentage of total S/G2 phase cells and a 1.5-fold increase in the percentage of total G1 phase cells in the IAA-treated group compared to control. These data are shown in Figure 5—figure supplement 1D-F and discussed in the Results section.</p><p>We also attempted to assess acetyl-p53 immunostaining in mESCs. Unfortunately, we did not see a discernible difference of acetyl-p53 intensity between control and treated mESCs due to a high degree of background staining. Also, we were unable to assess activation of CHEK2 in mESCs due to non-specificity and non-reactivity of the phospho-CHEK2 antibodies we tested (please see above).</p><p>Additionally, to validate the reactivity of phospho-CHEK2, phospho-p53 and acetyl-p53 antibodies used for mESC analyses and complement our data, we performed immunofluorescence assessments of mouse E16.5 cortical sections. We found that acetyl-p53 was upregulated in the progenitor zone of <italic>Smc5</italic> cKO cortical sections compared to control. We have added these data to Figure 2—figure supplement 1B and discussed it in the Results section. We did not observe any immunostaining with either the phospho-CHEK2 antibody or phospho-p53 antibody in <italic>Smc5</italic> cKO and control cortical sections due to non-reactivity with this form of immunohistology preparation (with and without antigen retrieval).</p><p>In summary, we show that we show the upregulation of acetyl-p53 in <italic>Smc5</italic> cKO cortices and of acetyl-p53 and phospho-p53 in SMC5-depleted mESCs. We demonstrate that acetylation of p53 is an early response to SMC5 depletion in mESCs. In addition, we show that p53 (S389) phosphorylation occurs significantly later than p53 acetylation and is most frequently present in prophase and G1 phase cells. This suggests that aberrancies caused by SMC5 depletion (for example, late replication defects during G2) lead to a DNA damage response during prophase and potentially, the inheritance of DNA damage by G1 daughter cells.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>This article from the Jordan laboratory describes an extensive set of analyses on a new mouse model where the Smc5 gene was conditionally inactivated. These analyses were complemented by studies on Smc5 degron cells. There have been several previous reports of the effects of impairing Smc5/6 functions in mouse or human cells, but the current study extends those analysis by focusing on effects in vivo and, more specifically, in the developing neocortex. Overall, I really liked the article and the clear manner in which the analyses were described. I think that it will be an important addition to the many times confusing array of studies on Smc5/6 function. There were, however, some concerns with the cellular analyses in particular.</p><p>1) In several places it is discussed that pericentromeric heterochromatin is a common fragile site. My understanding is that, at least in human cells, this heterochromatic region very rarely, if at all, shows gaps or breaks on mitotic chromosomes. Further, the marker of fragile sites used here, FANCD2, also does not generally localize to pericentromeric regions. I found the discussion around this point quite contrived as if it was intended to link the fact that Smc5/6 localizes to pericentromeric regions with some well recognized manifestation of replication stress like fragility (and MiDAS that they used) when there isn't such a clear association. The authors cite Bhowmick et al. as the reference for EdU foci (MiDAS) and FANCD2 being at centromeric heterochromatin (subsection “SMC5/6 is critical for completion of DNA replication”), but I could find no reference to pericentromeric regions in that paper.</p></disp-quote><p>We have edited text according to the reviewer’s comments and included additional references.</p><p>Abstract: “Further assessment using <italic>Smc5</italic> cKO and auxin-inducible degron systems demonstrated that absence of SMC5/6 leads to DNA replication stress at late-replicating regions such as pericentromeric heterochromatin regions.”</p><p>Results section: “Furthermore, late-replicating regions, such as pericentromeric heterochromatin, are additional sites prone to DNA replication stress (Mendez-Bermudez et al., 2018; Saksouk et al., 2015).”</p><p>Results section: “MiDAS often occurs at common fragile sites, AT-rich DNA sequences that are particularly prone to replication stress and subsequent breakage during mitosis, as well as at late-replicating heterochromatin regions (Fungtammasan et al., 2012; Glover et al., 2005; Mendez-Bermudez et al., 2018; Özer and Hickson, 2018; Saksouk et al., 2015).”</p><disp-quote content-type="editor-comment"><p>2) Related to 1) it would be important to show that real gaps/breaks and MiDAS foci co-localize with at centromeric heterochromatin regions – and that they are distinct from the telomeres that are adjacent in mouse chromosomes. Telomeres are hotspots for fragility and MiDAS. On a related note, the red and pink staining in Figure 6 is really hard to distinguish – couldn't the authors pseudo-color the foci differently?</p></disp-quote><p>We have changed FANCD2 foci color into red and centromeres into green in Figure 6B to achieve better color contrast between centromere and EdU signals.</p><disp-quote content-type="editor-comment"><p>It is important to see where the telomere is on the acrocentric chromosome end. The impression I get is that many of the FANCD2 and EdU foci are at telomeres. These images do not look very crisp either and the resolution could be improved by collecting better confocal images I would suggest.</p></disp-quote><p>We include better quality images. We recognize the possibility that on acrocentric chromosomes the foci in proximity to the centromeric signal could be telomeric. We have clarified this in the Results section. In addition, we have quantified the ratio of “acrocentric” EdU foci (that is, foci present on the end of the chromosome containing the centromeres) to “non-acrocentric” EdU foci (foci present on the opposite chromosomal end). This ratio was 1.47 and 1.91 in control and IAA-treated mESCs, respectively. These data have been included in Figure 6—figure supplement 1C and detailed in the Results section. If MiDAS foci occurred solely within the telomeric DNA, they should logically have equal likelihood of occurring at either telomeric end. Thus, the enrichment of acrocentric compared to non-acrocentric foci suggests that features unique to the pericentromeric DNA may confer increased MiDAS susceptibility.</p><disp-quote content-type="editor-comment"><p>3) Related to 2), what is the percentage of EdU foci in mitosis that co-localize with FANCD2? Unlike what has been shown in previous studies on human cancer cell lines, many of the EdU foci shown here don't seem to co-localize with FANCD2. This should be quantified and discussed in the context of the current literature.</p></disp-quote><p>We have quantified the percentage of EdU foci that do not co-localize with FANCD2, which is 59.4% and 56.2% for control and IAA-treated cells, respectively. We also found that 81.3% and 64.5% of FANCD2 foci were EdU- in control and IAA-treated cells, respectively (Figure 6—figure supplement 1B). Thus, FANCD2 foci are less frequently found outside of MiDAS foci upon SMC5 depletion, consistent with the increased number of EdU+FANCD2+ foci seen in IAA-treated cells (Figure 6D). These data have been included in Figure 6—figure supplement 1A, B and discussed in the Results section.</p><disp-quote content-type="editor-comment"><p>4) The fiber analyses should be repeated with a new control where CHEK2 inhibition is not employed in all of the samples, including the so-called negative control. As things stand, it is hard to compare the current analysis with previous analyses done with controls lacking any added compounds.</p></disp-quote><p>We performed additional DNA fiber experiments in the absence or presence of IAA alone (i.e. without CHEK2 inhibitor). We have included these results in Figure 5H and Figure 5—figure supplement 1H, I and discussed it in the Results section. In brief, we show that DNA fibers from IAA-treated mESCs exhibit increased frequency of converging forks and stalled forks, and reduced incidence of ongoing forks, which is similar to the results with CHEK2 inhibition. IAA-treated mESCs also have slightly shorter DNA fiber track length and increased CldU/IdU length ratio, similar to the results with CHEK2 inhibition.</p></body></sub-article></article>